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Multiple sclerosis (MS), the most common neurological disease among young 
adults, has an unpredictable course characterized by disparate motor, sensory, and 
cognitive symptoms. Over half of those with MS experience significant cognitive 
impairment that adversely impacts role functioning and employment. Since few treatment 
options exist, research relating physical activity to better cognitive performance in older 
adults provided support for a comparable linkage between greater physical activity and 
better cognitive functioning in persons with MS. 
The purpose of this study was to determine the feasibility and effects of a physical 
activity program on measures of clinical cognitive function, perceived cognitive abilities 
and concerns, and neurocognitive function in everyday life in ambulatory adults with MS 
experiencing cognitive problems. This quasi-experimental study investigated the effects 
of a six-month long program of combined aerobic exercise and strength training that met 
twice weekly for 60-minutes to an attention-control condition of stretching and relaxation 
that similarly met twice-a-week for 60 minutes for six months. The sample (N=16) of 
persons with MS consisted of mostly married, White, non-Hispanic females aged 31 to 
58 with average disease duration of 11.5+8.3 years and average EDSS score of 4.5+1.1.  
 viii 
This dissertation study provided initial evidence of the feasibility of a nurse-led 
community-based physical activity intervention. While no statistically significant 
interactions, between or within-group effects were found in this small sample size study, 
effect sizes were observed that might be used in future studies examining the effect of 
physical activity on cognitive function in persons with MS.    
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Chapter 1: Introduction 
Over 400,000 Americans and 2.3 million persons worldwide are diagnosed with 
multiple sclerosis (MS), the most common neurological disease of adults 20 to 50 years 
old (NMSS, 2013; MSIF, 2013). This chronic disabling disease of the central nervous 
system is characterized by cells of the immune system crossing the blood-brain barrier 
resulting in inflammation and scaring of the myelin sheath, axonal loss, and gray matter 
atrophy (Trapp et al., 1998). MS has an unpredictable course with disparate motor, 
sensory, and cognitive symptoms unique to each individual with the disease. Over time, 
MS leads to limitations in physical and cognitive functioning and varying levels of 
disability in the majority of individuals. 
Significant cognitive impairment is experienced by 43% to 70% of individuals 
diagnosed with MS (Langdon, 2011). Cognitive impairment in MS varies considerably 
among individuals and may present in the early stages of the disease; yet is not associated 
with disease duration and is reported as being more severe in progressive forms of MS 
(Beatty, Goodkin, Hertsgaard, & Monson, 1990; Chiaravalloti & DeLuca, 2008; Lynch, 
Parmenter, & Denney, 2005). Impairments in cognition commonly result in deficits of 
everyday life functions such as driving, managing complex medication regimes, and 
handling household responsibilities (Schultheis, Garay, & DeLuca, 2001; Kalmar, 
Gaudino, Moore, Halper, & DeLuca, 2008). While these day-to-day activities are critical 
to maintaining independence, arguably the most devastating consequence of cognitive 
impairment in MS is unemployment (Rao, Leo, Bernardin, & Unverzagt, 1991). 
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Cognitive impairment in MS is regularly under diagnosed and poorly managed 
leaving patients with few therapeutic options (Benedict & Zivadinov, 2011; Chiaravalloti 
& DeLuca, 2008). Research investigating pharmacologic therapies for cognitive 
impairment in MS has been disappointing (Krupp et al., 2011) and there are no approved 
medical therapies to treat cognitive symptoms in MS at this time. While disease-
modifying treatments for MS have demonstrated efficacy among several medical 
outcomes (e.g. annualized relapse rate, MRI progression), scant evidence exists to 
support any positive effects among cognitive outcomes (Amato et al., 2013; Benedict & 
Zivadinov, 2011). Cognitive rehabilitation research has been mixed (O’Brien, 
Chiaravalloti, Goverover, & DeLuca, 2008), with computer-assisted cognitive 
rehabilitation programs showing promise (Mattioli, Stampatori, Zanotti, Parrinello, & 
Capra, 2010; Shatil, Metzer, Horvitz, & Miller, 2010; Stuifbergen et al., 2012). Recent 
research building on the science relating physical activity to better cognitive performance 
in healthy and cognitively impaired older adults supports a relationship between greater 
physical activity and better cognitive functioning in persons with MS (Heyn, Abreu, & 
Ottenbacher, 2004; Kramer, Erickson, & Colcombe, 2006; Motl, Gappmaier, Nelson, & 
Benedict, 2011). This preliminary data suggests the intriguing possibility that improving 
physical activity in persons with MS, traditionally promoted for its impact on mobility 
and physical symptoms, might also have important impact on improving cognitive 
functioning (Motl, Sandroff, & Benedict, 2011). 
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PURPOSE 
The purpose of this study was to determine the feasibility and effects of a physical 
activity program on measures of clinical cognitive function and neurocognitive function 
in everyday life in ambulatory persons with MS experiencing cognitive problems. The 
study builds on existing research suggesting that increases in physical activity may have 
positive effects on disease activity, functional status, mental and physical health 
(Stuifbergen, Becker, Blozis, Timmerman, & Kullberg, 2003; Motl, Gappmaier, et al., 
2011). The study compared the effects of the Physically Active Lifestyle in MS 
(PALMS) intervention [a 6-month program of supervised strength and aerobic training 
two times a week for 60 minutes conducted in supervised small groups (4-5 persons) plus 
direction to be physically active at home for 30 minutes daily, 3+ days per week] to an 
attention-control group. The attention-control group program involved twice weekly 60-
minute sessions of group relaxation and stretching classes lead by a trained facilitator for 
6-months. The specific aims of this exploratory study are to: 
Aim #1. Determine the feasibility of delivering a small group moderate-intensity 
exercise program for persons with MS over a 6-month time period. 
Aim #2. Explore the effects of the Physically Active Lifestyle in MS (PALMS) 
intervention on the primary outcomes of clinical cognitive function (battery of 
neuropsychological tests), self-reported cognitive abilities and concerns, and 
neurocognitive function in everyday life (revised Everyday Problems Test, EPT-R) and 
the secondary outcomes of exercise self-efficacy, physical activity, depressive symptoms, 
and fatigue. 
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BACKGROUND AND SIGNIFICANCE 
Persons with multiple sclerosis (MS) affected by cognitive impairment experience 
significant reductions in productivity and participation in family and society defined roles 
(e.g., breadwinner, caregiver). Cognitive impairment in persons with MS is common and 
debilitating, yet a void of treatment options exists for those who are affected. Persons 
with cognitive impairments in MS commonly experience deficits in processing speed, 
visual learning and memory; deficiencies in attention, information processing efficiency, 
executive functioning (processing, planning, inhibition, prioritizing), and long-term 
memory are also reported (Chiaravalloti & DeLuca, 2008). Cognitive impairment in MS 
has been linked to dysfunction in daily activities, increased demands for assistive care, 
and loss of independence (Kalmar et al., 2008). Research investigating interventions to 
improve cognitive function in persons with MS is expanding but there are currently no 
evidence-based or federally approved protocols to manage the devastating cognitive 
symptoms associated with MS (Amato, Zipoli, & Portaccio, 2006; O’Brien et al., 2008). 
Based on research findings in the field of gerontology, increased physical activity 
has potential in managing and/or minimizing cognitive impairment in persons with MS 
(Motl, Sandroff, et al., 2011). Physical activity has been positively related with improved 
cognition in aging adults, persons with schizophrenia and stroke (Colcombe & Kramer, 
2003; Kluding, Tseng, & Billinger, 2011; Knöchel et al., 2012). In addition, a review of 
the literature on exercise and brain health suggested that physical activity may promote 
brain health through changes in neuroreactive proteins, immune factors, and stress 
hormones, which reduce long-term disability through neuroprotection, neuroplasticity, 
 5 
and neuroregeneration (White & Castellano, 2008a, 2008b). Therefore, physical activity 
is an attractive modifiable behavioral correlate for improving cognitive functioning in 
persons with MS. 
Research has shown that persons with MS are significantly less physically active 
than non-diseased populations (Motl, McAuley, & Snook, 2005). Until recently, physical 
activity was believed to increase MS progression and patients were instructed to rest 
(Döring, Pfueller, Paul, & Dörr, 2012; Vollmer et al., 2012). A cyclic pattern of increased 
inactivity, depression, and fatigue resulted in further deconditioning and disablement 
(MacAllister & Krupp, 2005). This presumed association between physical activity and 
increased fatigue, depression and MS exacerbation has not been supported by the 
literature (Pilutti, Platta, Motl, & Latimer-Cheung, 2014; Rietberg, van Wegen, 
Uitdehaag, & Kwakkel, 2011; Tallner et al., 2012). In fact, a substantial body of research 
exists supporting the positive effects physical activity has on persons with MS including 
improvements in mood, muscle function, and mobility (Rietberg et al., 2011; White & 
Dressendorfer, 2004). However, current research lacks high quality randomized 
controlled trials on the effects of physical activity on cognition in this same population. 
CONCEPTUAL FRAMEWORK 
This study and the PALMS intervention it tested are based on Alfred Bandura’s 
self-efficacy theory (1997) and social cognitive theory (1986). Social cognitive theory 
proposes that learning occurs within a social framework and that dynamic reciprocal 
relationships exist between personal factors, environmental events and behavior. The 
influence of any factor in the model on the others is situational: personal factors 
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(cognitions, beliefs and affect) impact behavior and the environment; behavior affects 
personal factors and environment; and environmental events influence behavior, 
thoughts, beliefs and affect in unceasing reciprocal fashion. Humans learn from and adapt 
to their environment. Social cognitive theory conceptualizes behavior adaptation and 
modification as a learning process. “Behavior can be changed though new learning 
experiences, guidance in the adjustment of perceptions, and support for the development 
of capacities” (Glanz, Rimer, & Viswanath, 2008, p. 176). 
Social cognitive theory is based on the concept of human agency, the uniquely 
human capacity to exercise influence over one’s behavior through acts intended to 
produce desired effects. Human agency and the inherent freedom to make behavior 
choices operate within a diverse social milieu grounded in social systems, norms and 
rules. In addition to human agency, social cognitive theory is grounded on the distinctly 
human capacities to cogitate and communicate symbolically, use forethought to imagine 
and contemplate future scenarios, learn vicariously by observing others (models), self-
regulate their behavior, and self-reflect on thoughts and beliefs. These capabilities 
coalesce to shape an individual’s judgment of their personal capability to successfully 
enact specific behaviors - self-efficacy. 
Bandura (2004) proposes that self-efficacy judgments function jointly with 
outcome expectations, goals, and sociostructural factors (perceived barriers and 
facilitators) in regulating human behavior. Self-efficacy has been cited as the most 
significant predictor of human behavior (McAuley & Elavsky, 2008; Pender, Murdaugh, 
& Parsons, 2011). Self-efficacy is not a static phenomenon that one has or does not have; 
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even possessing the skills necessary for a particular behavior does not ensure sufficient 
confidence to initiate behavior (Bandura, 1997). “Perceived self-efficacy is not a measure 
of the skills one has but a belief about what one can do under different sets of conditions 
with whatever skills one possesses” (Bandura, 1997, p. 37). Greater self-efficacy 
empowers individuals to initiate more challenging behaviors, expend greater effort and 
persevere despite aversive conditions (Bandura, 1997). Low self-efficacy undermines 
effort, lessens judgment of capability, and weakens persistence even thwarting attempts 
of new behavior. 
Social cognitive theory identifies four distinct sources of information to develop 
and foster self-efficacy skills: enactive mastery experiences, vicarious experiences, verbal 
persuasion and emotional/physiological states (Bandura, 1986). Mastery experiences and 
prior history of successful behavior are the most potent of the four sources (McAuley & 
Elavsky, 2008). Mastery experiences that promote self-efficacy strength and 
generalizability are nuanced. If successes were too easily gained, small failures may 
undermine existing self-efficacy beliefs. Development of greater self-efficacy is built 
upon small incremental successes. Mastering these behaviors fosters persistence in the 
face of difficulty and perseverance to overcome barriers. Vicarious experiences offer 
learning opportunities from observing others model behavior. Greater similarity between 
the personal characteristics of the model and the observer inspires greater confidence 
(McAuley & Elavsky, 2008). Thus, a model with MS-related fatigue who is able to 
overcome challenging barriers (e.g., fatigue, heat, self-doubt) to walk for 15 minutes a 
day instills greater efficacy beliefs in an observer with MS than would a healthy young 
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fitness trainer modeling the exact same behavior. Verbal persuasions from credible and 
well-informed sources (e.g., personal trainer, coach) can engender greater effort and 
perseverance (Bandura, 1997). Persuasion must be genuine and emanate from trustworthy 
sources to increase self-efficacy. Physical and emotional state can affect self-efficacy 
positively or negatively. Depression, anxiety, lack of rest, and hunger can be deleterious 
to self-efficacy beliefs. Persons with MS may have difficulty discriminating between 
fatigue related to physically activity and fatigue related to their MS. Somatic symptoms 
such as sweating and breathing heavily, indicators of exercise intensity, may be 
interpreted negatively as harbingers of “overdoing it” (McAuley & Elavsky, 2008). 
The focus of the present study, physical activity, is a specific type of health 
promoting behavior. Physical activity behaviors are influenced by the individual’s 
capability to learn and perform the new behavior, modeling of behavior (especially by 
like individuals), positive and negative reinforcement, outcome expectations, and self-
efficacy. Physical activity behavior is strongly influenced by self-efficacy – the belief in 
one’s ability to successfully engage in the target behavior. Self-efficacy has been 
described as a pivotal factor in facilitating physical activity behavior in persons with MS 
(McAuley et al., 2007; Motl, McAuley, Doerksen, Hu, & Morris, 2009). The PALMS 
intervention, using social cognitive theory determinants and structural pathways, 
proposes to foster exercise self-efficacy and boost physical activity behavior through 
modeling of appropriate exercise behavior, increased social support, positive verbal 
persuasion (coaching) and management of emotional and physiological state. It is then 
hypothesized that increased physical activity behavior will positively affect cognitive 
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function, and reduce depressive symptoms and fatigue. The conceptual model used for 
the current study is illustrated in Figure 1. 
 
 
Figure 1.  PALMS Theoretical Model 
 
 
 
 
 
      
 
SUMMARY 
Research guided by social cognitive theory and its determinants provided a 
comprehensive and well-supported conceptual framework for exploring the effects of 
physical activity on cognitive function in persons with MS. Social cognitive theory has 
been broadly applied in empirical studies of health-promotion and physical activity 
behavior among diverse populations including: physical activity and function in older 
adults (McAuley et al., 2012), physical activity in middle and older adults (White, 
Wójcicki, & McAuley, 2012) exercise in older women (Conn, Burks, Pomeroy, Ulbrich, 
& Cochran, 2003), and physical activity in older adults at risk for Alzheimer disease 
(Lautenschleger et al., 2008). A recently published review stated, “the most widely used 
PALMS 
Intervention 
Exercise  
Self-Efficacy 
Fatigue 
Physical 
Activity Cognitive Function 
Depressive Symptoms 
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theory for physical activity and MS is social cognitive theory and its constructs” (Dixon-
Ibarra, Vanderbom, Dugala, & Driver, 2014, p. 153). Intervention studies aimed at 
improving cognitive function in persons with MS by increasing physical activity behavior 
are rare. Social cognitive theory was selected as the theoretical framework for the current 
study based upon its application to the design of intervention studies exploring health 
promotion and physical activity in persons with MS (Stuifbergen et al., 2003; Dlugonski, 
Motl, & McAuley, 2011). In this intervention study, determinants derived from social 
cognitive theory were used to explore the feasibility and to determine the effects of the 
PALMS intervention on cognitive function outcomes, depressive symptoms, and fatigue. 
RESEARCH QUESTIONS AND HYPOTHESES 
The specific research questions addressed in this non-randomized controlled trial 
were: 
RQ 1. 
What is the feasibility of delivering a small group moderate-intensity exercise 
program for persons with MS over a 6-month time period? 
RQ 1.1. 
What is the pattern of response to and enrollment in the study? 
RQ 1.2. 
What is the attendance pattern across the 6-months for the intervention and 
attention-control groups? 
RQ 1.3. 
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What is the frequency, duration, and mode of physical activity documented in the 
PALMS physical activity log? 
RQ 1.4.  
How do the participants respond to the PALMS intervention (heart rate, ratings of 
perceived exertion, physical and mental fatigue, general wellbeing, and enjoyment)?  
RQ 2. 
What are the effects of the Physically Active Lifestyle in MS (PALMS) 
intervention? 
RQ 2.1. 
What are the within-group, between-groups, and group-by-time interaction effects 
on the primary outcomes of clinical cognitive function (California Verbal Learning Test 
[CVLT], Brief Visuospatial Memory Test [BVMT], Controlled Oral Word Association 
Test [COWAT], NIH Toolbox Flanker Inhibitory Control and Attention Test [Flanker], 
NIH Toolbox Oral Symbol Digit Test [OSD]), self-reported cognitive abilities and 
concerns (Patient-Reported Outcomes Measurement Information System [PROMIS] v1.0 
Cognitive Abilities and Cognitive Concerns Scales), and neurocognitive function in 
everyday life (revised Everyday Problems Test [EPT-R]) (Benedict, 1997; Benton, Sivan, 
Hamsher, Varney, & Spreen, 1994; Cella et al., 2007; Delis, Kaplan, & Kramer, 2000; 
Weintraub et al., 2013; Willis, Jay, Diehl, & Marsiske, 1992)? 
RQ 2.2.  
What are the within-group, between-groups, and group-by-time interaction effects 
on the secondary outcomes of exercise self-efficacy [ExSE], physical activity [GLTEQ 
and accelerometer counts: sedentary, light, moderate-to-vigorous physical activity, and 
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steps], depressive symptoms [CES-D], and fatigue [MFIS] (Fisk, Pontefract, Ritvo, 
Archibald, & Murray, 1994; Godin & Shepard, 1985; McAuley, 1993; Pearson, Busse, 
van Deursen, & Wiles 2004; Radloff, 1977)? 
Hypothesis 2.1. 
Primary outcome measures (clinical cognitive function, self-reported cognitive 
abilities and concerns, and neurocognitive function in everyday life) will be significantly 
improved at 3 and 6-months over baseline in the intervention group compared to the 
attention-control group. 
Hypothesis 2.2. 
Secondary outcome measures (exercise self-efficacy, physical activity, depressive 
symptoms, and fatigue) will be significantly improved at 3 and 6-months over baseline in 
the intervention group compared to the attention-control group. 
DEFINITION OF TERMS 
The following definitions were used for this study. 
1. Cognitive Function 
Conceptual definition. Cognitive functions encompass the human mental activities of 
thinking, learning, and memory (Pugh et al., 2006). Domains of cognition commonly 
affected in persons with MS include: sustained and complex attention, concentration, 
working and secondary memory, information processing speed, visiospatial skills, verbal 
fluency, and executive function – planning, organization, judgment, reasoning, problem 
solving (Amato et al., 2013; Bobholz & Rao, 2003; Chiaravalloti & DeLuca, 2008; 
LaRocca, 2000). 
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Operational definition. Scores on tests of clinical cognitive function - California Verbal 
Learning Test [CVLT], Brief Visuospatial Memory Test [BVMT], Controlled Oral Word 
Association Test [COWAT], Flanker Inhibitory Control and Attention Test [Flanker], 
Oral Symbol Digit Test [OSD], self-reported cognitive abilities and concerns [PROMIS 
v1.0 Cognitive Abilities and Cognitive Concerns Scales], and neurocognitive function in 
everyday life - revised Everyday Problems Test [EPT-R] (Benedict, 1997; Benton et al., 
1994; Cella et al., 2007; Delis et al., 2000; Weintraub et al., 2013; Willis et al., 1992). 
2. Depressive Symptoms 
Conceptual definition. Depressive symptoms are the major indicators commonly 
associated with the mental health disorder depression, which include unhappy feelings 
and/or perceptions, changes in sleeping behavior and somatic complaints (Kroenke, 2003; 
Radloff, 1977). 
Operational definition. Self-report scores on the 20-item Center for Epidemiologic 
Studies Depression Scale-Revised (CES-D) (Radloff, 1977). 
3. Exercise 
Conceptual definition. Exercise is a subcategory of physical activity that is planned, 
repetitive, structured, and goal oriented (Caspersen, Powell, & Christenson, 1985). 
Operational definition. PALMS intervention dose - measured by the number of sessions 
attended, rating of perceived exertion and heart rate recorded via chest-strap at ten-
minute intervals throughout the 60-minute session. 
4. Exercise Self-Efficacy 
Conceptual definition. Exercise Self-Efficacy is a person’s perceived capability to 
successfully engage in moderate intensity exercise behavior for 20 minutes or more three 
times a week for the subsequent one to six months (McAuley, 1993). 
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Operational definition. Self-report scores on the six-item Exercise Self-Efficacy scale 
(McAuley, 1993). 
5. Fatigue 
Conceptual definition. Fatigue is the subjective, multidimensional perception of the 
absence of physical, cognitive and/or psychosocial energy (MS Council for Clinical 
Practice, 1998; Rietberg, van Wegen, & Kwakkel, 2010). 
Operational definition. 
Self-reported scores on the 21-item Modified Fatigue Impact Scale (MFIS) that reports 
summated total score, as well as physical, cognitive and psychosocial subscale scores 
(Fisk, Pontefract, et al., 1994). 
6. Physical Activity 
Conceptual definition. Physical activity is the voluntary movement of skeletal muscles, 
which results in energy expenditure (Caspersen et al., 1985). 
Operational definition. Physical activity will be estimated using two measures: 1) self-
report scores on the two-item Godin Leisure Time Questionnaire (GLTQ) and 2) mean 
daily activity counts (sedentary, light, moderate-to vigorous) and step counts downloaded 
from waist-worn accelerometers (ActiGraph™, 2016; Godin & Shepard, 1985). 
ASSUMPTIONS 
Assumptions of the present study include: 
1. Participants have an accurate diagnosis of MS. 
2. Persons with MS want to increase their physical activity level. 
3. Improvements in or maintenance of cognitive function (neuroplasticity) is feasible in 
persons with MS. 
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4. Social cognitive determinants (self-efficacy, outcome expectancy, perceived barriers 
and facilitators) influence engagement in physical activity behavior. 
5. Increased physical activity has the potential to affect cognitive function either directly 
or indirectly through reduced depressive symptoms and/or fatigue. 
6. Participants truthfully and accurately respond to the self-report measures. 
7. Physical activity can be validly and reliably documented in ambulatory persons with 
MS by wearing an accelerometer on the waist. 
LIMITATIONS 
Possible limitations of the current study include: 
1. Results of the study may not be generalized to other persons diagnosed with MS, 
especially for those requiring the use of an assistive device (e.g., walker, scooter, 
wheelchair).  
2. Participants of this study may not accurately reflect other people with MS who may not 
be willing or able to participate in research studies involving a six-month physical 
activity program. 
3. The sample size may not be large enough to detect a statistically significant within-
group or between-groups difference, or a group-by-time interaction effect. 
4. Group assignment in a small sample may not be able to counteract the effect of other 
variables on the outcomes such as differences among participants in baseline cognition, 
physical function, or physical fitness. 
5. Self-report measures are susceptible to response bias. 
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6. Measures of clinical cognitive function (designed as diagnostic tools) may not capture 
or accurately measure change over time. 
7. Accelerometers worn for seven days at baseline, 3-months and 6-months may not 
capture or reflect change in participants’ level of physical activity. 
SUMMARY 
This chapter discussed the background and significance of cognitive impairment 
in persons diagnosed with MS. The primary purpose of this study was to determine the 
feasibility and effects of a physical activity program on: 1) primary outcome measures of 
clinical cognitive function, self-reported cognitive abilities and concerns, and 
neurocognitive function in everyday life and: 2) secondary outcome measures of exercise 
self-efficacy, physical activity, depressive symptoms and fatigue in ambulatory persons 
with MS experiencing cognitive problems. Alfred Bandura’s self-efficacy theory (1997) 
and social cognitive theory (1986) were used as the theoretical framework for this quasi-
experimental study. Conceptual and operational definitions of the concepts integral to this 
study were delineated. Findings from this study may provide critical information on the 
feasibility of the PALMS intervention (a 6-month long program of supervised, small 
group strength and aerobic exercise meeting two times a week for 60-minutes) and any 
effects the intervention had on cognitive function, exercise self-efficacy, physical 
activity, depressive symptoms, and fatigue in persons with MS experiencing cognitive 
problems compared to an attention-control condition. 
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Chapter 2: Review of the Literature1 
This chapter presents a review of the literature relevant to physical activity and 
cognition in persons with MS. The review commences with an overview of multiple 
sclerosis focusing on three significant sequelae of the disease: cognitive impairment, 
depression, and fatigue. The critical appraisal of these MS-related symptoms includes the 
number of individuals affected, impact on health, management strategies as well as the 
interrelationships between the symptoms. The chapter continues with a review of 
physical activity as a self-management approach to symptom management in persons 
with MS. The final section of this chapter reviews the effects of physical activity on 
cognition in older adults as the logical basis for conducting similar studies in person with 
MS. While experimental studies investigating the effect of physical activity on cognition 
in persons with MS are few, there is considerable evidence supporting the positive effects 
of physical activity on cognitive function and brain physiology in healthy as well as 
cognitively impaired older adults. 
MULTIPLE SCLEROSIS 
MS is characterized by sporadic bouts of disparate neurologic symptoms 
disseminated over time and space (McDonald et al., 2001). Symptoms are related to an 
autoimmune inflammatory process occurring within the central nervous system, resulting 
in discrete areas of demyelination and destruction of axons in the brain parenchyma 
                                                
1 Morrison, J.D., & Mayer, L. (2016). Physical activity and cognitive function in persons with multiple 
sclerosis: an integrative review. Disability and Rehabilitation. Advance online publication. 
doi:10.1080/09638288.2016.1213900. First author conceptualized and designed the paper, gathered and 
interpreted the data, drafted the manuscript and gave final approval of the submitted version.  
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and/or spinal cord (O’Conner, 2002). Transmission of neural signals is disrupted in the 
areas affected resulting in the great variability of symptoms expressed (O’Conner, 2002). 
The onset of MS symptom expression commonly occurs in young adults between the 
ages of 20 and 40 (Wallin, Page, & Kurtzke, 2000). Women outnumber men with MS 
approximately 2.5:1 (Wallin et al., 2000; McDonald et al., 2001). The specific cause of 
MS has yet to be determined but both environmental and genetic factors are thought to be 
involved (Wallin et al., 2000). Life expectancy is shortened by approximately 5% in 
persons with MS with the progressive accrual of disability resulting in great human and 
economic cost for those affected (Greer & McCombe, 2011; Rao, Leo, Bernardin, & 
Unverzagt, 1991). 
Due to the heterogeneous nature of MS, a standardized classification system was 
developed to facilitate communication of patients’ functional status among clinicians and 
researchers (Lublin & Reingold, 1996). In this system, MS is categorized into four 
different forms based on the course of the disease, symptoms expressed, residual 
functional impairment, and progression of neurological impairment over time (Lublin & 
Reingold, 1996; NMSS, 2014b; Scalfari, Neuhaus, Daumer, Muraro, & Ebers, 2014). 
Relapsing-remitting MS, the initial course in 85% of cases, is characterized by discrete 
episodes of worsening neurologic symptoms followed by a variable return of function 
and periods of stability between exacerbations (Fox & Cohen, 2001). Secondary-
progressive MS follows the relapsing-remitting course when progressive worsening of 
baseline neurologic symptoms occurs with or without further exacerbations – typically 10 
to 15 years after initial MS diagnosis if not treated with disease modifying drugs 
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(Weinshenker et al., 1989). The conversion rate from relapsing-remitting to secondary-
progressive MS of those treated with disease modifying drugs is unclear (Chelune, Stott, 
and Pinkston, 2008). Primary-progressive MS is distinguished by steadily worsening 
neurologic symptoms from the onset and nearly continuous gradual functional 
impairment. Progressive-relapsing MS, the least common form, is characterized by 
progressive neurologic impairment and deterioration from the start with sporadic 
exacerbations and variable recovery of function between acute relapses (Lublin & 
Reingold, 1996; NMSS, 2014b; Scalfari et al., 2014) 
MS-RELATED SYMPTOMS 
MS symptoms, manifestations of neurologic pathology, are widely diverse and 
follow an unpredictable fluctuating course. While motor symptoms such as spasticity and 
foot drop are readily apparent, many symptoms of MS are not visible to others (e.g., 
weakness, dizziness, cognitive and emotional changes) but are instrumental to functional 
status and disability. To systematically evaluate functional status and disability in persons 
with MS, Kurtzke (1983) developed the Expanded Disability Status Scale (EDSS) using a 
framework of eight functional groups: visual, brainstem, pyramidal, cerebellar, sensory, 
bowel and bladder, cerebral, and ambulation. A criticism of the widely used EDSS is that 
the total score is heavily weighted on ambulatory status and fails to reliably capture the 
effect of MS on cognitive and sensory functions (Cohen, Kessler, & Fischer, 1993). 
The cerebral function group consists of depression, decrease in mentation, and 
fatigue. This group of neurologic functions is singled out for their pervasiveness and 
profound influence on functional status, disability and quality of life in persons with MS. 
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COGNITIVE IMPAIRMENT IN PERSONS WITH MS  
Charcot documented distinctive cognitive deficits in persons with MS as long ago 
as 1877, yet research investigating this phenomenon was scarce until the early 1990’s and 
the work of Stephen Rao  (Charcot, 1877; Chelune et al., 2008; Messinis, Kosmidis, 
Lyros & Papathanasopoulos, 2010). Rao reported that significant cognitive impairment 
was experienced by over half of those diagnosed with MS (Rao, Leo, Bernardin, & 
Unverzagt, 1991). The scarcity of literature exploring cognitive impairment in persons 
with MS prior to the early 1990s has been attributed to the subtle onset and slow 
progression of MS-related cognitive impairment, especially when compared to dementia, 
as well as the focus of clinicians and patients being drawn to the more conspicuous 
physical impairments of MS (Chelune et al., 2008; Messinis et al., 2010). Research 
exploring cognitive function in persons with MS was propelled forward by the 
development of specific guidelines in 2001 that included magnetic resonance imaging in 
the diagnostic criteria for MS and approval by the U.S. Food and Drug Administration of 
the first disease modifying drug (interferon beta-1b) in 1993 (McDonald et al., 2001; 
NMSS, 2014a). Together, these advances allowed clinicians a long awaited therapeutic 
option to slow down the frequency of exacerbations, progression of pathology and 
accumulation of disability as well as a powerful non-invasive method to visualize the 
extent and pattern of MS pathology in vivo. 
Cognitive impairment in MS differs substantially from person to person and may 
present at any stage of the disease - even at the onset (Amato et al., 2006; Beatty et al., 
1990). While cognitive impairment is rarely a presenting symptom of MS, it may be 
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present early in the disease when physical function is minimally affected (Chelune et al., 
2008; Haase, Tinnefeld, Lienemann, Ganz, & Faustmann, 2003; Olivares et al., 2005; van 
den Burg, van Zomeren, Minderhoud, Prange, & Meijer, 1987). While Benedict and 
Bobholtz (2007) report that MS-related dementia is rare (perhaps less than 25% of those 
diagnosed), Westervelt (2015) describes a dearth of literature on MS-related dementia, 
which may be due to due to lack of clarity about the meaning of the term “dementia” in 
this population. The impact of impaired cognition function negatively affects the person 
with MS, their family and caregivers alike; commonly straining everyday household 
responsibilities, work status, and social functioning (Schultheis et al., 2001; Kalmar et al., 
2008). Individuals with moderate to severe cognitive impairment may experience 
substantial difficulty with activities of daily living and require assistance with personal 
care (Benedict et al., 2005; Rao, Leo, Ellington, et al., 1991). Perhaps the most 
detrimental of all of the consequences of MS-related cognitive impairment is the loss of 
employment and the harsh economic impact it has on the individual and their family 
(Julian, Vella, Vollmer, Hadjimichael, & Mohr, 2008). 
MS NEUROANATOMY AND PATHOLOGY 
The neuroanatomical changes related to MS pathology and the mechanisms 
underlying cognitive impairment have not yet been fully explained but considerable 
knowledge has been garnered from advances in imagining technology and techniques 
(Guimarães & Sá, 2012). While MS has traditionally been considered a white matter 
disease, gray matter changes have become the focus of research using new quantitative 
imaging techniques such as magnetization transfer imaging, diffusion tensor imaging, and 
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proton magnetic resonance spectroscopy (Messina & Patti, 2014). White matter in the 
brain consists of collections (tracts) of myelin-encased axons, the long cylindrical output 
processes of nerve cells that travel between and within the brain’s hemispheres 
transferring nerve impulses between neurons and connecting cortical and subcortical gray 
matter (Chelune et al., 2008). Gray matter consists of the neuron’s cell body and short 
receiving extensions (dendrites) located in the cerebral cortex (surface) and in deep 
subcortical structures such as the thalamus, hypothalamus, and hippocampus (Chelune et 
al., 2008). 
MS-related cognitive impairment has been associated with white matter lesion 
burden (Chiaravalloti & DeLucca, 2008; Rovaris, Comi, & Filippi, 2006). Stronger 
relationships have been reported between tests of neurocognitive function and different 
measures of brain volume in persons with MS: whole brain, deep gray matter (thalamus), 
cerebral cortex, and corpus callosum (Amato et al., 2004; Benedict, Bruce, et al., 2006; 
Houtchens et al., 2007; Rao et al., 1989; Simon et al., 1999). The hippocampus, a deep 
gray matter structure, has been the target of study in persons with MS due to its 
involvement with memory function (Prakash, Patterson, Janssen, Abduljalil, & Boster, 
2011). In two cross-sectional studies, third ventricular volume was shown to be a 
consistent predictor of neuropsychological function in MS (Benedict, Weinstock-
Guttman, et al., 2004; Benedict, Bruce, et al., 2006). 
MS NEUROIMAGING 
Traditional magnetic resonance imaging (MRI) using T2-weighted and 
Gadolinium enhanced T1-weighted images are used in the diagnostic process, measures 
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of brain volume (atrophy) and lesion burden (Rovaris et al, 2006). Newer MRI 
techniques allow researchers to investigate normal appearing white matter using 
fractional anisotropy (FA), a diffusion tensor imaging parameter that reflects fiber 
integrity and alignment (Filippi et al., 2010, Guimarães & Sá, 2012). Studies have 
correlated tract damage, decreased FA in the corpus callosum, with impaired attention, 
speed of information processing, and working memory in persons with MS (Dineen et al., 
2009, Roosendaal et al., 2009). Proton magnetic resonance spectroscopy allows in vivo 
assessment of key biochemical data from a specific location called a voxel (Kurth & 
Bigler, 2008). Increased choline peaks mark high cell membrane turnover suggestive of 
cell death or rapid cell division and N-acetylaspartate (NAA) levels are associated with 
neuronal and axonal viability (Filippi et al., 2010). Two studies have associated NAA 
with measures of attention and memory in persons with MS (Gadea et al., 2004; Staffen 
et al., 2005). 
MS-RELATED NEUROCOGNITIVE RISK FACTORS 
Several factors have been associated with higher risk of developing cognitive 
impairment in MS including advancing age, male gender, disability status, below average 
intelligence and low educational attainment (Benedict & Zivadinov, 2011; Haase et al., 
2003; Messinis et al., 2010). Cognitive impairment has been associated with disability 
status, low level of education, and disease duration among men but not women in a study 
of 563 patients with MS (Savettieri et al., 2004). Sartori and Edan (2006) reported that 
among 40 patients with MS, age (greater than 40) and low education level (less than 11 
years) were associated with cognitive deficits. Men tend to have earlier onset and a more 
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aggressive course of MS than women and be particularly vulnerable to cognitive 
impairment (Beatty & Aupperle, 2002; Chelune et al., 2008; Greer & McCombe, 2011). 
Cognitive impairment has also been related to disease course such that secondary-
progressive MS is consistently associated with greater risk than the relapsing-remitting or 
primary-progressive MS courses (Amato et al., 2006; Chiaravalloti & DeLuca, 2008; 
Lynch et al., 2005). Perhaps surprisingly, studies do not support more than weak 
associations between MS-related cognitive impairment measured with 
neuropsychological tests and perceived fatigue, length of diagnosis, or depression 
(Arnett, Barwick, & Beeney, 2008; Benedict & Zivadinov, 2011; Morrow, Weinstock-
Guttman, Munschauer, Hojnacki, & Benedict, 2009). Benedict & Zivadinov (2011) 
attribute these paradoxical relationships to the considerable heterogeneity found in MS-
related cognitive impairment. 
NEUROCOGNITIVE DOMAINS AFFECTED IN MS 
Domains of cognition often impaired in persons with MS include: attention, short 
and long-term memory, information processing speed, visiospatial skills, and executive 
function – planning, organization, judgment, reasoning, problem solving (Amato et al., 
2013; Bobholz & Rao, 2003; Chiaravalloti & DeLuca, 2008). Of these, visual learning, 
memory, and processing speed are the most frequently affected cognitive domains in 
persons with MS (Chiaravalloti & DeLuca, 2008). One recent study suggests that not 
only is impaired processing speed the most common cognitive deficit among persons 
with MS, it is often the first deficit to present clinically (Van Schependom et al., 2014). 
Intelligence is reported to remain relatively unimpaired in those with MS but verbal 
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intelligence measured with the Wechsler Adult Intelligence Scale-Revised was 
significantly lower (p < .001) in a sample of persons with MS than normal controls (Rao, 
Leo, Bernardin, & Unverzagt, 1991). 
MS NEUROCOGNITIVE ASSESSMENT 
Cognitive impairment in MS is regularly under diagnosed and poorly managed 
leaving patients with few therapeutic options (Benedict & Zivadinov, 2011; Chiaravalloti 
& DeLuca, 2008). Routine evaluation of cognitive function is advocated to detect deficits 
early on, monitor disease progression and provide documentation for work disability but 
substantial barriers (e.g. cost, time and expertise needed) impede early and routine 
assessment of cognitive function in persons with MS (Amato et al., 2013; Benedict & 
Zivadinov, 2011; Messinis et al., 2010). Regrettably, once cognitive function is impaired 
in persons with MS, improvement has been difficult to achieve despite therapeutic 
intervention (Amato et al., 2006). While the patient’s perception of cognitive deficits is 
integral to clinical assessment, self-report measures of cognitive impairment are apt to 
overstate cognitive impairment in those who are depressed and may go unnoticed in those 
with significant cognitive impairment (Kinsinger, Lattie, & Mohr, 2010). Self-reports of 
cognitive difficulty strongly relate to depressive symptoms (r = 0.61) when compared to 
caregiver-reports (r = 0.37) (Benedict, Cox, et al., 2004). Additionally, fatigue confounds 
perceptions of cognitive impairment in patients with MS; greater fatigue has been linked 
with self-reported cognitive deficits yet there is little association between fatigue and 
neuropsychological measures of cognitive impairment (Kinsinger et al., 2010). 
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Two psychometrically sound neurocognitive batteries are widely used by highly 
trained neuropsychologists to assess cognitive function in MS– the Brief Repeatable 
Battery of Neuropsychological tests (BRBN) and the Minimal Assessment of Cognitive 
Function in MS (MACFIMS) (Benedict et al., 2002; Rao et al., 1990). While the two 
batteries are quite similar and have considerable test overlap, there are also differences. 
The BRBN is older and has been more widely used while the newer MACFIMS assesses 
additional cognitive domains and has alternative forms for three of the seven tests 
(Guimarães & Sá, 2012; Strober et al., 2009). The BRBN consists of five neurocognitive 
tests assessing auditory processing speed, working memory, visual processing speed, 
auditory and spatial episodic memory, and expressive language (Benedict & Zivadinov, 
2011). The seven test MACFIMS assesses spatial processing and executive function in 
addition to the domains included in the BRBN (Benedict et al., 2002). Unfortunately, 
these batteries were not developed to monitor change in cognitive function over time or 
to define change in everyday cognitive function that is crucial to patients, clinicians and 
researchers alike (Becker, Stuifbergen, & Morrison, 2012). 
More recently, a consensus committee comprised of neurologists and 
neuropsychologists with expertise in MS has recommended a three-test cognitive 
monitoring tool - the Brief International Assessment of Cognition for MS [BICAMS] 
(Langdon et al., 2012). The objective of the panel was to recommend a psychometrically 
sound test battery that 1) could be administered by any healthcare professional without 
specific assessment training, 2) be completed in approximately 15 minutes, 3) doesn’t 
require special equipment, and 4) encompassed the cognitive domains of “information 
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processing speed, verbal memory and visual memory…as these three domains would 
capture a reasonable proportion of significant cognitive impairment in large clinical 
settings” (Langdon et al., 2012, p. 893). Tests assessing executive function were not 
included in the battery as the committee considered these types of test “too long and too 
challenging to administer in the target context” (Langdon et al., 2012, p. 893). The three 
tests of the BICAMS are: the Symbol Digit Modalities Test [SDMT] (Smith, 1982), the 
California Verbal Learning Test-II [CVLT-II] (Delis et al., 2000), and The Brief 
Visuospatial Memory Test-Revised [BVMT-R] (Benedict, 1997). 
The BICAMS consensus committee considered two tests to assess information 
processing speed: the Paced Auditory Serial Addition Test [PASAT] (Gronwall, 1977) 
and the Symbol Digit Modalities Test [SDMT] (Smith, 1982; Langdon et al., 2012). The 
two tests have comparable psychometric validity but the Symbol Digit Modalities Test 
[SDMT] (Smith, 1982) is noted for being better tolerated by subjects with weak 
computational skills and less irritating than the Paced Auditory Serial Addition Test 
[PASAT] (Gronwall, 1977) with its demanding response stimuli (Drake et al., 2010). 
Furthermore, the Symbol Digit Modalities Test [SDMT] (Smith, 1982) has been 
advocated as a potential single-test screen for MS-related cognitive impairment 
(Parmenter, Weinstock-Guttman, Garg, Munschauer, & Benedict, 2007). 
TREATMENT OF MS-RELATED COGNITIVE IMPAIRMENT  
Research investigating pharmacological treatments for cognitive impairment in 
MS has been disappointing (Krupp et al., 2011). Pharmacologic agents including 
pemoline, amantadine, ginkgo biloba, and amphetamine have failed to produce consistent 
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improvement in cognitive function in persons with MS (Geisler et al., 1996; Lovera et al., 
2007; Morrow, Kaushik, et al., 2009). Several studies have investigated the effectiveness 
of acetylcholinesterase inhibitors (e.g. donepezil, rivastigmine) – a class of drugs used to 
treat cortical cholinergic deficits in dementias such as Alzheimer’s Disease (Doraiswamy 
& Rao, 2004). Based on encouraging, but modest, results of a 24-week randomized 
clinical trial (n = 69) of daily donepezil dosing (10 mg) on verbal learning and memory, a 
larger (n = 120) multicenter trial was conducted by the same investigator (Krupp et al., 
2004; Krupp et al., 2011). Unfortunately, no statistically significant differences were 
found in verbal memory or self-reported memory change between the intervention and 
placebo-control groups (Krupp et al., 2011). 
The effectiveness of non-pharmacological therapies to treat cognitive impairment 
is equivocal, but patients may derive some benefit from treatment (Messinis et al., 2010). 
Studies investigating the impact of cognitive rehabilitation on attention, memory, and 
communication skills in persons with MS have been mixed (O’Brien et al., 2008). The 
studies have had significant methodological weaknesses including dissimilar cognitive 
outcome measures and small heterogeneous samples making comparisons among studies 
difficult (Mattioli, Stampatori, Bellomi, et al., 2010). Cognitive rehabilitation programs 
focus on two approaches: (1) restorative therapy, direct retraining of specific cognitive 
domains (e.g., attention, memory) which is hypothesized to improve functional abilities 
through the reorganization of intact neural networks (neuroplasticity) and (2) 
compensatory therapy, which assists patients learn and practice strategies designed to 
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work around their cognitive deficits (e.g., using lists, assistive-technology, mnemonics) 
(Messinis et al., 2010, Pierson & Griffith, 2006). 
Computer-assisted cognitive rehabilitation programs show promise in improving 
and maintaining cognitive function in persons with MS (Mattioli, Stampatori, Zanotti, et 
al., 2010; Shatil et al., 2010; Stuifbergen et al., 2012). Mattioli, Stampatori, Zanotti, et al. 
(2010) reported significant (p < 0.05) improvement in attention, information processing 
and executive function after a 3-month long computer-assisted cognitive rehabilitation 
program. Stuifbergen et al. (2012) took a novel approach by developing a small, in-
person group program that combined behavioral and lifestyle adjustments with 
compensatory strategies and practice playing computer games focused on attention, 
memory, problem solving and executive function. The 8-week program had significant (p 
< 0.05) group by time interaction effects on the use of compensatory strategies and verbal 
memory. The program is currently being tested in a multi-site randomized clinical trial 
with a larger sample (n = 180). 
DEPRESSION AND DEPRESSIVE SYMPTOMS IN PERSONS WITH MS  
Nearly one in two persons with MS will develop major depression through the 
course of the disease (Feinstein, 2006). Mood disorders, including major depressive 
disorder, are associated with higher lifetime prevalence in persons with MS (36%-54%) 
than in the general population (16.2%) and most other neurologic conditions (Minden et 
al., 2014). High prevalence rates of depression and depressive symptoms have been 
reported in samples derived from MS specialty clinics as well as community-residing 
samples (Chwastiak et al., 2002). Regrettably, while depression in MS prevalent, it is 
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frequently unrecognized and left untreated (Siegart & Abernethy, 2005). Depressed mood 
in persons with MS has been attributed to multiple factors including pathologic changes 
within the central nervous system as well as grief and loss associated with living with a 
chronic disabling condition (Minden et al., 2014) 
Depression is a mood disturbance diagnosed by clinicians using standardized 
classification systems such as the ICD-10 or DSM-V, while depressive symptoms are 
signs (e.g., low mood, irritability, worry) expressed verbally or through self-report 
questionnaires, scales, or checklists (Minden et al., 2014). Depressive symptoms have 
been associated with poor outcomes similar to those associated with fatigue: reduced 
quality of life, impaired cognition and treatment adherence (Gulick, 1997; D’Alisa et al., 
2006; Mohr et al., 1997). Common confounders of depression in persons with MS 
include: fatigue, sleep disturbance, changes in appetite, and impaired cognition 
(Feinstein, 2011a). Lynch, Kroencke & Denney (2001) reported that emotion-centered 
coping styles, MS-related disability, uncertainty, and hope were independent predictors 
of depression among 188 patients with MS and explained 40% of the variance in self-
reported depression. Major depression and the severity of depressive symptoms have 
been linked with higher morbidity and mortality (suicide) in patients with MS (Feinstein, 
2002). Data suggest that suicide is contemplated by more than one of every four patients 
with MS and that suicide risk factors include “the presence of major depression, social 
isolation and alcohol abuse” (Feinstein, 2002; Feinstein, 2011a, p. 1277). 
Evidence supporting the effectiveness of pharmacologic and cognitive-behavioral 
therapies in the treatment of depression in MS has been equivocal (Minden et al., 2014). 
 31 
The 2011 Cochrane Review by Koch, Glazenborg, Uyttenboogaary, Mostert and De 
Keyser found only two studies (70 subjects) out of 1217 met all inclusion criteria in their 
investigation of the efficacy and tolerability of pharmacologic treatments for depression 
in patients with MS. Data suggested a trend towards efficacy in treating depression in MS 
compared to placebo using either desipramine (a tricyclic antidepressant) for five weeks 
or paroxetine (a selective-serotonin reuptake inhibitor) for 12 weeks. Notable adverse 
effects (nausea and headache with paroxetine, constipation, dry mouth, and hypotension 
with desipramine), wide disparity in the length of the trials (5 versus 12 weeks), as well 
as high number of patients lost to follow-up contributed to the authors’ decision to forgo 
conducting a meta-analysis. Cognitive behavioral therapy (CBT) “is used to treat 
depression by conferring skills to identify and reappraise negative thoughts impacting on 
feelings and behaviors” (Hind et al., 2014, p. 2). Data from a recent meta-analysis 
investigating the effect of CBT for the treatment of depression in persons with MS found 
a medium treatment effect (0.56 SD, SMD -0.61, 95% -0.96 to -0.26, p = 0.0006) at the 
end of treatment for individual, group or computerized cognitive behavioral therapy 
(Hind et al., 2014). 
FATIGUE IN PERSONS WITH MS  
Fatigue related to MS is the most frequently reported and arguably among the 
most disabling symptoms of the disease. The majority of persons with MS experience 
significant fatigue on a daily basis (Fisk, Pontefract, et al., 1994). In a nationally 
representative sample of over 4000 individuals with MS, more respondents cited fatigue 
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(83%) as a current symptom than difficulties with ambulation (67%), spasticity (63%) or 
cognitive problems (56%) (Minden et al., 2006). 
Fatigue is a subjective, multidimensional phenomenon that is challenging to 
define, and is particularly vulnerable to retrospective bias (Bol, Duits, Hupperts, Vlaeyen, 
& Verhey, 2009). Fatigue has been postulated to have primary mechanisms related to MS 
pathology (demyelination and axonal loss) as well as secondary mechanisms attributed to 
disturbed sleep, pain, and anxiety (Kos, Kerckhofs, Nagels, D'Hooghe, & Ilsbroukx, 
2008). The sedating effects of medications used to treat these MS comorbidities may also 
potentiate fatigue (Kos et al., 2008). Exposure to heat or increased body temperature 
tends to exacerbate fatigue in persons with MS, which is not seen in other neurologic 
conditions (Kos et al., 2008). 
Fatigue also has underlying psychological mechanisms related to mood, cognition 
and personality (Bol et al., 2009). There is considerable overlap between symptoms of 
fatigue and depression - lack of energy, tiredness, lack of motivation (Bol et al., 2009; 
Kos et al., 2008). Impaired sleep, disease severity and depression have been identified as 
independent predictors of fatigue in persons with MS with sleep being the strongest 
predictor (β = .36, p < .001) interacting with depression (β = .31, p < .01) (Strober & 
Arnett, 2005). There is some evidence that certain personality traits [negative affectivity 
(neuroticism), high conscientiousness and low extraversion] may play a role in fatigue 
experience in persons with MS (Bol et al., 2009). 
While the causes of fatigue in MS are not clearly understood, its consequences are 
significant. Fatigue negatively impacts social, emotional, cognitive and physical 
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functioning in those with MS and is related to lower health-related quality of life and 
unemployment (Krupp, 2003; Rietberg, van Wegen, Uitdehaag, & Kwakkel, 2011). 
Despite MS-related fatigue being so prevalent, its pathophysiology is not well understood 
and therapeutic regimens lack robust effects (Kluger, Krupp, & Enoka, 2013). 
Multidisciplinary treatments suggested to manage MS-related fatigue include “a 
combination of aerobic exercise, a rehabilitation program, body cooling, energy 
conservation strategies and psychological and dietary interventions” (Kos et al., 2008, p. 
96). Pharmacological therapy (amantadine, modafinil) has been suggested in clinical 
practice guidelines, yet a recent meta-analysis reported a non-significant pooled effect 
size of 0.07 (95% CI: -0.22 – 0.37, p = 0.63) for the effect of pharmacological 
interventions using amantadine and modafinil on fatigue in persons with MS (Kesselring 
& Beer, 2005; Asano & Finlayson, 2014). The same meta-analysis reported significant, 
moderate pooled effects for exercise and educational interventions on fatigue in persons 
with MS (0.57, 95% CI: 0.10 – 1.04, p = 0.02 and 0.54, 95% CI: 0.30 – 0.77, p < .001 
respectively), respectively (Asano & Finlayson, 2014). 
INTERRELATIONSHIPS BETWEEN COGNITIVE IMPAIRMENT, DEPRESSION, AND FATIGUE 
IN PERSONS WITH MS  
Depression and fatigue are influential factors related to cognitive function in MS 
but the nature of the interrelationships is ambiguous. Features of MS-related depression 
and fatigue (e.g., attention, lethargy, poor concentration) confound performance on 
cognitive assessments and raise concern about construct validity (Bol et al., 2009; 
Langdon, 2011). Distinguishing the discrete contributions depression and fatigue may 
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have on cognitive impairment is difficult given substantial intra-individual differences 
and shared construct characteristics. 
 Methodological shortcomings have been identified among early studies, 
which found no relationship between depression and cognitive impairment in persons 
with MS (Feinstein, 2006). More recent and better designed studies impart cautious 
support to relationships existing between moderate to severe depression and impairments 
in cognitive capacity (attention), processing speed, working memory, and executive 
function (Arnett, Higginson, Voss, Bender, et al., 1999; Arnett, Higginson, Voss, Wright, 
et al., 1999; Demaree, Gaudina, & DeLuca, 2003). While cognitive limitations 
experienced by persons with MS may contribute to depressive symptoms, Feinstein 
(2006) reports that depression may potentiate cognitive impairment by depleting 
attentional and cognitive capacity, which in turn is hypothesized to impede memory and 
executive functions in a hierarchical fashion. It is currently unknown whether treatment 
of depression will result in improved cognition, justifying further investigation (Feinstein, 
2006; Siegert & Abernethy, 2005). 
 The relationship between fatigue and cognitive function is even more 
equivocal. Difficulty in quantifying fatigue, a subjective and complex construct, has 
impeded research related to fatigue characteristics, mechanisms and treatment (Chadhuri 
& Behan, 2004; Pierson & Griffith, 2006). Medications commonly used to manage MS 
symptoms (e.g., spasticity, neurogenic pain, depression) may exacerbate fatigue and 
impair cognitive function further confounding the relationship (Patti, 2009; Pierson & 
Griffith, 2006). Studies investigating fatigue and cognitive impairment have yielded 
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inconsistent results. A number of studies have reported significant associations between 
fatigue and cognitive function, specifically processing speed (r = -0.35, p < .05), attention 
(β = 0.298, p = 0.014), recognition reaction time (β = 0.559, p < .05), and accuracy (β = -
0.405, p < .05) (Andreasen, Spliid, Andersen, & Jakobsen, 2010; Holtzer & Foley, 2009; 
Weinges-Evers et al., 2010). Other studies have reported null relationships between 
fatigue and cognition (Bailey, Channon, & Beaumont, 2007; Krupp & Elkins, 2000; 
Parmenter, Denney, & Lynch, 2003). 
 In summary, cognitive impairment, fatigue and depression are common, 
confounding, debilitating symptoms of MS. Methodological shortcomings such as small 
sample size and selection bias have plagued studies examining the relationship between 
cognition and depression as well as between cognition and fatigue. Additionally, fatigue 
is an abstract concept that is uniquely subjective, difficult to define and quantify 
adequately. Strategies to manage depression, fatigue and cognitive impairment in persons 
with MS (e.g., pharmacotherapy, cognitive behavioral therapy) offer mixed effects. 
PHYSICAL ACTIVITY 
Physical activity has been posited as a therapeutic intervention to minimize 
cognitive impairment, depression, depressive symptoms and fatigue related to MS (Bol et 
al., 2009; Ensari, Motl, & Pilutti, 2014; Feinstein, 2011b; Motl, Sandroff, & Benedict, 
2011; Pilutti et al., 2013). Physical activity is defined as “bodily movement that is 
produced by the contraction of skeletal muscles that results in a substantial increase in 
caloric requirements over resting energy expenditure” (Pescatello, 2014, p. 2). 
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Physical activity is an umbrella concept encompassing all forms of muscle 
movement. Therefore, it is often categorized by the context in which it occurs: leisure-
time, occupational, sport, transportation and household (Caspersen et al., 1985). Another 
method of classifying physical activity is based on physiological outcomes: aerobic, 
muscle strengthening, bone strengthening, and stretching (USDHHS, 2011). Aerobic 
activity is promoted for improving heart and lung function; muscle strengthening 
activities for stimulating muscle power, strength, and endurance; bone strengthening 
activities for fostering bone growth and reducing the risk for developing osteoporosis; 
and stretching activities for improving or maintaining joint range of motion and 
flexibility which may reduce the risk of falling (Physical Activity Guidelines Advisory 
Committee, 2008). 
Exercise is a subset of physical activity that is structured, planned, repetitive, and 
goal directed (Caspersen et al., 1985). Exercise is focused; it has specific aims such as 
improved health, physical performance or physical fitness (Bouchard, Blair, & Haskell, 
2012). Common forms of exercise include aerobic/endurance training (e.g., walking, 
cycling, rowing), which is aimed at maintaining or improving heart and lung function and 
strength/resistance training (lifting weights) that focuses on preserving or increasing 
muscle mass and strength. 
Physical fitness is defined as “a set of attributes which allow individuals to 
perform physical activity with greater ease” (Porcari & Foster, 2010, p. 68). Important 
components of health-related physical fitness include: cardiovascular endurance, body 
composition, muscular strength and endurance, and flexibility (Bouchard et al., 2012; 
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Pate, 1988). While physical fitness and physical activity are related, health-related 
benefits of physical activity may be realized despite any measurable improvements in 
fitness status (Pescatello, 2014; Physical Activity Guidelines Advisory Committee, 
2008). 
Regular physical activity has been related to better quality of life, health status, 
and longevity in adults regardless of gender, age, ethnicity and race (Bouchard, Blair, & 
Haskell, 2012; Chodzko-Zajko et al., 2009; Physical Activity Guidelines Advisory 
Committee, 2008). Despite substantial health benefits, data from the 2010 Behavioral 
Risk Factor Surveillance System indicates that one in four American adults do not report 
engaging in any leisure-time physical activity (Moore, Harris, Carlson, Kruger, & Fulton, 
2012). Leisure-time physical activities are self-selected discretionary activities, such as 
taking the stairs rather than the elevator, which increase the total daily energy expenditure 
(Bouchard et al., 2012). The World Health Organization (2010) has identified physical 
inactivity as the fourth leading risk factor for mortality worldwide. Physical inactivity 
substantially increases the risk for developing chronic diseases, premature mortality, and 
the number of years lived with disability (USDHHS, 2008; US Burden of Disease 
Collaborators, 2013). 
While the rates of physical activity among adults are low, rates among older 
adults and persons with living with a disability are lower still. This presents a substantial 
problem as the number of older adults age 65 years and older is expected to exceed 70 
million individuals (19% of the total population) by the year 2030 (Administration on 
Aging, 2013). Only 1 in 4 (27%) adults age 65-74 reports participating in leisure-time 
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physical activity (Schoenborn, Vickerie, & Powell-Griner, 2006). Physical activity rates 
continue to fall as adults enter their 7th and 8th decade of life; only 18% of 75-84 year olds 
and 8.2% of adults 85 years and older report any leisure-time physical activity 
(Schoenborn et al., 2006). Lack of physical activity is twice as likely among the 50 
million Americans who report living with a disability than those with no disability and 
nearly 10.1 million adults with a disability do not get any aerobic physical activity (CDC, 
2007; CDC, 2013; CDC, 2014). 
To address the increasingly low rate of physical activity and high prevalence of 
chronic disease and disability in the United States, the Physical Activity Guidelines 
Advisory Committee published the Physical Activity Guidelines for Americans in 2008. 
The committee’s extensive review of the literature resulted in recommendation of “at 
least 150 minutes a week of moderate-intensity, or 75 minutes of vigorous-intensity 
aerobic physical activity, or an equivalent combination of moderate- and vigorous-
intensity aerobic activity” for adults, older adults, and adults with disabilities (USDHHS, 
2008, p. 22). Individuals with disabilities are advised to follow these recommendations as 
their condition allows and for those “who are unable to meet these guidelines, they 
should engage in regular physical activity according to their abilities and should avoid 
physical inactivity” (USDHHS, 2008, p. 43). 
Meta-analytic evidence indicates that persons with MS are less physically active 
than adults without chronic disabling conditions (Motl, McAuley, & Snook, 2005). 
Cross-sectional data from a nationally representative sample of persons with MS suggests 
that up to 70% of adults with MS are inactive (Marrie et al., 2009). Additionally, there is 
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substantial evidence of diminished fitness (i.e., aerobic capacity, muscle strength, and 
endurance) among persons with MS (Döring et al., 2012). Physical inactivity and 
sedentary lifestyles place persons with MS at increased risk of developing cardiovascular 
disease, diabetes, and obesity in addition to secondary conditions related to MS (e.g., 
bladder/bowel problems, pressure sores, osteoporosis) (Dalgas, Stenager, & Ingemann-
Hansen, 2008). Advancing age and progressive disability contribute to sedentary 
behavior and further challenges health maintenance in persons with MS. A cyclic pattern 
of increased inactivity, depression, and fatigue may result in further deconditioning and 
disablement (MacAllister & Krupp, 2005). Historically, physical activity was thought to 
increase the risk of MS exacerbations; this presumed association has not been supported 
by the literature (Pilutti, Platta, et al., 2014; Rietberg et al., 2011; Tallner et al., 2012). In 
fact, a substantial body of research exists supporting the positive effects physical activity 
has on persons with MS including improvements in mood, muscle function, and mobility 
(Latimer-Cheung, Pilutti, et al., 2013; Rietberg et al., 2011; White & Dressendorfer, 
2004). 
Physical activity guidelines specifically designed for persons with MS have been 
developed and are available online through The Canadian Society for Exercise 
Physiology (Ginis  & Hicks, 2007). More recently, a consensus panel of experts 
developed physical activity guidelines for adults with MS using a rigorous process based 
on an extensive systematic review of the literature (Latimer-Cheung, Martin Ginis, et al., 
2013; Latimer-Cheung, Pilutti, et al., 2013). The guidelines promote fitness benefits for 
adults with MS who have mild to moderate disability through “30 minutes of moderate 
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intensity aerobic activity 2 times per week and strength training exercises for major 
muscle groups 2 times per week” (Latimer-Cheung, Martin Ginis, et al., 2013, p. 1829). 
In summary, many individuals with MS lead sedentary lifestyles and are less 
physically active than the general population of whom, according to the data from the 
2015 National Health Interview Survey, only 20.9% of adults 18 years and older meet the 
2008 guidelines for both aerobic activity and muscle strengthening based on leisure-time 
activity (USDHHS, 2016). Physical inactivity contributes to negative health outcomes 
and secondary conditions in persons with MS. Increasing physical activity in persons 
with MS has been recognized as a feasible strategy for maintaining function, promoting 
health and improving quality of life through its positive effects on physical, mental and 
psychosocial function (Stuifbergen & Roberts, 1997; Physical Activity Guidelines 
Advisory Committee, 2008; Motl & Gosney, 2008; Rietberg, Brooks, Uitdehaag, & 
Kwakkel, 2004). Physical activity guidelines to promote health and wellness for persons 
with MS have recently been developed and published (Latimer-Cheung, Martin Ginis, et 
al., 2013). 
INTERVENTIONS DESIGNED TO INCREASE PHYSICAL ACTIVITY IN PERSONS WITH MS 
There is great variation among approaches used in intervention studies designed 
to increase physical activity in persons with MS: directly supervised exercise (Oken et 
al., 2004; Petajan et al., 1996; Velikonja. Curic, Ozura, & Jazbec, 2010), internet-
delivered health promotion (Pilutti, Dlugonski, Sandroff, Klaren & Motl, 2014; Sandroff 
et al., 2014), group health promotion (Stuifbergen et al., 2003), group efficacy-
enhancement (McAuley et al., 2007) and telephone-delivered counseling (Bombardier et 
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al., 2008).  Dixon-Ibarra et al. (2014) claim that the science of physical activity research 
in persons with MS is “still in its infancy” (p. 155) due to a limited number of studies 
focused on changing physical activity behavior in persons with MS. 
The establishment of physical activity guidelines is essential to the development 
of effective programs (Dixon-Ibarra et al., 2014). Only recently has the effectiveness of 
physical activity interventions on critical outcomes been quantified to develop physical 
guidelines for persons with MS (Latimer-Cheung, Martin Ginis et al., 2013). The authors’ 
concluded after reviewing 54 studies that physical activity interventions are effective for 
improving muscular strength and aerobic capacity in persons with mild to moderate 
disability related to MS (Latimer-Cheung, Pilutti et al., 2013). While promising, they 
concluded that there was insufficient evidence to support the effectiveness of physical 
activity interventions to improve mobility, fatigue or health-related quality of life 
outcomes in persons with MS (Latimer-Cheung, Pilutti et al., 2013). The guidelines 
define the target population (persons with MS who have mild to moderate disability), 
intensity (moderate), aerobic training session duration (30 minutes) and frequency (2 
times per week aerobic and resistance training), yet fail to provide guidance on the 
optimal program duration (Latimer-Cheung, Martin Ginis et al., 2013). 
An earlier Cochrane Review examined nine randomized controlled trials (RCTs) 
finding support for exercise therapy over no exercise therapy for improving muscle 
power, mobility and exercise tolerance but not fatigue among persons with MS (Rietberg, 
et al., 2004). The authors recommended that a core set of outcome measures be 
developed and that future studies clearly define the exercise dose (e.g., type, intensity, 
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session length, frequency and program duration). These recommendations have yet to be 
satisfied; perhaps due to the great variability MS has on each individual’s physical (e.g., 
balance, strength) and cognitive functional systems. Of 11 RCTs reviewed by Asano, 
Dawes, Arafah, Moriello, and Mayo (2009), five of the studies did not present 
information on exercise intensity and over 31 different target outcomes were identified 
(i.e., aerobic capacity, muscle strength, fatigue, health-related quality of life, mobility). 
Similar heterogeneity was described by Latimer-Cheung, Pilutti, et al. (2013) among the 
24 RCT studies they reviewed that included numerous physical activity interventions: 
aerobic exercise, resistance training, combination aerobic and resistance training, robotic-
assisted treadmill training, yoga, swimming, as well as stability and plyometric exercises. 
Among the 28 RCTs included in both systematic reviews, intervention sessions ranged in 
length from 25 to 90 minutes (mean = 46.3 + 17.5), met from 1 to 7 times per week 
(mean = 3.1 + 1.5), and the programs lasted from 4 to 26 weeks (mean = 10.7 + 6.7). The 
moderating effects of exercise type, intensity, session length, frequency or program 
duration were not reported in any of the reviews (Asano et al., 2009; Latimer-Cheung, 
Pilutti et al., 2013; Rietberg et al., 2004). The outcomes reported by Latimer-Cheung, 
Pilutti et al. (2013) were “reported immediately after the intervention, thus precluding the 
potential to determine the long-term effects of exercise training” (p. 1825). Therefore, the 
optimal dose of physical activity intervention (exercise type, intensity, session length, 
frequency or program duration) has yet to be determined for studies investigating the 
effects of physical activity on MS-specific outcomes such as cognitive impairment, 
fatigue and depressive symptoms. 
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EFFECTS OF PHYSICAL ACTIVITY INTERVENTIONS ON MS-RELATED SYMPTOMS  
There has been an emphasis on research exploring potential relationships between 
physical activity behavior and MS-related health outcomes including depression, fatigue 
and cognitive function (Dixon-Ibarra et al., 2014). Inquiry into the effectiveness of 
physical activity behavior change interventions on MS-related symptoms is less common. 
The following reviews the literature examining the effects of physical activity on fatigue, 
depression, depressive symptoms, and cognitive function. 
EFFECT OF PHYSICAL ACTIVITY ON DEPRESSION, DEPRESSIVE SYMPTOMS, AND FATIGUE 
IN PERSONS WITH MS  
Evidence of the effectiveness of physical activity interventions to ameliorate 
depressive symptoms or fatigue in MS has been unclear based on reviews of the literature 
(Andreasen, Stenager, & Dalgas, 2011; Feinstein, Rector, & Motl, 2013). Two recent 
meta-analyses addressed this paucity of evidence in the MS literature (Ensari et al., 2014; 
Pilutti et al., 2013). Ensari et al. (2014) found physical activity interventions had a small, 
statistically significant effect on improving depressive symptoms (Hedge’s g = 0.36, SE 
= 0.09, 95% CI = 0.18 – 0.54, z = 3.92, p < .001). Correspondingly, Pilutti et al. (2013) 
reported that exercise training had a significant, small-to-moderate effect on reducing 
fatigue (Cohen’s d = 0.45, SE = 0.12, 95% CI = 0.22 – 0.68, z = 3.88, p < .001). 
Both meta-analyses used the Physiotherapy Evidence Database (PEDro) scale to 
evaluate the quality of the studies included in their analysis (Maher, Sherrington, Herbert, 
Moseley, & Elkins, 2003). The majority of the studies were of high quality (69% in 
Ensari et al., 2014 and 76% in Pilutti et al., 2013). The authors of both meta-analyses 
noted wide variation among the exercise interventions employed (e.g., mode, duration, 
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intensity, individual versus group), instruments used to measure depressive 
symptoms/fatigue, identification of depressive symptoms/fatigue as secondary rather than 
primary outcomes, and potential ceiling effect since depressive symptoms/fatigue were 
not screened for or used as inclusion criteria. In summary, while the effect sizes were 
small, the findings of these meta-analyses support the utility of physical activity to 
improve depressive symptoms and fatigue in persons with MS. 
EFFECTS OF PHYSICAL ACTIVITY ON COGNITIVE FUNCTION. 
In older adults 
Robust effects derived from five meta-analyses evaluating the effectiveness of 
physical activity interventions on cognitive function in older adults provide the rationale 
for the proposed study (see Appendix H; Table 1). Samples in the studies included in the 
meta-analyses were comprised of healthy older adults, adults with mild cognitive 
impairment and dementia, as well as adults with chronic conditions (i.e., chronic 
obstructive pulmonary disease, fibromyalgia, and MS). Smith et al. (2010) included three 
samples involving younger adults among the 29 studies they analyzed. Of note, only the 
Colcombe and Kramer (2003) meta-analysis failed to evaluate the quality of the studies 
included in their analysis, which may account for the much larger effect sizes reported in 
this early meta-analysis. 
Effects pooled from physical activity interventions were significant for several 
cognitive outcomes including: general cognitive function, attention and processing speed, 
executive function, memory, and verbal fluency (Colcombe & Kramer, 2003; Gates, 
Fiatarone Singh, Sachdev, & Valenzuela, 2013; Heyn et al., 2004; Hinden & Zelinski, 
 45 
2012; Smith et al., 2010). Moderator analyses suggest that combined resistance-aerobic 
programs were more effective than aerobic training alone for all cognitive outcomes in 
Colcombe and Kramer (2003) and for attention and processing speed in Smith et al. 
(2010). Additionally, Colcombe and Kramer (2003) reported that program and session 
duration were significant moderating variables with longer programs (six-months or 
longer) and moderate session length (31 – 45 minutes) resulting in larger effect sizes.  
IN PERSONS WITH MS 
Studies investigating physical activity and cognition in persons with MS have 
proliferated over the past decade. Much of the interest in this phenomenon can be 
attributed to the robust effect physical activity has on cognition in older adults previously 
discussed. Sixteen studies exploring physical activity and cognition in persons with MS 
were found in the literature; six are observational studies, three are quasi-experimental, 
and seven are experimental (see Appendix H; Tables 2-4). 
The six descriptive studies reported several significant associations between 
measures of physical activity and measures of cognitive function (information processing 
speed, attention, memory, and executive function), brain structures and brain functions. 
Physical activity was measured using data collected by accelerometers (Motl, Gappmaier, 
et al., 2011; Prakash et al., 2011; Prakash, Snook, Kramer, & Motl, 2010). Use of 
accelerometers to quantify physical activity has been validated in ambulatory persons 
with MS (Gosney, Scott, Snook, & Motl, 2007; Motl, McAuley, Snook, & Scott, 2006). 
Cardiorespiratory fitness, measured as peak oxygen consumption, was used as a proxy for 
physical activity in three of the studies (Prakash et al., 2007; Prakash, Snook, Motl, & 
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Kramer, 2010; Beier, Bombardier, Hartoonian, Motl, & Kraft, 2014). Concern has been 
raised that measures of physical fitness, which are physiologic attributes related to 
physical activity, may not be directly modifiable by change in behavior and as such may 
not reflect the relationship between physical activity behavior and cognitive outcomes 
(Motl, Gappmaier, et al., 2011; Prakash, Snook, Kramer, & Motl, 2010).  
The type of MS varied among the studies; three studies included individuals with 
any form of MS documented by a physician while the others included only persons with 
the most common form of the disease, relapsing-remitting MS (Multiple Sclerosis 
International Federation, 2013). The study sample sizes ranged from 21 to 88 persons and 
consisted mainly of females. The Expanded Disability Status Scale (EDSS) was 
employed in all but one study to describe the impact of MS on the participants’ 
neurologic status (Kurtzke, 1983). The EDSS measures neurologic impairment in MS 
based on assessment of eight functional domains: visual (optic), brain stem, pyramidal, 
cerebellar, sensory, bowel/bladder, cerebral, and ambulation. 
There was great variation in the type of cognitive function, brain structure and 
brain function variables explored as well as in the methods used to measure the variables 
in the studies reviewed. Cognitive function variables focused on areas of cognition 
commonly impaired among persons with MS; specifically processing speed, attention, 
and executive function. Several clinical instruments were employed to assess cognitive 
function. The most frequently used instruments were the Paced Auditory Serial Addition 
Test (Gronwall, 1977), which measures attention, processing speed, and working memory 
(Tombaugh, 2006) and the Symbol Digit Modalities Test, a test of complex scanning and 
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visual tracking (Smith, 1982). One study used the Perceived Deficits Questionnaire, a 
self-report instrument to assess cognitive function (Sullivan, Edgley, & Dehoux, 1990). 
MRI was used to assess brain structures and function in three studies (Prakash et al., 
2007; Prakash et al., 2011; Prakash, Snook, Kramer, & Motl, 2010). 
Findings among the descriptive studies included significant relationships between 
physical activity and self-reported cognitive function, processing speed, and hippocampal 
connectivity (Motl, Gappmaier, et al., 2011; Prakash, Snook, Kramer, & Motl, 2010; 
Prakash et al., 2011). Cardiovascular fitness was significantly associated with 
information processing speed, attention, working memory, executive function, 
cerebrovascular function, gray matter volume and fractional anisotropy values (Prakash 
et al., 2007; Prakash, Snook, Motl, & Kramer, 2010; Beier et al., 2014). In summary, 
findings from these cross-sectional studies provide preliminary evidence to support 
experimental investigation into the causal relationship and temporal sequencing of 
physical activity and cognition in persons with MS. 
Three quasi-experimental studies (one group, pretest/posttest) examining the 
effects of physical activity on cognition were included in the review. Samples ranged in 
size from 10 to 33 and were composed mainly of women. One study included persons 
with progressive MS and a wide range of disability with EDSS scores from 1.5 
(independent ambulation) to 8.0 (limited to bed, chair or passive use of wheelchair) while 
the other two included participants with confirmed MS of any type and EDSS scores 
from 1.0 (little disability fully ambulatory) to 6.5 (moderate disability, able to walk 25 
feet with or without an assistive device) (Filipi et al., 2010; Freeman & Allison, 2004; 
 48 
Kurtzke, 1983; Roehrs & Karst, 2004). The interventions employed varied in type (floor, 
aquatic, resistance), frequency (1 or 2 days per week) and duration (10 to 24 weeks). The 
level of exercise intensity was not defined for any of the studies. Significant findings 
related to cognition were limited to one study, which reported improvement in attention 
and memory measured using the Paced Auditory Serial Addition Test (Filipi et al., 2010; 
Gronwall, 1977). 
Experimental studies investigating the effects of physical activity on cognition, 
including cognitive function related to fatigue, were reviewed (see Appendix H; Table 4). 
The studies included one randomized prospective design (Velikonja et al., 2010), and six 
reports of five RCTs (Oken et al., 2004; Romberg, Virtanen, & Ruutiainen, 2005; 
Kargarfard, Etemadifar, Baker, Mehrabi, & Hayatbakhsh, 2012; Briken et al., 2014; 
Pilutti, Dlugonski, et al., 2014; Sandroff et al., 2014). Velikonja et al. (2010) reported a 
statistically significant effect (p < .01) of a ten-week yoga program on selective attention 
and cognitive function related to fatigue but this study had concerning quality issues 
including small sample size, unstated assignment to treatment arms, and no report of the 
participants’ gender. Oken et al. (2004) and Romberg et al. (2005) reported no significant 
findings among the cognitive function outcomes measured after yoga, stationary cycling, 
or a combined program of inpatient rehabilitation for 3 weeks followed by 23 weeks of 
an independent home-based program of resistance training.  
In summary, limited research exists which examines the effects of physical 
activity on cognition in persons with MS and what research does exist is predominantly 
cross-sectional or single group pretest/posttest design. Reports of more rigorous studies 
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are increasing. Five reports of four RCTs were found that measured cognitive function 
outcomes after a physical activity intervention in persons with MS. Notably, only three of 
the four experimental design studies identified cognitive function as a primary outcome 
(Oken et al., 2004; Sandroff et al., 2014; Velikonja et al., 2010). No significant 
improvements in cognitive function were found in the Oken et al. (2004) and Romberg et 
al. (2005) studies. Kargarfard et al. (2012) found a significant group by time interaction 
for an eight-week supervised aquatic program on the cognitive subscale of the Modified 
Fatigue Impact Scale.  
Exercise components used in the experimental studies varied a great deal. 
Quantifying the volume of exercise required to elicit an effect in the studies reviewed was 
not feasible due to great variability among types (aquatic exercise, yoga, sports climbing, 
and combination resistance/aerobic endurance training), methods of delivery (group, 
home, and internet) and length (eight weeks to six months) of physical activity 
interventions implemented. Additionally, there was considerable variation among the 
instruments used to assess cognitive function since no single test exists to adequately 
assess cognitive impairment (Benedict, 2011). The studies may have been underpowered 
as only one reported conducting a power analysis to determine adequate sample size 
(Sandroff et al., 2014). Lastly, intention to treat analysis, which avoids artifact due to 
non-random attrition of participants, was used in only two studies (Kargarfard et al., 
2012; Sandroff et al., 2014).  
The gaps in knowledge and the dearth of treatments available to manage cognitive 
impairment in persons with MS demand an innovative approach. Research of physical 
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activity in persons with MS has established its therapeutic value as an effective, well 
tolerated therapy for impaired physical functioning, depressive symptoms, fatigue and 
quality of life (Döring et al., 2012; Ensari et al., 2014; Motl & Gosney, 2008; Motl & 
Pilutti, 2012; Pilutti et al., 2013); the next step is to add to the emerging body of research 
by determining the feasibility and effectiveness of a methodologically rigorous physical 
activity program to promote cognitive functioning in persons with MS. 
SUMMARY 
This chapter reviewed the literature related to the prevalence, impact and 
treatment of cognitive impairment, depression and fatigue in persons with MS. Based on 
studies involving persons with MS, healthy older adults, older adults with cognitive 
impairment, and persons with chronic conditions, physical activity is advanced as a 
viable self-management approach for addressing MS-related cognitive impairment, 
depression, and fatigue. Research studies have shown that physical activity is a safe and 
effective therapeutic option for maintaining functional abilities, decreasing the severity of 
MS-related symptoms and promoting quality of life. 
This study aspires to decrease the impact and burden of cognitive impairment and 
resultant day-to-day functional limitations individuals with MS, their families, and 
society experience. This study explored the feasibility and effectiveness of the Physically 
Active Lifestyle in MS (PALMS) intervention – a tailored, small group, moderate 
intensity physical activity intervention for this population. The information gleaned from 
this study can be integrated into clinical practice in numerous healthcare disciplines 
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including: nursing, neurology, neuropsychology, physical therapy, occupational therapy, 
and rehabilitative medicine. 
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Chapter 3: Methods 
This chapter details the study design, setting, and sample characteristics, as well 
as the procedures used for the protection of human subjects. Furthermore, data collection 
methods, instrumentation, intervention protocol and data analyses are described.  
DESIGN 
This study employed a quasi-experimental design conducted in a community setting 
with a convenience sample of 16 adults with MS prescreened for cognitive problems and 
physical inactivity. The purpose of the study was to determine the feasibility and effects 
of a physical activity intervention on the primary outcomes of clinical cognitive function 
and neurocognitive function in everyday life in addition to the secondary outcomes of 
exercise self-efficacy, physical activity, depressive symptoms and fatigue. Data were 
collected at baseline, 3-months and 6-months (post-intervention) using self-report 
measures, an objective measure of physical activity, and neuropsychological tests. An 
attention-control group was selected for this study as this form of comparison group 
allows for equal exposure (contact time) and attention over the six-month intervention 
period of this trial of a non-pharmacologic intervention. 
STUDY PROCEDURES 
Participant recruitment 
Participants were recruited from communities in and around metropolitan Austin, 
Texas. Austin is the state capital and the center of a metropolitan area of approximately 1 
million people. According to the 2011 US Census Bureau estimates, the population is 
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approximately 50% White/non Hispanic, 34% Hispanic, 9% Black, and 6% Asian and 
2% other. The Lone Star Chapter of the National MS Society serves more than 1400 
Persons with MS in Travis County. The investigator’s prior work on the dissertation 
chair’s studies has allowed her to build strong connections with this population and 
service providers throughout the community.  
Participants were recruited in a variety of ways including referrals from local 
neurologists, advanced practice nurses at a MS-specific neurology clinic with 
approximately 1,200 MS patients (see Appendix C), 10 presentations to MS support 
groups, and “word of mouth.” Recruitment materials were distributed instructing 
potential participants to email the principal investigator or call the dissertation chair’s 
research office toll-free number for additional information about the study.  
Recruitment began upon receipt of IRB approval on November 25, 2014 and was 
ongoing to establish small groups of subjects. Based on the literature and prior experience 
in previous studies, small group cohorts (2 to 4 persons) allow for optimal interaction 
among subjects to enhance self-efficacy through vicarious experience and modeling 
(Bandura, 1997). Individuals were assigned to either the intervention (strength and 
aerobic exercise program) or attention-control (relaxation and stretching) group after 
successful completion of baseline data collection. The first nine participants were 
randomly assigned using a computer-generated list of random numbers. Randomization 
assignment was recorded on a letter and sealed in an opaque envelope; following the 
completion of baseline testing the investigator opened the next envelope in the sequence 
and assigned the participant to either the intervention or attention-control group. After 
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nine months of continuous recruiting efforts (including 10 presentations to three different 
MS support groups in the Austin area) nine individuals had been successfully enrolled in 
the study, seven had been randomly assigned to the attention-control group and two into 
the intervention group. The random assignment of the tenth participant on September 13, 
2015 (ten months into recruitment) was to the attention-control group. The PI 
immediately consulted the dissertation chair by phone while the participant was 
undergoing baseline neuropsychological testing. The decision was made to assign the 
tenth participant to the intervention group since the randomization protocol for the study 
had resulted in a great size disparity between the intervention and attention-control 
groups. The dissertation committee and the NIH program official were consulted on 
October 6, 2015 and all agreed that the design of the study would be changed to quasi-
experimental in order to have sufficient data about the primary aim of this study, its 
feasibility. The next four participants were assigned to the intervention group. Thereafter, 
participants were assigned in alternating fashion to the intervention and attention-control 
groups. In addition, a large number (14) of those expressing interest in the study had been 
excluded solely because they engaged in low-intensity lifestyle or transportation-related 
physical activity (e.g., walking their dog, biking a short distance to work). The PI and the 
dissertation chair made the decision to change the definition of physical inactivity in the 
inclusion criteria by replacing “regular physical activity” with “structured exercise” after 
consultation with exercise physiology content expert and committee member Dr. Robert 
Motl on October 5, 2015. The Institutional Review board at The University of Texas at 
Austin approved the above changes to the study on October 8, 2015.  
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Sample 
The sample for this study consisted of 16 adults with physician-diagnosed MS living 
in the Austin metropolitan area who met screening criteria for cognitive problems and 
physical inactivity. The goal of the study was to determine the feasibility of the 
intervention protocol and to provide estimates of effect size for future studies. Using 
G*Power 3, a 2x3 repeated measures ANOVA within and between design, small to 
medium effect size (ES f = .175), alpha = .05, and power = .80 computed a total sample 
size of 26 (Faul, Erdfelder, Lang, & Buchner, 2007). Since there are no similar studies 
with persons with MS, the small to medium effect size estimate was based on two meta-
analyses of aerobic exercise interventions on neurocognitive performance in older adults 
and adults over age 18 (Colcombe & Kramer, 2003; Smith et al., 2010). Allowing for a 
10% attrition rate (based on the dissertation chair’s 5-month long cognitive intervention 
study R21NR011076), 30 persons with MS (15 per group) were to be recruited to 
participate in the study.  
To participate, subjects had to be diagnosed with MS, age 21 to 60, and capable of 
understanding and complying with the study protocol. Participants also needed to be able 
to read and write in English and be ambulatory with minimal assistance as objective 
physical activity measurement devices have only been validated with individuals who 
walk with or without a cane, but not a walker, wheelchair or scooter (Motl, McAuley, 
Snook, & Scott, 2006). All participants had a diagnosis of clinically definite MS and 
written approval to participate in the physical activity program documented by their 
healthcare provider. 
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Participants had stable disease at the time of entry into the study (relapse free for 
at least 90 days), reported being physically inactive, defined as not engaging in structured 
exercise (30 minutes accumulated each day) on more than 2 days per week during the 
previous 6 months, score 55 or less on the Symbol Digit Modalities Test (SDMT) – a test 
of complex scanning and visual tracking (Smith, 1982) considered the standard for 
effective cognitive impairment screening in the clinical setting for persons with MS 
(Parmenter et al., 2007) and be willing to participate in a 6-month study involving 
physical activity and data collection. One participant who scored 56 on the SDMT was 
included in the study after consultation with the dissertation chair and referring to the 
SDMT testing manual that states:  
Given the variances and reliabilities reported in this manual, standard error of 
measurement (SEM) estimates of between 2.8 and 5.4 points indicate that any 
score within 6 to 11 points (depending on the sample and administration 
procedure) of a specific cutoff value needs to be carefully interpreted and verified 
against other evidence relevant to a particular case. (Smith, 1982, p. 3)  
The sample included males, females, Whites, African-Americans, Hispanic and non-
Hispanic subjects. Subjects were excluded if they were pregnant or planned to be, had 
cardiovascular or respiratory disease, other medical causes of dementia (e.g., stroke, 
Parkinson’s disease) or other neurological disorders that may impact cognition or 
emotions, evidence of major psychiatric disorder, or if they had major functional 
limitations that precluded them from participating in the study. Evidence of exclusion 
criteria included self-report by the participant or inference by failure of the healthcare 
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provider to authorize participation in the study. 
Intervention Protocol 
The investigator used a script and the Physical Activity Readiness Questionnaire for 
Everyone (PAR-Q+) (see Appendix D) to phone-screen potential participants for 
inclusion/exclusion criteria and to explain the study procedures and requirements (Jamnik 
et al., 2011). Informants who responded yes to more than one of the follow-up questions 
in Section 2 - Chronic Medical Conditions of the PAR-Q+ were excluded from 
participating in the study. Based on the phone screen eligibility and responses to the 
PAR-Q+, potential subjects were invited to an in-person meeting (at a location, date, and 
time selected by the subject) to review the study requirements, sign the informed consent 
and undergo a brief (5 minute) cognitive function screen using the Symbol Digit 
Modality Test [SDMT] (Smith, 1982), which has been proposed as a promising screening 
test for cognitive impairment in persons with MS (Parmenter el al., 2007). Participants 
scoring 55 or less were eligible to participate in the study. Those eligible were asked to 
provide the name and address of their healthcare provider to 1) verify their MS diagnosis 
and 2) authorize medical clearance to participate in a physical activity program (see 
Appendix D). The investigator and participant signed and dated the two forms, which the 
investigator faxed or delivered in person, along with a cover letter explaining the study, 
to the healthcare provider. The demographic information sheet, baseline questionnaire, 
accelerometer and accelerometer log were given to the participant at the meeting. 
Participants were instructed to complete the survey forms and to wear the accelerometer 
for seven days during waking hours on their non-dominant hip/waist. At the end of the 
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seven-day period, the investigator picked up the demographic information sheet, baseline 
questionnaire, accelerometer, and accelerometer log at a mutually agreed upon location 
and time convenient for the participant. Neurocognitive testing with a trained research 
assistant was scheduled upon receipt of the two signed and dated healthcare provider 
forms. The date, time and location of the first program session (intervention or attention-
control) was determined after the neurocognitive testing was complete and baseline 
materials had been returned. 
Participants assigned to the intervention group met twice a week with the investigator 
(an ACSM/NCHPAD Certified Inclusive Fitness Trainer) for 60 minutes of supervised 
aerobic physical activity for six months at one of six YMCA of Austin locations. The 
methodological factors - intervention length (six-months) and session length (60 minutes) 
- were derived from the meta-analysis by Colcombe & Kramer (2003) that examined the 
magnitude of effects of physical activity interventions on cognitive function in older 
adults and the Canadian Physical Activity Guidelines for Persons with MS (Canadian 
Society for Exercise Physiology, 2013). Each participant underwent a baseline exercise 
assessment and had an individualized progressive program of exercise based on the 
assessment and baseline physical activity measures (i.e., Godin Leisure-Time Exercise 
Questionnaire, accelerometer data). The supervised program consisted of a five-minute 
dynamic warm-up, up to 30 minutes of aerobic exercise (walking on a treadmill, riding a 
stationary bike, using an elliptical trainer, or recumbent elliptical trainer) and twenty 
minutes of strength training, followed by a five-minute cool down with stretching. 
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To assess and monitor the level of exercise intensity, participants wore a Polar® heart 
rate monitor aiming for 40 – 60% of maximum heart range using the Tanaka, Monahan, 
& Seals (2001) formula: 208 – (0.7 x Age) and verbalized rating of perceived exertion 
between 3 (moderate) and 7 (very strong) using the 10-point Borg Scale (Borg, 1998; 
Morrison et al., 2008). Heart rate and rating of perceived exertion were recorded every 10 
minutes. Participants were encouraged to exercise on their own at least three additional 
days a week and to document their PALMS physical activity in a log (see Appendix D). 
The overall purpose of the PALMS intervention was to (a) enhance self-efficacy for 
exercise, (b) increase physical activity through a supervised progressive strength and 
aerobic exercise program informed by studies conducted in older adults that gradually 
builds physical activity intensity and duration from baseline level up to 30 minutes of 
moderate intensity aerobic physical activity twice a week as recommended by the 
Canadian Physical Activity Guidelines for Persons with MS (CSEP, 2013) and (c) to 
determine the effects of the intervention on measures of cognitive function (clinical 
cognitive functioning, self-reported cognitive abilities and concerns, and neurocognitive 
functioning in everyday life), exercise self-efficacy, physical activity, depressive 
symptoms, and fatigue (Colcombe & Kramer, 2003; Latimer-Cheung, Martin Ginis, et 
al., 2013). Increased physical activity and exercise self-efficacy is fostered by 
development and practice of physical activity skills, exercise self-evaluation by keeping 
an exercise log, positive reinforcement, supportive coaching, and peer modeling by 
fellow group members or other gym members with visible functional limitations. 
Participants assigned to the attention-control group were offered six months access to 
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twice weekly, 60-minute long relaxation and stretching classes based on the National 
Multiple Sclerosis Society’s Stretching for People with MS Manual (2012) led by a 
trained facilitator in a community setting. While stretching is movement, the intensity 
was kept low. 
PROTECTION OF HUMAN SUBJECTS 
The non-randomized controlled study was reviewed and approved by The 
University of Texas at Austin School of Nursing Departmental Review Committee and 
The University of Texas at Austin Institutional Review Board (IRB) for the protection of 
human subjects. The IRB approval letters and consent form are included in Appendix A 
and B. Potential subjects were told that their participation in the study was voluntary and 
that they could withdraw from the study at any time without recourse. They were 
informed about the study’s purpose, its length (6-months), how many subjects were to be 
in the study and what they would be asked to do if they agree to participate. Possible 
benefits and risks associated with the study such as physical injury, temporary increases 
in their MS symptoms, becoming upset or frustrated during neurocognitive testing were 
discussed. Procedures and policies in place to protect the participant’s privacy and 
confidentiality were explained. Participants were informed that they would not receive 
any type of payment for taking part in the study. Protections put into place against the 
risk of increasing depressive symptoms and suicidal ideation included providing each 
participant who met with the principal investigator a list of mental health agencies 
(names and phone numbers) in the Austin area developed by neuropsychology content 
expert and committee member, Dr. Andreana Haley. Additionally, the consent form 
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included language allowing the principal investigator to intervene should the participant 
exhibit an increase in depressive symptoms or suicidal ideation:  
“The risks associated with the study are that you might experience an 
increase in your feelings (depression, anxiety, and anger). We have provided you 
a list of counseling services available in the area if you need assistance. It is 
important that you understand that if you need assistance with the management of 
your emotions such as medication or counseling, you should talk to your 
healthcare provider about this. If you say during the study that you have thoughts 
of harming yourself, the principal investigator, Janet Morrison RN, MSN, will 
talk with you and contact your healthcare provider. Signing this consent document 
will give her permission to contact your healthcare provider if that situation 
should arise.” 
INSTRUMENTATION 
Participants were pre-screened using a two-step process to determine their 
eligibility: 1) an initial phone interview using a script and the PAR-Q+ (Jamnik et al., 
2011) to explore general health status and comorbid medical conditions and then for 
those meeting initial phone criteria 2) an in-person meeting to take the Symbol Digit 
Modalities Test to assess cognitive processing speed (Smith, 1982). Those meeting 
inclusion criteria were scheduled an in-person appointment to undergo baseline testing, 
which included the collection of self-report data, objective data, and neuropsychological 
testing data. The baseline self-report questionnaire packet (formatted using 16-point font) 
included: Background Information Sheet, Self-Administered Expanded Disability Status 
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Scale (Bowen et al., 2001; Kurtzke, 1983), Exercise Self-Efficacy Questionnaire 
(McAuley, 1993), Godin Leisure-Time Exercise Questionnaire (Godin & Shepard, 1985), 
Center for Epidemiologic Studies Depression Scale – Revised (Radloff, 1977), Modified 
Fatigue Impact Scale (Fisk, Pontefract, et al., 1994), PROMIS v1.0 Cognitive Abilities 
and Cognitive Concerns Scales (Cella et al., 2007), and the 7-day Accelerometry Log 
(See Appendix D). Objective data were downloaded from an ActiGraph model wGT3X-
BT accelerometer worn by the participant on the non-dominant waist/hip during waking 
hours for 7-days. After receipt of the 1) Verification of MS Diagnosis and 2) Physician 
Approval to Participate in the Physical Activity Program, a trained research assistant 
collected neurocognitive test data at an in-person meeting in The University of Texas at 
Austin Clinical Neuroscience Lab of the psychology department. The baseline 
neuropsychological test battery included: 2nd edition of the California Verbal Learning 
Test (standard form) [Delis et al., 2000], Revised Brief Visuospatial Memory Test (form 
1) [Benedict, 1997], Controlled Oral Word Association Test (F-A-S form) [Benton et al., 
1994], NIH Toolbox Flanker Inhibitory Control and Attention Test, NIH Toolbox Oral 
Symbol Digit Test (Weintraub et al., 2013) and the Revised Everyday Problems Test 
(Willis et al., 1992). 
Data were collected a second time (T2) three months after the start of the program 
(intervention or attention-control). The T2 questionnaire packet and accelerometer were 
given to the participant at their program meeting (intervention or attention-control). The 
T2 questionnaire packet contained: the Exercise Self-Efficacy Questionnaire (McAuley, 
1993), Godin Leisure-Time Exercise Questionnaire (Godin & Shepard, 1985), Center for 
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Epidemiologic Studies Depression Scale – Revised (Radloff, 1977), Modified Fatigue 
Impact Scale (Fisk, Pontefract et al., 1994), PROMIS v1.0 Cognitive Abilities and 
Cognitive Concerns Scales (Cella et al., 2007), and 7-day Accelerometry Log. The T2 
neuropsychological test battery included: 2nd edition of the California Verbal Learning 
Test (alternate form) [Delis et al., 2000], Revised Brief Visuospatial Memory Test (form 
2) [Benedict, 1997], Controlled Oral Word Association Test (C-F-L form) [Benton et al., 
1994], NIH Toolbox Flanker Inhibitory Control and Attention Test, NIH Toolbox Oral 
Symbol Digit Test (Weintraub et al., 2013) and the Revised Everyday Problems Test 
(Willis et al., 1992). 
 Data were collected a third and final time (T3) at the end of the 6-month program 
(intervention or attention-control). The T3 questionnaire packet and accelerometer was 
given to the participant at their last program meeting (intervention or attention-control). 
The T3 questionnaire packet contained: the Exercise Self-Efficacy Questionnaire 
(McAuley, 1993), Godin Leisure-Time Exercise Questionnaire (Godin & Shepard, 1985), 
Center for Epidemiologic Studies Depression Scale – Revised (Radloff, 1977), Modified 
Fatigue Impact Scale (Fisk, Pontefract, et al., 1994), PROMIS v1.0 Cognitive Abilities 
and Cognitive Concerns Scales (Cella et al., 2007), and 7-day Accelerometry Log. The 
T3 neuropsychological test battery included: 2nd edition of the California Verbal Learning 
Test (standard form) [Delis et al., 2000], Revised Brief Visuospatial Memory Test (form 
3) [Benedict, 1997], Controlled Oral Word Association Test (P-R-W form) [Benton et al., 
1994], NIH Toolbox Flanker Inhibitory Control and Attention Test, NIH Toolbox Oral 
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Symbol Digit Test (Weintraub et al., 2013) and the Revised Everyday Problems Test 
(Willis et al., 1992). 
In addition to the data collected to evaluate the efficacy of the PALMS 
intervention described above, attendance and feasibility data were collected throughout 
the 6-month intervention using an attendance log and PALMS Intervention Log (see 
Appendix D). 
Physical Activity Readiness Questionnaire for Everyone 
The PAR-Q+ is an evidence-based questionnaire designed to facilitate the 
clearance process for physical activity participation among asymptomatic populations as 
well as persons with chronic diseases or conditions. The PAR-Q+ was recently developed 
by an expert panel to address concerns from healthcare providers and fitness 
professionals regarding the utility and effectiveness of the Physical Activity Readiness 
Questionnaire (PAR-Q) (Jamnik et al., 2011; Warburton et al., 2011). The PAR-Q+ 
contains seven general health questions followed by a section of questions probing for the 
presence and impact of chronic medical conditions (e.g., back problems, cancer, 
cardiovascular, pulmonary and metabolic disease). Data collected from the PAR-Q+ is 
reported in the study flow diagram under the number excluded prior to group assignment. 
Symbol Digit Modalities Test (Oral administration) 
The SDMT uses a key of nine abstract geometric symbols paired with a single 
digit number to assess cognitive processing speed (Smith, 1982). The participant is given 
90 seconds to verbalize the digit paired to each of 110 quasi-randomized symbols printed 
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on a single sheet of 8.5 x 11-inch paper with the key printed at the top. The total score 
derived is the number of correct responses recorded by the tester in 90 seconds. A score 
of 55 or less has been suggested as an effective screen to classify patients with MS as 
cognitively impaired versus unimpaired with high reliability, good sensitivity (0.82) and 
specificity (0.60) (Benedict et al., 2012; Parmenter, et al., 2007). High test-retest 
reliability (r = 0.97) has been reported for persons with MS (Benedict, 2005). The SDMT 
has been validated as part of the minimal assessment of cognitive function in multiple 
sclerosis (MACFIMS) battery with very large effect size reported (d = 1.31, p < .001) 
discriminating MS patients and healthy controls (Benedict, Cookfair, et al., 2006). 
Accelerometry 
Accelerometers are a type of motion sensor worn on the wrist, ankle or waist to 
measure physical activity and energy expenditure (Motl et al., 2006). Activity counts 
derived from accelerometers have been identified as the benchmark measure of 
ambulation in persons with neurologic diseases (Pearson et al., 2004). Extensive evidence 
of the validity and reliability has been provided for persons with MS using model 7164 
and model GT3X manufactured by the ActiGraph™ company (ActiGraph™, Pensacola, 
FL) (Gosney, Scott, Snook, & Motl, 2007; Motl et al., 2006; Motl et al., 2010). Activity 
output cut-points for quantifying time spent in sedentary, light and moderate-to-vigorous 
physical activity have been established in persons with MS using both the 7164 and 
GT3X models of accelerometers from ActiGraph™ (Sandroff, Motl, & Suh, 2012). 
ActiGraph™ model wGT3X-BT was used in this study (model 7164 and GT3X models 
have been discontinued). The device captures and records high-resolution human activity 
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information using a solid-state 3-axis accelerometer and proprietary filtering algorithm 
(ActiGraph™, 2016). Data from the devices were downloaded onto a PC via an ActiLife 
USB cable into the ActiLife 6 software. The software converts the raw data file into a 
proprietary *.agd file. The *.agd file data was validated for weartime then scored using 
the cut-points defined by Sandroff et al. (2012). Raw, *.agd, weartime, and scored 
counts/cuts files were created and saved onto password protected devices (PC and jump 
drive). Mean sedentary, light, and moderate-to-vigorous activity counts as well as step 
counts from days with 600+ minutes of wear time at baseline, T2 and T3 were entered 
into SPSS. 
Background Information Sheet 
The background information sheet was used to collect demographic 
characteristics to describe the sample and to evaluate the equivalence between the 
intervention and attention-control groups. Data collected included: age, gender, race, 
ethnicity, years of education, employment status, MS duration and course (relapsing-
remitting, secondary-progressive, primary-progressive, or progressive-remitting). 
Self-Administered Expanded Disability Status Scale 
Bowen, Gibbons, Gianas, and Kraft (2001) developed the self-administered 
modification of Kurtzke’s Expanded Disability Status Scale (EDSS) (Kurtzke, 1983). The 
self-administered form was found to have strong intraclass correlation coefficient to the 
EDSS using gait alone (r = 0.89) or EDSS using functional systems (r = 0.87) compared 
to physician-administered form (Bowen et al., 2001). While Kurtzke’s EDSS has been 
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the subject of both reliability and validity concerns, it is undeniably the most widely used 
method to quantify MS-related functional disability by clinicians and researchers alike 
(Bowen et al., 2001; Schwartz, Vollmer, & Lee, 1999). Scores derived from the EDSS 
range from 0 (normal neurologic function) to 10 (death due to MS) with a score of 4.5 
reflecting the ability to “walk without aid or rest for some 300 meters” (Kurtzke, 1983, p. 
1446). 
Exercise Self-Efficacy Scale 
This is a six-item self-report questionnaire used to measure participants’ level of 
confidence in being able to exercise (0% - not confident at all to 100% - highly confident) 
for 20 plus minutes three times a week at moderate intensity for the next one to six 
months (McAuley, 1993). Score validity and reliability have been supported in studies of 
persons with MS (Motl & McAuley, 2009). 
Godin Leisure-Time Exercise Questionnaire 
This is a self-report measure of physical activity that is used in clinical and 
epidemiologic studies (Godin & Shepard, 1985). The GLTEQ is a two-item measure of 
usual physical activity. The first item measures frequency of physical activity by asking 
the number of times per week the person does strenuous (heart beating rapidly, e.g. 
running), moderate (not exhausting, e.g. fast walking), and mild (minimal effort, e.g. easy 
walking) physical activity for more than 15 minutes during their free time in a typical 
week. These frequencies are multiplied by nine, five, and three metabolic equivalents 
(METS), respectively, and summed to determine a measure of total leisure activity: active 
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- 24 METS or more, moderately active - 14 to 23 METS, or insufficiently active - less 
than 14 METS (Godin, 2011). The second item asks how frequently (often, sometimes, 
never/rarely) the person engages in physical activity long enough to produce sweat during 
a typical week. Validity of the GLTEQ has been established in samples of healthy adults 
and in samples of persons with MS (Amireault & Godin, 2015; Gosney et al., 2007; 
Jacobs, Ainsworth, Hartman, & Leon, 1993; Miller, Freedson, & Kline, 1994; Motl et al., 
2006). 
Center for Epidemiologic Studies Depression Scale 
The CES-D is a measure of depressive symptoms (Radloff, 1977). Evidence 
supports the validity of the CES-D as a measure of depressive symptoms with 
demonstrated internal consistency (α =. 90) in a sample of 696 persons with MS (Verdier-
Taillefer et al., 2001). Individual items on this 20-item summated rating scale are rated 
from 0 to 3 with the total score ranging from 0 to 60. Higher scores indicate more 
depressive symptoms during the past week. The scale is commonly used to classify 
people scoring 15 or less as having no depression and those scoring 16 or above 
indicating elevated depressive symptomology (Radloff, 1977; Verdier-Taillefer et al., 
2001). 
Modified Fatigue Impact Scale 
The MFIS is a 21-item measure of physical, cognitive, and psychosocial function 
effects of fatigue in persons with MS adapted from the Fatigue Impact Scale (Fisk, 
Pontefract et al., 1994). Total and subscale scores are computed with responses scored: 0 
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= never, 1 = rarely, 2 = sometimes, 3 = often, and 4 = almost always. Higher scores 
indicate greater perceived fatigue. The total scale consists of 21 items with scores ranging 
from 0 to 84. The physical subscale has nine items with scores ranging from 0 to 36, the 
cognitive subscale has ten items with scores ranging from 0 to 40, and the psychosocial 
subscale has two items with scores ranging from 0 to 8. Face validity and internal 
consistency (α = .80) for the modified form has been reported previously (Fisk, Ritvo et 
al., 1994). More recently, Cronbach’s alpha reliabilities for the total scale (r = .81), 
physical (r = .91), cognitive (r = .95), and psychosocial (r = .81) subscales have been 
reported (National Multiple Sclerosis Society, 1997). 
Patient-Reported Outcome Measurement Information System (PROMIS) –
Cognitive Abilities and Concerns Scales 
  Two instruments were used to assess self-reported cognitive function: PROMIS 
v1.0-Applied Cognition-Abilities-Short Form 8a and PROMIS v1.0-Applied Cognition-
General Concerns-Short Form 8a. These instruments were developed using Item 
Response Theory, which links item responses to latent traits (e.g., cognitive abilities, 
cognitive concerns) (Cella et al., 2007). Reeve et al. (2007) and Cella et al. (2010) 
provide evidence supporting the psychometric properties of the PROMIS item banks in 
the general population as well as clinical groups. Becker, Stuifbergen and Morrison 
(2012) provide additional evidence of acceptable psychometric properties for the 
PROMIS cognitive abilities and concerns scales in a sample of community-dwelling 
persons with MS.  
The 8-item positively worded cognitive abilities scale assesses perceived 
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cognitive abilities (e.g., attention, thinking, memory) over the preceding 7 days. Item 
responses range from 1 (Not at all) to 5 (Very much). The total score is the sum of item 
responses, which range from 8 to 40. Higher scores represent greater perceived cognitive 
ability.  
The 8-item negatively worded cognitive concerns scale assesses perceived 
cognitive concerns (e.g., slow thinking, trouble concentrating) over the preceding 7 days. 
Item responses range from 1 (Never) to 5 (Very often – Several times a day). The total 
score is the sum of item responses, which also range from 8 to 40. Higher scores 
represent greater perceived cognitive concerns.   
California Verbal Learning Test 
The CVLT-II is a test of auditory/verbal memory (Delis et al., 2000). A list of 16 
words is read aloud to the subject who has been instructed to listen to the list then repeat 
aloud as many as possible. Five trials are conducted with the examiner presenting the 16-
word list aloud each time and recording the number of correct responses after each trial. 
A second list of 16 words is presented and after a 25-minute delay the subject recalls as 
many words as possible then responds to a yes/no recognition test of the second list. Total 
and delayed-recall scores are reported. Two forms of the test, standard and alternate, are 
available for serial testing. Acceptable test-retest reliability (r = 0.78) has been reported 
for the CVLT-II in persons with MS (Benedict, 2005). The CVLT-II has been validated 
as part of the MACFIMS battery with large effect sizes reported for the Total Recall (d = 
.70, p < .001) and Delayed Recall scores (d = .79, p < .001) discriminating MS patients 
and healthy controls (Benedict, Cookfair, et al., 2006). 
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Brief Visuospatial Memory Test 
The BVMT-R is a test of visual/spatial learning and memory (Benedict, 1997). 
The subject is instructed to view a piece of paper showing six graphic figures arranged in 
a 2 x 3 matrix for 10 seconds before the stimulus is withdrawn from view. The subject 
then takes as much time as needed to draw from memory the six figures on a blank 8.5 x 
11-inch piece of paper using a pencil. Three trials are conducted followed by a 25-minute 
delayed recall and yes/no recognition trial. The six-figure trials are judged on accuracy 
and location. Each figure is given 0 to 2 points with the total score ranging from 0 to 12. 
The Total Recall score is the sum of raw scores from the first three trials. The Delayed 
Recall is the raw score of the 25-minute delayed recall trial. Six alternate forms exist for 
serial testing. Good test-retest reliability (r = 0.91) has been reported for the BVMT-R in 
persons with MS (Benedict, 2005). The BVMT-R has been validated as part of the 
MACFIMS battery with very large effect sizes reported for the Total Recall (d = 1.04, p 
< .001) and Delayed Recall scores (d = 1.07, p < .001) discriminating MS patients and 
healthy controls (Benedict, Cookfair, et al., 2006). 
Controlled Oral Word Association Test 
The COWAT is a test of verbal fluency and word finding (Benton et al., 1994). 
Subjects are given three separate trials of 60 seconds to articulate as many words as they 
can that start with one of three stimulus alphabet letters (F-A-S). Alternate forms using 
three different letters (C-F-L and P-R-W) are available for serial testing. The total score 
is the number of different words generated across the three trials. Test-retest reliability 
examined at one-week intervals in 34 persons with MS was high (r = .90) (Benedict, Cox, 
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et al., 2004). The COWAT has been validated as part of the MACFIMS battery with a 
medium effect size reported (d = 0.53, p < .001) discriminating MS patients and healthy 
controls (Benedict, Cookfair, et al., 2006). 
Flanker Inhibitory Control & Attention Test 
The Flanker is a test of attention as well as inhibition of automatic response 
tendencies that tend to interfere with goal achievement. This test is part of the NIH 
Toolbox, a computer-administered battery of brief neuropsychological tests designed for 
use as outcome measures in epidemiologic, longitudinal and clinical trial studies 
(Gershon et al., 2013). Test-retest reliability, convergent and discriminant validity 
derived from an English speaking representative sample of 476 participants has been 
reported for all of the NIH Toolbox instruments (Weintraub et al., 2013). The Flanker 
consists of 20 trials where the participant is asked to indicate the direction of the middle 
stimulus (< or >) using the keyboard arrow key corresponding the stimulus. The task 
requires the participant to inhibit attention to stimuli adjacent to the middle stimulus. The 
middle stimulus is randomly presented congruently or incongruently to the “flanking” 
stimuli. The Flanker test takes about 3 minutes to administer and produces several scores: 
computed accuracy + reaction time score, age-adjusted scale score, fully-adjusted scale 
score, and national percentile ranking. The computed accuracy + reaction time score was 
used in the analysis since the goal of this study is to ascertain individual and group 
differences rather than comparisons to normative data.  
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Oral Symbol Digit Test 
The OSD, also part of the NIH Toolbox, is a computerized version of the Oral 
Symbol Digit Test that assesses processing speed (mental efficiency) – the amount of 
time it takes to process a set amount of information (Weintraub et al., 2013). Participants 
are shown a key of nine abstract symbols paired with a number from 1 to 9. They use the 
key to verbally indicate which number goes with each symbol presented in a long string 
of 144 symbols on the computer screen. The participant is given 120 seconds to call out 
the number matching each symbol, in order, without skipping, as fast as possible. The 
score is the number of correct responses given ranging from 0 to 144.  
Everyday Problems Test 
The Everyday Problems Test-Revised (EPT-R) is a measure of neurocognitive 
functioning in everyday life developed in a study of elders (Willis et al., 1992). The 
revised 30-item EPT-R assesses performance in seven areas: household management, 
transportation, financial management, shopping, phone use, medication use, and nutrition 
and meal preparation. Internal consistency and 2-month test/retest reliability for the EPT-
R were greater than 0.83 after pilot testing in a sample of 29 persons with MS (Becker et 
al., 2012). Construct and convergent validity were established in the original study with 
elders (Willis et al., 1992). The EPT-R holds promise for being sensitive to change after 
interventions designed to promote cognitive function in persons with MS (Becker et al., 
2012). 
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PALMS Intervention Log 
The PALMS Intervention Log was used to collect physiologic and subjective data 
to evaluate the feasibility of the intervention program (See Appendix D). Data collected 
included: heart rate and ratings of perceived exertion using the 10 point modified Borg 
scale taken every 10 minutes starting at baseline then throughout the intervention session. 
At the end of the intervention session participants were asked how they felt on a 10-point 
scale (+5 = very good, 0 = neutral, to – 5 = very bad), rated their physical and mental 
fatigue on a 0 (none) to 10 (strongest feeling) scale, and rated how much they enjoyed the 
session from 1 (not at all) to 7 (very much). Brief qualitative notes were taken to 
document participant behavior and/or comments. 
PALMS Physical Activity Log 
The PALMS Physical Activity Log was given to intervention participants to 
collect self-report data on the frequency, type and length (in minutes) of physical activity 
the intervention group participants do outside of the PALMS intervention sessions. 
Participants took the form home with them but did not fill it out and return it to the 
principal investigator despite several gentle requests.   
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Table 3. Summary of Study Instruments 
Instrument Variable(s) Subscales Number 
Physical Activity Readiness 
Questionnaire Plus [PAR-Q+] 
(Jamnik et al., 2011) 
Health-related physical activity risk 
N/A 16-items 
Symbol Digit Modalities Test1 
[SDMT] (Smith, 1982) 
Psychomotor speed, attention/integration N/A 110-trials 
Accelerometry - ActiGraph™ 
model wGT3X-BT 
Physical activity: sedentary, light, moderate-
to-vigorous activity, and step counts N/A N/A 
Background Information Sheet Demographic data and MS characteristics N/A 14-items 
Self-Administered Expanded 
Disability Status Scale1 
[EDSS] (Bowen et al., 2001; 
Kurtzke, 1983) 
Functional disability based on eight 
functional systems: ambulation, pyramidal, 
cerebellar, sensation, bladder/bowel, vision, 
brainstem, and cerebral 
N/A 42-items 
Exercise Self-Efficacy 
Questionnaire [ExSE] 
(McAuley, 1993) 
Exercise self-efficacy 
N/A 6 items 
Godin Leisure-Time Exercise 
Questionnaire [GLTEQ] 
(Godin & Shepard, 1985) 
Physical activity 
N/A 4 items 
Center for Epidemiologic 
Studies Depression Scale-
Revised [CES-D] (Radloff, 
1977) 
Depressive symptoms 
N/A 20 items 
Modified Fatigue Impact Scale 
[MFIS] (Fisk, Pontefract et al., 
1994) 
Perceived fatigue Total Scale 21 items 
Physical 
subscale 9 items 
Cognitive 
subscale 
10 
items 
Psychosocial 
subscale 2 items 
PROMIS Cognitive Abilities 
(Cella et al., 2007) 
Self-reported cognitive abilities 
N/A 8 items 
PROMIS Cognitive Concerns 
(Cella et al., 2007) 
Self-reported cognitive concerns N/A 8 items 
California Verbal Learning 
Test1 [CVLT-II] (Delis et al., 
2000) 
Auditory/verbal learning Total Recall 5 trials 
Delayed recall 1 trial 
Brief Visuospatial Memory 
Test1  [BVMT-R] (Benedict, 
1997) 
Nonverbal learning and memory Total Recall 3 trials 
Delayed recall 1 trial 
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Table 3. Summary of Study Instruments (continued) 
 
Instrument Variable(s) Subscales Number 
Controlled Oral Word Association 
Test [COWAT] (Benton et al., 
1994) 
Verbal fluency and word finding 
N/A 1 trial 
NIH Toolbox - Flanker Inhibitory 
Control & Attention Test2 
[Flanker] (Weintraub et al., 2013)  
Executive function, visuospatial attention, 
and inhibitory control N/A 1 trial – 20 stimuli 
NIH Toolbox - Oral Symbol Digit 
Test2 [OSD] (Weintraub et al., 
2013) 
Processing speed 
N/A 1 trial – 144 stimuli 
Everyday Problems Test-Revised1 
[EPT-R] (Willis et al., 1992) 
Self-reported neurocognitive functioning in 
everyday life N/A 30 items 
PALMS Intervention Log Log maintained by investigator to evaluate 
participant response to PALMS 
intervention sessions 
N/A 22 items 
PALMS Physical Activity Log Participant log to evaluate frequency, 
duration, and mode of physical activity 
outside of PALMS intervention sessions 
N/A Daily 
1=Proprietary; 2=Proprietary/Online only 
 
DATA ANALYSIS 
All analyses were conducted using SPSS Statistics version 23 (IBM, 2015). Data 
were checked for accuracy and evaluated for violations of statistical tests described 
below. If assumptions were violated, alternative tests were used if available. Internal 
consistency reliability was determined for each instrument (as appropriate) yielding 
reliability coefficients of .79 and above. Descriptive data analyses were performed to 
obtain a profile of the sample on demographic and illness-related variables. The groups 
were compared at baseline on demographic and disease variables; if differences were 
found, these variables were considered as covariates in the analyses described below. The 
significance level for all tests was .05. Analyses were conducted using the “intention to 
treat” principle (Hollis & Campbell, 1999). Physical activity data were downloaded from 
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the accelerometers worn for seven days at baseline, 3-months, and 6-months (post-
intervention). 
RQ 1. 
What is the feasibility of delivering a small group moderate-intensity exercise 
program for persons with MS over a 6-month time period? 
RQ 1.1. 
What is pattern of response to and enrollment in the study? 
RQ 1.2. 
What is the attendance pattern across the 6-months for the intervention and 
attention-control groups? 
RQ 1.3. 
What is the frequency, duration, and mode of physical activity documented in the 
PALMS physical activity log? 
RQ 1.4. 
How do participants respond to the PALMS intervention (heart rate, ratings of 
perceived exertion, physical and mental fatigue, general wellbeing, and enjoyment)?  
The feasibility of conducting the intervention was assessed using process 
evaluation methods and descriptive statistics (e.g., frequencies, percentages). Data were 
collected using recruitment and attendance logs to examine the processes of (a) 
recruiting, (b) enrolling participants and (c) delivering the intervention. The recruitment 
log documented where letters were sent, notices posted, and recruiting presentations 
made. Inquiries received were queried as to which recruitment method they were 
responding to, whether the inquirer was subsequently enrolled, and into which arm of the 
study they were assigned.  
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RQ 2. 
What are the effects of the Physically Active Lifestyle in MS (PALMS) 
intervention? 
 RQ 2.1. 
What are the within-group, between-groups, and group-by-time interaction effects 
on the primary outcomes of clinical cognitive function (California Verbal Learning Test 
[CVLT], Brief Visuospatial Memory Test [BVMT], Controlled Oral Word Association 
Test [COWAT], NIH Toolbox Flanker Inhibitory Control and Attention Test [Flanker], 
NIH Toolbox Oral Symbol Digit Test [OSD]), self-reported cognitive abilities and 
concerns (Patient-Reported Outcomes Measurement Information System [PROMIS] v1.0 
Cognitive Abilities and Cognitive Concerns Scales), and neurocognitive function in 
everyday life (revised Everyday Problems Test [EPT-R]) (Benedict, 1997; Benton et al., 
1994; Cella et al., 2007; Delis et al., 2000; Weintraub et al., 2013; Willis et al., 1992)?  
 
RQ 2.2. 
What are the within-group, between-groups and group-by-time interaction effects 
on the secondary outcomes of exercise self-efficacy [ExSE], physical activity [GLTQ and 
accelerometer counts: sedentary, light, moderate-to-vigorous physical activity, and steps], 
depressive symptoms [CES-D], and fatigue [MFIS] (Fisk, Pontefract et al., 1994; Godin 
& Shepard, 1985; McAuley, 1993; Pearson et al., 2004; Radloff, 1977)? 
To determine the effect of the PALMS intervention on the outcome measures - 
California Verbal Learning Test (CVLT), Brief Visuospatial Memory Test (BVMT), 
Controlled Oral Word Association Test (COWAT), NIH Toolbox Flanker Inhibitory 
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Control and Attention Test (Flanker), NIH Toolbox Oral Symbol Digit Test (OSD), 
PROMIS Cognitive Abilities and Cognitive Concerns Scales, revised Everyday Problems 
Test (EPT-R), Exercise Self-Efficacy Questionnaire (ExSE), Godin Leisure-Time 
Exercise Questionnaire (GLTEQ), Accelerometer counts (sedentary, light, moderate-to-
vigorous physical activity, steps), Center for Epidemiologic Studies Depression Scale-
Revised (CES-D), and Modified Fatigue Impact Scale (MFIS) - a 2 (intervention and 
control) by 3 (baseline, 3-month and 6-month post-intervention data) mixed effects 
analysis of variance design was used (Benedict, 1997; Benton et al., 1994; Cella et al., 
2007; Delis et al., 2000; Fisk, Pontefract et al., 1994; Godin & Shepard, 1985; McAuley, 
1993; Radloff, 1977; Weintraub et al., 2013; Willis et al., 1992). The multivariate 
approach to repeated measures was applied to avoid the more stringent assumptions of 
the univariate model. Each outcome was analyzed separately. Because this was a pilot 
feasibility study with a small sample size (N = 16), there is increased risk of making a 
type II error. Therefore, the α level for all analyses remained at the .05 level rather than 
adjusting for experiment wide error (Lipsey, 1990). The test of the time-by-group 
interaction was assessed for differences in gains over time between the experimental and 
control groups on the primary and secondary outcomes. Effect sizes for all analyses were 
calculated (η2) to provide data for future studies with larger sample sizes. 
SUMMARY 
 This chapter provided a description of the methods that were used to collect and 
analyze the data in this quasi-experimental study, which focused on the feasibility and 
effects of a six-month program of supervised physical activity. The study investigated 
 80 
clinical cognitive function, self-reported cognitive abilities and concerns, and cognitive 
function in everyday life as primary outcomes as well as exercise self-efficacy, physical 
activity, depressive symptoms and fatigue as secondary outcomes. Data was collected at 
baseline, 3-months and at 6-months (immediately post-intervention). Descriptive 
statistics, mixed effects analysis of variance and determination of effect size using SPSS 
23.0 (IBM, 2015) was employed to address the research questions posed in this study. 
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Chapter 4: Results 
Chapter 4 presents the results of this dissertation study. The first section presents 
the results derived from screening the data and assessing scale reliability. The second 
section profiles the study sample (n=16) on demographic and illness-related variables 
using descriptive statistics. This section also presents data comparing the intervention 
(n=8) and attention-control (n=8) groups at baseline. The third section presents analyses 
of the first research question related to the feasibility of the PALMS study. The final 
section presents the results of analyses examining the effects of the PALMS study.  
DATA SCREENING 
Data were extracted from questionnaires, neuropsychological test records, and 
ActiGraph accelerometers collected at baseline, T2 (3 months), and T3 (6 months) 
immediately after the intervention ended. Attendance data were collected over the course 
of the study for all participants (n=16) while data for the participants in the intervention 
group (n=8) were extracted from each participant’s PALMS intervention log. Data were 
entered into and analyzed using IBM SPSS Statistics version 23 for Windows. Analyses 
were conducted using the “intention to treat” principle (Hollis & Campbell, 1999). 
Baseline values were copied and pasted into T2 and T3 for the single individual who 
dropped out of the study. The SPSS data file was proofread against the original data for 
accuracy by the principal investigator and a volunteer. Univariate descriptive statistics 
were examined for missing data, out-of-range values, plausible means and standard 
deviations as outlined by Tabachnick and Fidell (2013).  
Cronbach’s alpha coefficient, a measure of internal consistency reliability, was 
determined to be greater than .83 at baseline, 3- and 6-months for the three summed 
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scales with fewer items than participants used in this study: ExSE, PROMIS cognitive 
abilities and concerns (Cella et al., 2007; Godin & Shepard, 1985). Alpha coefficients 
greater than 0.70 support the proposition that the items in a scale ‘hang together’ and 
reflect the same underlying construct (Warner, 2013). Internal consistency reliability was 
not appraised for the 21-item MFIS or 20-item CES-D since alpha coefficients tend to be 
imprecise (inflated) and not accurately reflect the population when the sample size is 
smaller than the number of items in a scale (Charter, 2003; Fisk, Pontefract et al., 1994; 
Radloff, 1977). 
Table 4.1 Internal Consistency Reliability  
  Cronbach’s Alpha Coefficient 
Instrument # of Items Baseline (n=16) 
T2 (3-months) 
(n=16) 
T3 (6-months) 
(n=16) 
ExSE 6 0.97 0.99 0.99 
PROMIS Cognitive Abilities 8 0.93 0.92 0.92 
PROMIS Cognitive Concerns 8 0.96 0.88 0.83 
ExSE = Exercise Self-Efficacy Scale 
SAMPLE  
Demographic characteristics of the participants successfully recruited into this 
study are as follows: the sample was primarily female (n = 11) and middle-aged with 
mean age of 45.6 + 9.1 years. The sample was mostly White (n=11) but included three 
African American and three Hispanic participants. Marital status varied among the 
sample: eight were married, four had never been married, two were divorced, one 
separated, and one lived with a significant other. Educational achievement among the 
sample was high; 12 had college degrees (associates to graduate) and four had graduated 
from high school. Employment was diverse: four worked full-time, four part-time, four 
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were unemployed due to disability, two were full-time homemakers, one was a full-time 
homemaker who also had a part-time job, one was unable to find work because of where 
she lived. Over 80% of the sample described their MS course as relapsing-remitting while 
two indicated primary progressive and another secondary progressive MS. Neurologic 
functional status was characterized using the self-reported form of Kurtzke’s Expanded 
Disability Statues Scale [EDSS] (Bowen et al., 2001, Kurtzke, 1983). Scores ranged from 
3.0 to 6.0 on the 0 - 10 EDSS scale (‘normal neurologic function’ to ‘death ascribed to 
MS’, respectively). Mean EDSS score for the sample was 4.5 + 1.1. Scores less than 4.0 
reflect mild MS, scores 4.0 to 5.5 moderate MS, and scores 6.0 and higher indicate severe 
MS (Oynhausen et al., 2014). Ambulatory aides, such as the use of a single cane, are 
heavily weighted in the EDSS system garnering a score of 6.0 or higher even though 
other neurologic functional systems (cognition, vision, sensation, balance, strength, 
bladder/bowel, brainstem) may be relatively intact. The four participants with total EDSS 
scores of 6.0 used a single cane when ambulating. Cognitive function impairment was 
appraised using the Symbol Digit Modality Test (SDMT) administered prior to 
enrollment. Participants had an average score of 41.7 + 10.0 with scores ranging from 20 
to 56. 
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Table 4.2 Sample Demographics (N=16) 
Characteristic   n % Mean (SD) Range 
Age (years)  16  45.6 (9.1) 31-58 
MS duration (years)  16  11.5 (8.3) <1-29 
Education (years)  16  16.6 (2.6) 12-20 
EDSS score  16  4.5 (1.1) 3.0-6.0 
SDMT score  16  41.7 (10.0) 20-56 
Gender Female 11 69   
 Male 5 31   
Race White 13 81   
 African American 3 19   
Ethnicity Hispanic 3 19   
 Non-Hispanic 13 81   
Marital Status Married 8 50   
 Never married 4 25   
 Divorced 2 13   
 Separated 1 6   
 Living with significant other 1 6   
Highest Education High school diploma 4 25   
 Associates degree 3 19   
 Bachelors degree 6 38   
 Graduate degree (masters or doctorate) 3 19   
Employment Work full-time 4 25   
 Work part-time 4 25   
 Homemaker full-time 2 13   
 Homemaker full-time + part-time job 1 6   
 Unemployed due to disability 4 25   
 Unable to find suitable work 1 6   
MS Course Relapsing-Remitting 13 81   
 Primary Progressive 2 13   
 Secondary Progressive 1 6     
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 Baseline data for demographic and illness variables were examined for 
group equivalence. Continuous level variables examined include: age, years of education, 
MS duration, EDSS scores and SDMT scores. Nominal level variables examined include: 
gender, race, ethnicity, marital status, highest education, employment, and MS course.  
A number of outliers were identified and the Shapiro-Wilkes test of normality was 
not met for all continuous variables. Therefore, both parametric (independent-samples t-
test) and nonparametric (Mann-Whitney U test) procedures were used. Results from 
parametric (t >.05) and nonparametric tests (U >.05) support accepting the null 
hypothesis:  
Ho: the means for the selected variables (age, MS duration, EDSS, SDMT, years 
of education) for the intervention and attention-control groups are equal (i.e., µ1 = µ2) 
Nominal level variables were examined using descriptive statistics. Assumptions 
for using a chi-square or related test (Fisher’s exact or McNemar’s test) were not met due 
to the small sample size, which require cell size frequencies greater than 10 (Plitchta, 
Kelvin, & Munro, 2013, p. 290). The intervention and attention control groups were 
reasonably alike for gender, marital status, highest education attained, employment, and 
MS disease course. The two groups were less similar for race or ethnicity. The attention 
control group was 100% White while the intervention group, with three African 
Americans, was 63% White. The three Hispanic participants were in the attention-control 
group while the intervention group was 100% non-Hispanic. The data presented below 
were collapsed into larger categories for clarity. 
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Table 4.3 Group Demographics  
    Intervention           (n=8) 
Attention-Control 
(n=8) 
Characteristic   n % Mean (SD) n % Mean (SD) 
Gender        
 Female 5 63%  6 75%  
 Male 3 38%  2 25%  
Race        
 White 5 63%  8 100%  
 African American 3 38%  0 0%  
Ethnicity        
 Hispanic 0 0%  3 38%  
 Non-Hispanic 8 100%  5 63%  
Marital 
Status        
 
Married or living with a significant 
other 4 50%  4 50%  
 Never married, divorced or separated 4 50%  4 50%  
Employment        
 Work full- or part-time 4 50%  5 63%  
 Do not work outside of the home 4 50%  3 38%  
MS Course        
 Relapsing-Remitting 6 75%  7 88%  
  Progressive 2 25%  1 13%  
Education        
 High school diploma 1 13%  3 38%  
 
Associates, bachelors, or graduate 
degree 7 88%  5 63%  
 Total years 8  16.6 (2.2) 8  15.5 (3.1) 
EDSS        
 Total score 8  4.0 (1.1) 8  4.7 (1.4) 
SDMT        
 Total score 8  43.0 (7.9) 8  40.4 (12.3) 
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FEASIBILITY OF THE PALMS STUDY 
RQ 1.  
What is the feasibility of delivering a small group moderate-intensity exercise 
program for persons with MS over a 6-month time period? 
RQ1.1.  
What is the pattern of response to and enrollment in the study? 
Study participants were recruited through several strategies implemented over 13 
months (November, 2014 to December, 2015). The largest number of participants heard 
about the study from 10 presentations the PI made to National MS Society (NMSS) 
support groups (n=7). The other 9 participants heard about the study through emails sent 
to NMSS support members by the group leaders (n=3), referrals from MS neurologists 
and nurses (n=3), personal referrals from study participants (n=2), as well as YMCA staff 
(n=1). The first six participants were recruited from November 2014 to February 2015. 
While most (n=12) of those expressing interest in the study by calling or emailing the PI 
were enrolled within one month’s time, four participants were enrolled many months (8 
to 11 months) after initially expressing interest. 
Thirty-seven individuals contacted the PI to express interest in participating in the 
study. Reasons for not being deemed eligible to participate in the study included: being 
too physically active (n=11), age over 60 (n=2), using more than one cane to ambulate 
(n=2), not having transportation to get to the intervention or attention-control site (n=2), 
living outside of the Austin area (n=1), scoring well above the 55 cut point on the SDMT 
(n=1), or being too busy to attend twice weekly classes for 6 months (n=2).  
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Figure 4.1 PALMS Flowchart 
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RQ 1.2.  
What is the attendance pattern across the 6-months for the intervention and 
attention-control groups? 
Participants were offered a total of 52 classes (two classes a week for 6 months). 
The 8 participants assigned to the intervention group attended an average of 43.5 + 7.93 
classes; range 31 to 52 classes (60% - 100%). The 8 participants assigned to the attention-
control group attended an average of 24.6 + 15.19 classes; range 2 to 42 classes (4% to 
81%). Attendance for the two groups was significantly different, t(14) = -3.12, p<.01. 
Absence patterns varied between the two groups. Seven of the 8 intervention 
group participants had no discernable pattern among class absences while one was unable 
to attend classes 39-52 after moving to San Antonio. This participant attended three 
classes after her move even though the drive to the YMCA was more than an hour each 
way in rush hour traffic and she had worked all day. In the attention-control group, one 
participant attended the first two classes before dropping out of the study. Another 
participant in this group notified the PI that he was unable to continue attending classes 
due to work obligations (part-time occasional job). He had attended 8 classes over 13 
weeks. The remainder of the group’s absences had no discernable pattern.
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Figure 4.2 Group Attendance 
 
RQ1.3.  
What is the frequency, duration, and mode of physical activity documented in the 
PALMS physical activity log? 
Participants in the intervention group were asked to keep a log of physical 
activities done outside of the twice-a-week meetings with the PI. The PI provided 
participants copies of the log (see Appendix D). Despite numerous prompts and 
reminders from the PI, none of the eight participants completed the log. Therefore, the PI 
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routinely asked participants what they had done outside of class and made notes in their 
PALMS Intervention Log. While some of the participants occasionally remarked that 
they had taken short walks with their family, gone to a park, or ridden a bike; few 
participated in additional physical activities outside of class.  
RQ 1.4.  
How do participants respond to the PALMS intervention (heart rate, ratings of 
perceived exertion, physical and mental fatigue, general wellbeing, and enjoyment)? 
Data were collected at each intervention class to monitor and assess level of 
exercise intensity. Baseline resting heart rate was used to calculate goal heart rate range 
(40-60% of heart rate reserve) for each participant. Participants wore a Polar® FT-1 heart 
monitor around their chest which displays continuously on the FT-1 wrist unit. 
Participants were asked, “How hard do you feel you are working?” using the 10-point 
Berg Scale Heart rate to determine their rating of perceived exertion [RPE] (Borg, 1998).  
Heart rate and RPE were assessed at the beginning of each class and every 10 minutes 
thereafter and documented in the participant’s PALMS activity log.  
The majority of participants (n=5) attained a heart rate within their goal heart rate 
range at every class. One participant achieved their goal at 96% of the classes, while two 
hit their goal infrequently (36% and 11% respectively). Figure 4.3 illustrates the mean 
heart rate for each intervention participant taken every 10 minutes throughout the hour -
long class. The pattern of response shows an increase in HR during the first 30 minutes of 
the class that corresponds to the aerobic exercise component. Some participants’ heart 
rate increase was greater than others, which was directly related to the effort (intensity) 
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put into the exercise. Anecdotally, participants’ level of effort did not change much over 
the course of the program; those that exerted themselves at the start did so consistently to 
the end of the 6-month program and the same for those who did not exert a great deal of 
effort.  
Figure 4.3 Intervention Mean Heart Rate 
The PI used the ‘talk test’ method to monitor participant exercise intensity during 
the classes. Persons able to talk comfortably in short sentences during exercise are 
considered to be below the first ventilator threshold (VT1), the point at which ventilation 
rates increase to expel carbon dioxide resulting from buffering lactic acid (American 
Council on Exercise, 2010). VT1 approximates the study’s target rating of perceived 
exertion (RPE) of 3 to 4 on the 0 to 10 Borg RPE scale (American Council on Exercise, 
2010; Borg, 1998). Participants exercising at higher intensity spoke much less and in 
short one- or two-word sentences than participants exercising at lower intensity who 
spoke a great deal. One participant had a consistently high heart rate upon arrival to the 
YMCA. Her resting heart rate was 78 and her mean baseline heart rate was 
110.63+12.36. The PI interrupted the aerobic exercise sessions a number of times when 
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her heart rate exceeded 90% HRR to get the participant to ‘take it easy.’ Assessment of 
the participant at the time noted that she was smiling, able to talk albeit in one or two 
words, and feeling ‘good.’ Upon further investigation, the participant reported taking a 
prescription stimulant for fatigue, which would explain the elevated heart rate. The PI 
monitored the participant’s heart rate continuously throughout the exercise session by 
observing the signal from the Polar® chest strap, which was displayed on the cardio 
equipment.  
Figure 4.4 Intervention Mean Ratings of Perceived Exertion 
Six of the eight participants attained the targeted goal RPE (from 3 to 7 on the 10-
point scale) at every class (Borg, 1998). The other two achieved their goal (92% and 
96%). Most of the time participants reported RPE levels above 3 even though their heart 
rate did not reflect a corresponding increase. Two participants were notable in this regard. 
One participant with Primary Progressive MS told the PI that he needed to conserve 
energy to get through the day. His RPE peaked around 20-minutes, which the PI 
interpreted as the point where he decided he had pushed himself enough for the day. A 
second participant whose heart rate remained low throughout the class reported extreme 
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fatigue (clearly apparent to the PI) at baseline and displayed a rising RPE pattern, which 
did not decrease after 5 minutes of cool down and stretching at the end of the class.  
At the end of every exercise class, participants were shown diagrams and asked to 
use them to rate their (1) mental and physical fatigue on a scale from 0 (no 
mental/physical fatigue) to 10 (strongest feelings of mental/physical fatigue ever felt); (2) 
general well being on a scale from +5 (very good) to -5 (very bad); and (3) their level of 
enjoyment on a scale from 1 (not at all) to 7 (very much) to assess their response to the 
intervention. Figures 4.5 - 4.6 show overall mean ratings for individual participants rather 
than for the total group. Numbers on the horizontal axes correspond to the same 
participant in each figure. Individual participant ratings of fatigue (physical and mental), 
well being, and enjoyment are displayed in Appendix E.  
Figure 4.5 Individual Post-Class Mean Fatigue 
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Mean physical fatigue rating for the total group was 3.99 + 2.33, ranging from 
0.97 to 6.73 on the 0 to 10-scale (higher ratings indicate higher levels of physical 
fatigue). Mean mental fatigue rating for the total group on the same scale was 3.20 + 
2.30, ranging from 0.39 to 5.54. Figure 4.5 shows that there was a great deal of variance 
in mean ratings of physical and mental fatigue among the participants in the intervention 
group.  
Figure 4.6 Individual Post-Class Mean Well Being 
Total group ratings of general well being had a mean score of 3.19 + 1.66, and 
ranged from 0.03 to 4.92 on the +5 to -5 scale. Positive scores indicated feeling good, 
negative scores indicated feeling bad, and 0 indicated a neutral feeling. None of the 
participants reported feeling bad after the class. The participant with the lowest well 
being mean score (0.03+1.5) attended 38 of the 52 classes. Despite frequent comments to 
the PI about parathesias (e.g., tingling sensations, pins and needles) involving her right 
chest wall, leg and foot and significant fatigue most days, the participant reported 
enjoying the class ‘very much’ after every class (7.0+0.0). Notably, four months into the 
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intervention, she applied for, and got, a part-time job. This was the first time in seven 
years she had sought employment.  
Total group mean rating of enjoyment was 6.38 + 0.85, ranging from 4.8 
(somewhat) to 7.0 (very much). As can be seen in Figure 4.7, there was very little 
variation in responses to the question “How much did you enjoy your exercise session 
today”. The PI did not probe further about the source of enjoyment. Participants may 
have interpreted the question more broadly than ‘doing the exercises’ to include the 
friendly ambiance of the YMCA, the one-on-one attention from the PI, or the sense of 
personal satisfaction derived from completing the exercise session.  
Figure 4.7 Individual Post-Class Mean Enjoyment 
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RQ 2.1.  
What are the within groups, between-groups, and group-by-time interaction 
effects on the primary outcomes of clinical cognitive function (California Verbal 
Learning Test [CVLT] Brief Visuospatial Memory Test [BVMT], Controlled Oral Word 
Association Test [COWAT], the NIH Toolbox Flanker Inhibitory Control and Attention 
Test, and the NIH Toolbox Oral Symbol Digit Test), self-reported cognitive abilities and 
concerns (PROMIS v1.0 Cognitive Abilities and Cognitive Concerns Scales), and 
neurocognitive function in everyday life (revised Everyday Problems Test [EPT-R] 
(Benedict, 1997; Benton et al., 1994; Cella et al., 2007; Delis et al., 2000; Weintraub et 
al., 2013; Willis et al., 1992)? 
Primary outcome data were examined for outliers and violations of the 
assumptions required for conducting a two-way mixed analyses of variance (ANOVA): 
normality, homogeneity of variance, homogeneity of covariance, and sphericity (Table 
4.4). There were three outliers, as assessed by boxplot, but none as assessed by 
studentized residuals. The data were normally distributed, as assessed by Shapiro-Wilk’s 
test of normality (p>.05). Levene’s test of homogeneity of variance was not met (p>.05) 
for BVMT-total, COWAT, and EPT-R, while the assumption of homogeneity of 
covariance, as assessed by Box’s M test, was met for all variables (p>.05). Mauchley’s 
test of sphericity indicated that the assumption of sphericity was violated for the two-way 
interactions in: BVMT-delayed, Χ2(2) = 7.009, p=.030; Flanker, Χ2(2) = 11.290, p=.004; 
PROMIS-concerns, Χ2(2) = 6.104, p=.047; and PROMIS-abilities, Χ2(2) = 10.666, 
p=.005; but the assumption was met in: BVMT-total, Χ2(2) = 2.826, p=.243; CVLT-total, 
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Χ2(2) = .617, p=.734; CVLT-delayed, Χ2(2) = .012, p=.994; COWAT, Χ2(2) = .889, 
p=.641; and OSD Χ2(2) = 1.326, p=.515. 
Outlying values were located in the original data collection instrument (e.g., 
questionnaire) to confirm that the value had been entered correctly. The analyses 
proceeded as planned without deleting cases or transformations. Unfortunately, there is 
not a nonparametric alternative to the two-way mixed ANOVA and transformation of 
variables “are not universally recommended” and “are sometimes harder to interpret” 
(Tabachnick & Fidell, 2013, p. 86). 
Table 4.4 Primary Outcome Variables - Outliers and Assumptions  
Instrument 
Outliers: 
Box 
Plots 
Outliers: 
Studentized 
Residuals 
+/- 3 SD  
Sharpiro-
Wilkes 
Test of 
Normality 
Levene's 
Homogeneity 
of Variance 
Box's 
Homogeneity 
of 
Covariances 
Mauchley's 
Test of 
Sphericity 
BVMT-total     Yes No Yes Yes 
BVMT-
delayed     Yes Yes Yes No 
CVLT-total     Yes Yes Yes Yes 
CVLT-delayed     Yes Yes Yes Yes 
COWAT 116-T2   Yes No Yes Yes 
Flanker     Yes Yes Yes No 
OSD     Yes Yes Yes Yes 
EPT-R     Yes No Yes Yes 
PROMIS-
concerns 103-T2   No Yes Yes No 
PROMIS-
abilities 111-T1   Yes Yes Yes No 
BVMT, Brief Visuospatial Memory Test-Revised; CVLT, California Verbal Learning Test-II; COWAT, Controlled Oral Word 
Association Test; Flanker, Flanker Inhibitory Control and Attention Test; OSD, Oral Symbol Digit Test; PROMIS-abilities, PROMIS 
Cognitive Abilities; PROMIS-concerns, PROMIS Cognitive Concerns; EPT-R, Everyday Problems Test-Revised 
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There were no statistically significant interactions between group and time on any 
of the primary outcome variables (see Table 4.5). The main group effect showed that 
there were no statistically significant differences between groups. The main effect of time 
was significant for CVLT-total, COWAT, OSD, and PROMIS-concerns, while not 
significant for BVMT-total, BVMT-delayed, CVLT-delayed, Flanker, EPT-R and 
PROMIS-abilities. 
Effect size, a reflection of practical significance, was reported in the SPSS output 
as partial eta squared. Partial eta squared in this two-way mixed ANOVA is interpreted as 
the proportion of variance in the dependent variable that is predicted by the level of the 
independent variable (time, group, and their interaction) after variance attributable to 
using the same subjects has been removed (Tabachnick & Fidell, 2013; Warner, 2013).  
Partial eta squared is computed by dividing the sum of squares for the treatment (e.g., 
group, time, or their interaction) by the sum of the sum of squares for the treatment plus 
the sum of squares for the error term: 
Partial η2 = SStreatment/(SStreatment + SSerror)  (Warner, 2013, p. 991) 
The repeated-measures design allows individual differences that do not vary to be 
partialled out from the error term because the same subjects are used resulting in better 
statistical power compared to when different subjects are used (i.e., two-way ANOVA). 
Cohen (1988) offers guidance for cautiously interpreting the size of eta squared: small 
effect (η2= .01), medium effect (η2 = .09), and large effect (η2 = .25). While none of the 
interaction effects among the primary outcomes were statistically significant, effect sizes 
usable in future studies were obtained. PROMIS-cognitive concerns had a medium effect 
size (η2 = .114) associated with the interaction effect; CVLT-total, CVLT-delayed, 
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COWAT, Flanker, OSD, EPT-R and PROMIS-cognitive abilities had small effect sizes 
(η2 = .016 to .073); BVMT-total, BVMT-delayed were trivial (η2 = .005 and .003 
respectively). There were also a number of moderate effects associated with the change 
over time for both groups and large effects for cognitive concerns, COWAT, and the 
OSD.  
Post-hoc pairwise comparisons for the total sample that had significant main 
effects for time indicate several statistically significant mean differences among the 
primary variables: CVLT-total, T2:T3, p=.023; OSD, T1:T2, p=.011 and T1:T3, p=.010; 
PROMIS-concerns, T1:T2, p=.038 and T1:T3, p=.029; PROMIS-abilities, T1:T3, p=.022 
(means/standard deviations displayed in Table 4.6).  
Figure 4.8 Significant primary outcome pairwise comparisons 
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Figure 4.8 Significant primary outcome pairwise comparisons (continued) 
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Figure 4.8 Significant primary outcome pairwise comparisons (continued) 
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Table 4.5 Primary Outcome Variables - Two way Mixed ANOVA  
Instrument Interaction effect Main Effect of Group Main effect of Time 
BVMT-
total F(2, 28) = .066, p = .936, partial η
2 = .005 F(1, 14) = .159, p = .696, partial η2 = .011 F(2, 28) = .085, p = .919, partial η2 = .006 
BVMT-
delayed F(2, 28) = .043, p = .909, partial η
2 = .003 F(1, 14) = .423, p = .526, partial η2 = .029 F(2, 28) = .821, p = .416, partial η2 = .055 
CVLT-total F(2, 28) = .402 p = .673, partial η2 = .028 F(1, 14) = .056, p = .817, partial η2 = .004 F(2, 28) = 4.462, p = .021*, partial η2 = .242 
CVLT-
delayed F(2, 28) = .232 p = .794, partial η
2 = .016 F(1, 14) = .192, p  = .668, partial η2 = .014 F(2, 28) = 1.197, p = .317, partial η2 = .079 
COWAT F(2, 28) = .862 p = .433, partial η2 = .058 F(1, 14) = 1.695, p = .214, partial η2 = .108 F(2, 28) = 4.710, p = .017*, partial η2 = .252 
Flanker F(2, 28) = .654 p = .465, partial η2 = .045 F(1, 14) = .101, p = .755, partial η2 = .007 F(2, 28) = 2.931, p = .097, partial η2 = .173 
OSD F(2, 28) = .362 p = .699, partial η2 = .025 F(1, 14) = .220, p = .647, partial η2 = .015 F(2, 28) = 9.467, p = .001***, partial η2 = .403 
EPT-R F(2, 28) = .489, p = .618, partial η2 = .034 F(1, 14) = .247, p = .627, partial η2 = .017 F(2, 28) = 2.495, p = .101, partial η2 = .151 
PROMIS-
concerns F(2, 28) = 1.796, p = .196, partial η
2 = .114 F(1, 14) = .153, p = .702, partial η2 = .011 F(2, 28) = 7.538, p = .007**, partial η2 = .350 
PROMIS-
abilities F(2, 28) = 1.100, p = .326, partial η
2 = .073 F(1, 14) = 1.421, p = .253, partial η2 = .092 F(2, 28) = 4.010, p = .052, partial η2 = .223 
*p<0.05; **p<0.01; ***p<0.001. 
BVMT, Brief Visuospatial Memory Test-Revised; CVLT, California Verbal Learning Test-II; COWAT, Controlled Oral Word Association Test; Flanker, Flanker Inhibitory Control and 
Attention Test; OSD, Oral Symbol Digit Test; PROMIS-abilities, PROMIS Cognitive Abilities; PROMIS-concerns, PROMIS Cognitive Concerns; EPT-R, Everyday Problems Test-Revised 
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Table 4.6 Primary Outcome Variables - Means and Standard Deviations  
    Time 1 Time 2 Time 3 
  N T1 Mean (SD) T2 Mean (SD) T3 Mean (SD) 
BVMT-total 
    Control 8 18.5 (9.12) 19 (8.09) 18.88 (8.89) 
Intervention 8 20.25 (6.78) 20.5 (4.66) 19.88 (6.53)  
Total 16 19.38 (7.81) 19.75 (6.42) 19.38 (7.55) 
BVMT-delay 
    Control 8 6.63 (2.56) 7.38 (3.25) 7.00 (3.30) 
Intervention 8 7.63 (3.07) 8.13 (2.42) 7.75 (1.98) 
Total 16 7.13 (2.78) 7.75 (2.79) 7.38 (2.66) 
CVLT-total 
    Control 8 44.88 (19.21) 43.88 (15.42) 48.75 (18.26) 
Intervention 8 48.13 (15.32) 45.38 (11.17) 49.38 (12.43) 
Total 16 46.50 (16.78) 44.63 (13.03) 49.063 (15.09) 
CVLT-delay 
    Control 8 8.63 (3.58) 8.63 (5.29) 9.63 (4.60) 
Intervention 8 9.88 (3.76) 9.50 (3.66) 10.13 (3.98) 
Total 16 9.25 (3.61) 9.06 (4.42) 9.88 (4.16) 
COWAT 
    Control 8 27.75 (12.49) 29.50 (14.63) 31.50 (14.79) 
Intervention 8 33.50 (9.46) 38.88 (8.87) 38.00 (6.85) 
Total 16 30.63 (11.10) 34.19 (12.65) 34.75 (11.63) 
Flanker 
    Control 8 7.74 (1.07) 8.20 (0.56) 8.31 (0.45) 
Intervention 8 7.84 (1.06) 8.02 (0.73) 8.03 (0.90) 
Total 16 7.79 (1.03) 8.11 (0.64) 8.17 (0.70) 
OSD 
    Control 8 49.38 (17.37) 59.25 (24.59) 60.38 (18.88) 
Intervention 8 55.88 (15.30) 63.50 (19.14) 62.88 (21.12) 
Total 16 52.63 (16.17) 61.38 (21.40) 61.63 (19.39) 
PROMIS-abilities     Control 8 24.50 (7.54) 25.94 (4.07) 26.75 (5.70) 
Intervention 8 19.50 (9.20) 21.50 (6.65) 26.00 (6.12) 
Total 16 22.00 (8.52) 23.72 (5.80) 26.38 (5.73) 
PROMIS-concerns 
    Control 8 27.75 (7.72) 23.75 (6.80) 24.88 (5.54) 
Intervention 8 29.63 (10.65) 23.13 (4.45) 20.38 (2.50) 
Total 16 28.69 (9.04) 23.44 (5.56) 22.63 (4.76) 
EPT-R 
    Control 8 20.50 (7.37) 21.38 (6.82) 21.50 (7.89) 
Intervention 8 21.25 (4.43) 22.50 (3.51) 23.75 (2.92) 
Total 16 20.88 (5.89) 21.94 (5.27) 22.63 (5.86) 
BVMT, Brief Visuospatial Memory Test-Revised; CVLT, California Verbal Learning Test-II; COWAT, Controlled Oral Word Association Test; Flanker, Flanker Inhibitory 
Control and Attention Test; OSD, Oral Symbol Digit Test; PROMIS-abilities, PROMIS Cognitive Abilities; PROMIS-concerns, PROMIS Cognitive Concerns; EPT-R, Everyday 
Problems Test-Revised 
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 RQ 2.2. 
 What are the within-group, between-groups, and group-by-time interaction 
effects on the secondary outcomes of exercise self-efficacy [ExSE], physical activity 
[GLTEQ and accelerometer activity counts: sedentary, light, moderate-to-vigorous 
physical activity, and steps], depressive symptoms [CES-D], and fatigue [MFIS] (Fisk et 
al., 1994; Godin & Shepard, 1985; McAuley, 1993; Pearson et al., 2004; Radloff, 1977)? 
Secondary outcome data were examined for outliers and violations of the 
assumptions required for conducting a two-way mixed analyses of variance (ANOVA): 
normality, homogeneity of variance, homogeneity of covariance, and sphericity (Table 
4.7). There were nine outliers among the eight secondary outcome variables, as assessed 
by boxplot, and three as assessed by studentized residuals. The data were normally 
distributed for Sedentary PA, Light PA, and MFIS as assessed by Shapiro-Wilk’s test of 
normality (p>.05) but ExSE, GLTEQ, MVPA, Steps, and CES-D violated the assumption 
of normality. Levene’s test of homogeneity of variance was met (p>.05) for all secondary 
variables except ExSE. The assumption of homogeneity of covariance, as assessed by 
Box’s M test, was met for ExSE, Sedentary PA, Light PA, MVPA, and MFIS (p>.05) but 
not for GLTEQ, Steps, and CES-D. Mauchley’s test of sphericity indicated that the 
assumption of sphericity was violated for the two-way interactions in: Steps, Χ2(2) = 
8.216, p=.016, but the assumption was met in: ExSE, Χ2(2) = .570, p=.752; GLTEQ, 
Χ2(2) = 1.979, p=.372; Sedentary PA, Χ2(2) = 1.579, p=.454; Light PA, Χ2(2) = .260, 
p=.878; MVPA, Χ2(2) = 3.804, p=.149; MFIS, Χ2(2) = 5.589, p=.061; and CES-D, Χ2(2) 
= 1.060, p=.589. 
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As with the primary outcomes, outlying values among the secondary outcomes 
were located in the original data collection instrument (e.g., questionnaire) to confirm 
that the value had been entered correctly. Again, the analyses proceeded as planned 
without deleting cases or transforming the data based on the general robustness of the 
ANOVA procedure.  
Table 4.7 Secondary Outcome Variables - Outliers and Assumptions 
Instrument Outliers: Box Plots 
Outliers: 
Studentized 
Residuals 
+/- 3 SD  
Sharpiro-
Wilkes Test 
of 
Normality 
Levene's 
Homogeneity 
of Variance 
Box's 
Homogeneity 
of 
Covariances 
Mauchley's 
Test of 
Sphericity 
ExSE 103-T2   No No Yes Yes 
GLTEQ 102-T2, 113-T1 
102-T2, 
113-T1 No Yes No Yes 
SedPA 116-T3   Yes Yes Yes Yes 
LightPA 103-T3   Yes Yes Yes Yes 
MVPA 101-T3, 109-T1   No Yes Yes Yes 
STEPS 117-T2 117-T2 No Yes  No  No  
MFIS     Yes Yes Yes Yes 
CES-D 103-T2   No Yes No Yes 
ExSE, Exercise Self-Efficacy Scale; GLTEQ, Godin Leisure Time Exercise Questionnaire; SedPA, Sedentary Physical Activity; PA, 
Physical Activity; MVPA, Moderate to Vigorous Physical Activity; MFIS, Modified Fatigue Impact Scale; CES-D, Center for 
Epidemiologic Studies Depression Scale 
There were no statistically significant interactions between group and time among 
the secondary outcome variables (see Table 4.8). The main group effect showed that 
there were no statistically significant differences between the intervention and attention-
control groups. The main effect of time was significant for MFIS, which had a large 
effect size (η2 = .35). There were no significant time effects among ExSE, GLTEQ, 
Sedentary PA, Light PA, MVPA, Steps, or CES-D. 
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Interaction effect sizes for the secondary outcomes are reported here for use in 
future studies. Sedentary PA, MVPA, MFIS, and CES-D had medium effect sizes (η2 = 
.128, .093, .095, and .160 respectively); EXSE, Light PA, and Steps, had small effect 
sizes (η2 = .017, .044, and .038 respectively); while GLETQ was trivial (η2 = .005). 
Post-hoc pairwise comparisons for the total sample indicate one statistically 
significant mean difference among the secondary variables: MFIS, T1:T3, p=.013 
(means/standard deviations displayed in Table 4.9).  
Figure 4.9 Significant secondary outcome pairwise comparison 
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Table 4.8 Secondary Outcome Variables - Two way Mixed ANOVA  
Instrument Interaction effect Main Effect of Group Main effect of Time 
ExSE F(2, 28) = .245, p = .784, partial η2 = .017 F(1, 14) = 1.622, p = .224, partial η2 = .104 F(2, 28) = 1.098, p = .348, partial η2 = .073 
GLTEQ F(2, 28) = .066, p = .936, partial η2 = .005 F(1, 14) = 1.675, p = .217, partial η2 = .107 F(2, 28) = 2.563, p = .095, partial η2 = .155 
SedPA F(2, 28) = 2.062, p = .146, partial η2 = .128 F(1, 14) = 2.258, p = .155, partial η2 = .139 F(2, 28) = .668, p = .521, partial η2 = .046 
LightPA F(2, 28) = .640, p = .535, partial η2 = .044 F(1, 14) = .330, p = .575, partial η2 = .023 F(2, 28) = .694, p = .508, partial η2 = .047 
MVPA F(2, 28) = 1.434, p = .255, partial η2 = .093 F(1, 14) = 1.294, p = .274, partial η2 = .085 F(2, 28) = .681, p = .514, partial η2 = .046 
STEPS F(2, 28) = .559, p = .516, partial η2 = .038 F(1, 14) = .785, p = .390, partial η2 = .053 F(2, 28) = .414, p = .590, partial η2 = .029 
MFIS F(2, 28) = 1.474, p = .246, partial η2 = .095 F(1, 14) = .016, p = .902, partial η2 = .001 F(2, 28) = 6.027, p = .007**, partial η2 = .301 
CES-D F(2, 28) = 2.665, p = .087, partial η2 = .160 F(1, 14) = .356, p = .560, partial η2 = .025 F(2, 28) = 1.068, p = .357, partial η2 = .071 
*p<0.05; **p<0.01; ***p<0.001. 
ExSE, Exercise Self-Efficacy Scale; GLTEQ, Godin Leisure Time Exercise Questionnaire; SedPA, Sedentary Physical Activity; PA, Physical Activity; MVPA, Moderate to Vigorous 
Physical Activity; MFIS, Modified Fatigue Impact Scale; CES-D, Center for Epidemiologic Studies Depression Scale 
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Table 4.9 Secondary Outcome Variables - Means and Standard Deviations 
  Time 1 Time 2 Time 3 
  N Mean (SD) Mean (SD) Mean (SD) 
ExSE 
    Control 8 7.81 (2.34) 7.13 (2.77) 7.77 (2.13) 
Intervention 8 8.63 (1.83) 8.44 (2.72) 9.25 (0.89) 
Total 16 8.22 (2.07) 7.78 (2.74) 8.51 (1.75) 
GLTEQ 
    Control 8 6.00 (3.59) 30.00 (49.13) 18.56 (17.52) 
Intervention 8 20.56 (40.13) 39.06 (21.04) 33.94 (22.34) 
Total 16 13.28 (28.53) 34.53 (36.81) 26.25 (20.96) 
Sedentary PA 
    Control 8 551.37 (90.08) 534.78 (61.48) 533.90 (62.69) 
Intervention 8 570.13 (81.18) 580.50 (79.44) 614.69 (60.82) 
Total 16 560.75 (83.40) 557.64 (72.57) 574.29 (72.81) 
Light PA 
    Control 8 235.49 (55.22) 231.75 (58.33) 226.58 (70.71) 
Intervention 8 225.70 (52.40) 201.02 (54.08) 221.50 (65.92) 
Total 16 230.59 (52.25) 216.38 (56.61) 224.04 (66.09) 
MVPA 
    Control 8 11.93 (10.89) 10.64 (7.82) 13.25 (13.38) 
Intervention 8 13.51 (8.41) 21.04 (13.09) 16.66 (11.37) 
Total 16 12.72 (9.44) 15.84 (11.72) 14.96 (12.12) 
Steps 
    Control 8 3808.38 (1204.30) 3769.84 (921.68) 4050.55 (2010.31) 
Intervention 8 4022.77 (1105.78) 4733.76 (1680.38) 4328.00 (1323.51) 
Total 16 3915.57 (1122.37) 4251.80 (1400.69) 4189.28 (1650.43) 
MFIS 
    Control 8 46.75 (12.67) 38.50 (8.32) 39.00 (8.19) 
Intervention 8 47.00 (15.18) 43.00 (14.79) 32.63 (5.18) 
Total 16 46.88 (13.50) 40.75 (11.82) 35.81 (7.40) 
CES-D 
    Control 8 13.25 (11.18) 12.38 (8.03) 14.75 (9.45) 
Intervention 8 19.25 (9.15) 17.00 (11.16) 11.25 (7.15) 
Total 16 16.25 (10.34) 14.69 (9.69) 13.00 (8.29) 
ExSE, Exercise Self-Efficacy Scale; GLTEQ, Godin Leisure-time Exercise Questionnaire; PA, Physical activity; MVPA, Moderate to Vigorous Physical Activity; Steps, Mean 
Step Count; MFIS, Modified Fatigue Impact Scale; CES-D, Center for Epidemiologic Studies Depression Scale 
 
 110 
Chapter 5: Discussion 
Chapter 5 presents a summary and discussion of this dissertation study. Sections 
of this chapter include a discussion of the study’s findings: sample, outcome measures, 
research questions, and limitations. Implications for nursing practice and public health 
policy are discussed followed by recommendations for future research. 
SUMMARY OF THE STUDY 
Cognitive impairment is highly prevalent among persons diagnosed with MS, an 
immune-mediated neurodegenerative disease affecting approximately 2.3 people 
worldwide (Chiaravalloti & DeLuca, 2008; MSIF, 2013). The negative impact of MS-
related cognitive impairment on those affected is considerable. Moreover, cognitive 
impairment in persons with MS is under diagnosed, difficult to treat, and little or no 
effective management therapies exist, including MS disease modifying treatments 
(Amato et al., 2013; Benedict & Zivadinov, 2011; Chiaravalloti & DeLuca, 2008; 
Schultheis et al., 2001; Kalmar et al., 2008). Therefore, based on findings among older 
adults and a growing body of research among persons with MS, management of cognitive 
impairment through increasing physical activity holds substantial promise and 
importance (Colcombe & Kramer, 2003; Motl, Gappmaier, et al., 2011; Smith et al., 
2010). 
The purpose of this study was to determine the feasibility and effects of a physical 
activity program on measures of clinical cognitive function and neurocognitive function 
in everyday life in ambulatory persons with MS experiencing cognitive problems. The 
conceptual framework proposed to guide this study was Alfred Bandura’s self-efficacy 
theory (1997) and social cognitive theory (1986).  However, high levels of exercise self-
efficacy in both groups at all data collection time points as well as the inability to deliver 
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the intervention in small groups as intended, made use of the framework less tenable. 
Slow recruitment of participants into the intervention arm precluded forming small 
groups, yet YMCA members working out at the same time as the study’s participants 
provided uniquely well-suited role models.  
After receiving IRB approval from The University of Texas at Austin, a 
convenience sample of 16 people with MS confirmed by their healthcare provider; (1) 
age 21 to 60; (2) able to read and write in English; (3) ambulatory with minimal 
assistance; and (4) with written approval to participate in the PALMS physical activity 
program were recruited into the study over an 12-month period. The 16 participants 
enrolled into the study signed The University of Texas at Austin IRB-approved informed 
consent document prior to any data being collected.  
DISCUSSION 
Sample 
There was significant demographic diversity among the 16 persons successfully 
recruited into the study. More males were recruited (5 of the 16 participants) than 
anticipated, since the proportion of women to men with MS is reported to be 2.3-3.5:1 
(Harbo, Gold, & Tintoré, 2013). Only 3 of the 16 participants were Hispanic, while low 
for an area where 33.5% of the population is Hispanic (U.S. Census Bureau, 2016) it’s 
not surprising given that MS predominates in persons with Caucasian ancestry (Aguirre-
Cruz, Flores-Rivera, De La Cruz-Aguilera, Rangel-López, & Corona, 2011). Other 
demographic variables (e.g., age, marital status, education, employment) were more 
characteristic of other studies of persons with MS.  
Participants’ ages averaged 45.6 + 9.1 years and ranged from 31 to 58, which was 
predictable as most people are diagnosed with MS between ages 20 and 50 (NMSS, 
 112 
2016). More than half were employed (full or part-time), which impeded attendance in 
both groups. Employment-related absences were less of a problem in the intervention 
than the attention-control group because the PI accommodated for schedule changes 
while the attention-control facilitator maintained a Tuesday/Friday 10:30am to 11:30 am 
schedule throughout the study.  
While about half of the sample were married or lived with a significant other, four 
had never been married and three were divorced or separated. One participant separated 
from her partner midway through the study but attended 17 intervention classes after the 
separation until moving to San Antonio. The participant commented that exercising gave 
her “something to do,” relieved stress, and afforded her a therapeutic relationship with 
the PI.   
Functional impairment varied widely among the sample from those with very 
minimal impairment to those with moderate physical and cognitive function impairment 
(EDSS 4.5+1.1, range 2.5 to 6.0). Only one participant routinely used a cane during the 
study although a few did on occasion especially when feeling “unsteady.” The PI 
discussed the possibility of using an assistive device with several of the participants but 
almost all reported not wanting to unless they “had to,” which is consistent with the 
literature (Finlayson, Peterson, & Cho, 2006). Cognitive impairment was assessed prior 
to enrollment using the SDMT (mean 41.7+10.0, range 20 to 56). The PI and facilitator 
observed slow “thinking” (processing speed), forgetfulness (memory), and difficulty with 
organizational skills (executive function) among several participants throughout the 
study. One participant in his mid-30s was particularly challenged with everyday cognitive 
function. He stated that he did not work or drive because of his cognitive impairment and 
had to rely on family members for household task such as bill paying.  
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There was considerable variation in the type and duration of MS among the 
participants. One had been diagnosed with primary progressive MS 11 months before 
enrolling while another had been diagnosed with relapsing-remitting MS for almost 30 
years. The recently diagnosed participant heard about the study six-months before 
contacting the PI, saying that he had to “adjust” to his MS diagnosis as well as accept 
retiring from work on social security disability insurance (SSDI) before contacting the PI. 
The participant with longstanding MS (Morrison & Stuifbergen, 2014) was also 
receiving SSDI having retired from full-time employment due to disability but she had 
had many years to adapt to living with MS.  
Outcome Measures 
Cognitive Function  
There were no significant group-by-time interaction effects or differences 
between among the seven clinical cognitive function tests employed in this study (BVMT 
total, BVMT delayed, CVLT total, CVLT delayed, COWAT, Flanker, and OSD) or for 
the revised Everyday Problems Test. All tests were administered during the same testing 
session at baseline, T2 and T3. Several significant (p<.05) time effects and pairwise 
comparisons for the total sample (n=16) were found including: improved auditory/verbal 
learning (CVLT), processing speed (OSD), and self-reported cognitive function ability 
(PROMIS-cognitive abilities) as well as lower self-reported cognitive function concerns 
(PROMIS-cognitive concerns)[Figure 4.8]. It is arguable that these significant pairwise 
comparisons stem from the time spent with and/or attention from the group facilitator or 
PI, the influence of the control condition (relaxation, stretching/yoga, meditation), or 
practice effects from repeated testing. Ultimately, evidence is lacking from this small 
study to demonstrate that increasing physical activity can improve cognitive performance 
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as measured by these neuropsychological tests compared with the improvement in the 
attention-control group. The EPT-R has only one form, so any change in scores may be 
due to practice effects related to using the same questions at baseline, T2 and T3. 
Furthermore, it is uncertain if the clinical neuropsychological tests employed are sensitive 
to change over time.  
Exercise Self-Efficacy 
Exercise self-efficacy (ExSE) was very high in both groups at baseline 
(8.22+2.07), 3-months (7.78+2.74) and 6-months (8.51+1.75) on the 0-10 scale where 
10-indicates 100% confidence. It is certainly plausible that high exercise self-efficacy is 
prerequisite for persons with MS to participate in a twice-weekly exercise program 
lasting 6 months. Persons with lower levels of exercise self-efficacy may not have had 
enough confidence in their ability to exercise to even consider participating in a physical 
activity study, yet these are the individuals most in need and apt to derive the greatest 
benefits from such a program. The challenge is how to attract persons with low exercise 
self-confidence to participate in an exercise program designed to meet participants 
‘where they are’ and tailored to build new skills.  
There were small, non-significant differences between the two study groups on 
the ExSE scale at each measurement point (Table 4.9). Mean scores rose slightly in the 
intervention group from baseline to T3 while the attention-control group remained stable. 
These improved scores and the smaller standard deviations in the intervention group may 
reflect additional self-confidence gained from successfully participating in PALMS study 
and indicate clinical significance. Participants’ were noticeably more comfortable and 
confident exercising at the YMCA as the study progressed. They learned how to use the 
cardio equipment, how to set up a weight machine, and improved their exercise skills in a 
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uniquely welcoming and inclusive environment at the YMCA. One participant reported 
that he ‘hated’ using the elliptical machine at first but over time, he became proficient 
and thoroughly enjoyed himself.  
Physical Activity  
Quantifying physical activity among this small sample of participants proved to 
be challenging. Participants reported that wearing the ActiGraph® accelerometer on an 
elastic belt around their hips for 7 days was bothersome. Examination of baseline output 
from the devices showed that several participants had not worn the ActiGraph® daily as 
instructed: during waking hours for 7 days. To increase the number of days participants 
wore the device, the PI sent daily text reminders to participants during T2 and T3 data 
collection periods, which improved adherence to the protocol (Morrison, Stuifbergen, & 
Cassill, 2016).  
Inspection of data derived from self-report instruments and ActiGraph® devices 
reveal several interesting patterns. Self-reported physical activity data was categorized as 
moderately active or active using Godin’s (2011) formulae and the ActiGraph® data was 
categorized using MS specific cutoffs for moderate-to-vigorous physical activity 
developed by Sandroff et al. (2012). The tables shown in Appendix F, display data based 
on (1) USDHHS 1996, 1999 physical activity guidelines for Adults developed by Godin 
(2011); (2) Canadian physical activity guidelines for persons with MS (2013); and (3) 
USDHHS physical activity guidelines for adults (2008). Visual inspection of the tables in 
Appendix F show that the control group reported less moderately active and active 
physical activity than the intervention group did at all data collection time points. Self-
reported physical activity categorized as moderately active and active using Godin (2011) 
criteria appears under-reported compared to ActiGraph® data categorized as meeting 
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Canadian Physical Activity Guidelines for Persons with MS using Sandroff et al. (2012) 
criteria. But self-reported physical activity was more comparable to ActiGraph® data 
categorized as meeting USDHHS physical activity guidelines for adults (2008). Notably, 
no patterns were discerned at the individual-participant level. While these are rough 
estimates and do not reflect the recommended twice-weekly strength training criteria in 
both guidelines, over half of all of the participants in the intervention group met the 
Canadian guidelines at all data collection time points while few met the more rigorous 
USDHHS 2008 guidelines.   
Depressive Symptoms (CES-D) 
Clinically significant depression is common in MS, occurring in over 50% of 
persons diagnosed with the disease (Feinstein, 2011a). Appendix G shows that while half 
of the participants had CES-D scores above the cutoff for elevated depressive 
symptomology at baseline, there were more individuals above the cutoff score in the 
intervention group (n=6) than in the control group (n=2) (Verdier-Taillefer et al., 2001). 
Depressive symptoms fell below the cutoff except for one intervention and two control 
participants at T2. At T3, two intervention and three control participants scored above the 
cutoff. These fluctuations in depressive symptoms were not unexpected and may reflect 
usual variance in day-to-day mood.  
Two participant’s CES-D scores remained above the cutoff at all time points. 
One, participant 11 (see Appendix G), was the individual who dropped out after only 
attending two attention-control classes so her baseline score was used at T2 and T3 in this 
intention-to-treat analysis. The other participant with persistently high depressive 
symptoms, participant 1 in the intervention group, was the individual who during the 
intervention applied for, and got, a part time job after 7+ years of unemployment. This 
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may suggest an increase in self-confidence derived from participating in the PALMS 
intervention, which allowed her to compensate for her MS symptoms including depressed 
mood.  
Fatigue Impact (MFIS) 
Fatigue, the most frequently reported symptom among persons with MS, varied 
widely among the participants in this study (Minden et al., 2006). Anecdotal reports of 
fatigue experienced by participants indicated that fatigue contributed to class absences as 
well as decreased functional performance during intervention classes. Several participants 
reported being very fatigued before and during the intervention class at different times 
over the 6-month study. The PI observed outward signs of fatigue (heavy eyelids, slow 
movement, sighing) in these participants. Mean post-exercise physical and mental fatigue 
varied widely among the eight intervention participants (see Figure 4.5). As can be seen 
in Appendix E, individual patterns of physical and mental fatigue reported at the end of 
each class attended varied over time. Some participants had high ratings of fatigue 
(participant 1 and 8), some had almost none (participants 4 and 6), some improved 
(participants 1, 4, and 6), some stayed about the same (participant 2), and others 
worsened over time (participants 2 and 5) as indicated by the solid trend-line 
superimposed over the individual ratings in Appendix E. 
As was discussed in Chapter 1, symptoms of fatigue and depression in persons 
with MS overlap, their relationship is equivocal, and both may confound performance on 
neurocognitive function assessment (Bol et al., 2009; Chadhuri & Behan, 2004; Langdon, 
2011; Pierson & Griffith, 2006). Additionally, MS symptoms commonly vary in intensity 
throughout the day as well as from one day to the next. Fatigue decreased significantly in 
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both groups, which speaks to the value of both group interventions that involved 
movement in reduced fatigue. 
Research Question 1 
What is the feasibility of delivering a small group moderate-intensity exercise 
program for persons with MS over a 6-month time period? 
This study presents several novel insights into the feasibility of delivering a nurse-
led community-based physical activity program twice a week for 6 months. Foremost is 
the ability of community and faith-based organizations (e.g., YMCA, Mt Zion Baptist 
Church, National MS Society) to successfully collaborate over shared health-promotion 
goals and provide material support. The YMCA of Austin provided free memberships at 
six locations in Travis and Hays counties to intervention participants for the 6-months 
they were in the study. The facilities and the YMCA staff were uniquely well suited to 
addressing the physical and psychosocial needs of the study participants in a welcoming 
and inclusive environment. Staff at each site warmly welcomed members (participants) 
each time they entered the facility reflecting the organization’s goal to promote and 
provide an inclusive environment for the community. Each site was ADA accessible and 
had equipment available that was specifically designed for use by persons with functional 
impairment including a recumbent stepper, which allows persons with poor balance to 
safely exercise both upper and lower extremities. The YMCA’s inclusive environment 
offered unique opportunities for study participants to observe and model their behavior 
after other YMCA members with disabilities. YMCA members with functional 
limitations (e.g., stroke, traumatic brain injury, cancer, advanced age, intellectual 
disability) were warmly welcomed by the YMCA staff and frequently exercised at the 
same time as this study’s participants. Some exercised alone, others with a trainer, and 
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some in groups. Over the six months of the study, members and participants came to 
greet as well as encourage each other. Modeling of positive health behaviors by peers 
with similar, if not greater, physical limitations can have far-reaching effects that may be 
large and long lasting (Bandura, 1986).  
Mt Zion Baptist Church provided accessible classroom space and onsite parking 
at no charge for the attention-control group twice a week from January 2015 to July 2016. 
The church has a long history of supporting health promotion programs for its 
congregation as well as for the community.  
The NMSS supported recruiting efforts throughout the study. Community 
support-group leaders distributed recruiting flyers to their large email network numerous 
times from November of 2014 to January of 2016. They also welcomed the PI to recruit 
in-person five times to a large group in north Austin, three times at a smaller central 
Austin group, and twice to a small group in south Austin. Two groups meet monthly; one 
in central Austin targeted at persons mildly affected by MS and another in north Austin 
that meets on Saturday morning for persons with MS as well as their families. A third 
small group meets weekly at a coffee house in South Austin that is close to where they 
live and on the bus line. A common topic of conversation at all of these groups is the 
difficulty of getting to places around Austin as many of them do not drive. Many people 
on the large email distribution list do not attend meetings because of transportation 
barriers. Despite all of these efforts and NMSS support, it was difficult to recruit 
sufficient numbers of participants for this study.  
Transportation was a key barrier for interested persons being recruited into the 
study as well as among those who were successfully enrolled. Two study participants 
used public transportation to get to their respective study sites. One intervention 
participant used Austin’s Capitol Metro bus transportation system to get to the YMCA. In 
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fact, the YMCA facility selected was further away from her home but was closer to a bus 
stop. The other person in the attention-control group coupled two transportation systems 
to get to the attention-control site: the Capitol Area Rural Transportation System 
(CARTS) and Austin’s Capitol Metro Special Transportation Service (STS) for persons 
with disabilities. This individual was frequently dropped off or picked up at a time 
convenient for the driver but either significantly early or late for the class. The time spent 
commuting between home and the study site as well as making arrangements added up to 
many hours each week for the participant. Notwithstanding these considerable barriers, 
the participant was able to attend 33 of 52 classes (63.5%).  
An important component of the study’s feasibility was the ability to find people 
qualified to facilitate the attention-control group and conduct the neuropsychological 
testing. The attention-control facilitator was highly qualified to lead a relaxation and 
stretching program. She was certified in meditation by the Deepak Chopra Center and has 
a 200-hour yoga teacher-training certificate. She was also willing to drive to Austin twice 
a week (50+ miles each time) for over 18 months. Likewise, the study’s psychometrist 
was highly qualified to conduct neuropsychological testing and was available evenings 
and weekends for the duration of the study.  
Feasibility also entails the cost of the study, which took a great deal of time (18 
months from IRB approval to completion of data collection) and money to conduct. The 
attention-control group facilitator and psychometrist were paid significantly less than 
their usual rate for private lessons or working for a psychologist. Their combined salaries 
accounted for the largest proportion of the research budget. Travel time and expense was 
considerable; the PI accumulated over 6,600 miles traveling between the School of 
Nursing and the five YMCA sites and spent 348 hours conducting intervention classes.  
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Conducting the intervention in small groups of 3-4 individuals as planned was not 
feasible. Contributing factors included (1) slow recruitment of participants into the study; 
(2) use of five different YMCA sites to accommodate participant preference; and (3) 
participants’ work-related availability to attend class. The PI tailored the intervention 
class time and location to maximize attendance. This strategy was particularly effective 
for participants who were employed (two worked evening/night shifts) or had family 
responsibilities such as the participant who was employed fulltime and was the primary 
caregiver for a multi-generational family with young grandchildren and a mother with 
early-onset dementia.  
Programs such as Shape Up RI (www.shapeupri.org) offer creative strategies to 
promote feasibility in future studies. This statewide exercise and weight loss program is 
based on promoting teamwork and peer support. The program entails using an online 
social wellness platform, team competitions and self-reported steps, exercise and weight 
loss.   
RQ 1.2.  
What is the attendance pattern across the 6-months for the intervention and 
attention-control groups? 
Attendance was significantly better in the intervention group than the attention-
control group (p<.01). Several factors may have contributed to the difference including 
participants were recruited specifically for a physical activity study. All but one initially 
stated they had strong preference to be in the intervention group but later, at T2 and T3 
testing, everyone expressed pleasure with their group assignment.  The intervention 
group was conducted one-on-one and tailored to the participants’ availability while the 
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attention-control group was held on the same two days each week regardless of the 
participants’ availability to attend.   
Attendance barriers in this study of physical activity were similar to those 
previously cited in the literature: facilities too far away, lack of time, lack of 
transportation (Becker, Stuifbergen, & Sands, 1991). The length of the study was a 
barrier for some participants related to work (new job or shift), family obligations, and 
moving away from Austin. 
RQ 1.3.  
What is the frequency, duration, and mode of physical activity documented in the 
PALMS physical activity log? 
Completing the PALMS physical activity log proved too great a burden for the 
intervention participants. The PI asked intervention participants to log any physical 
activity done outside of the intervention classes into a blank calendar that was provided at 
the first meeting. Participants were asked to bring the calendar with them to subsequent 
classes to discuss what physical activity they did on their own. The PI ceased asking for 
formal feedback after the first two participants repeated failed to fill in the log. Instead, 
the PI opted to ask informal questions during the class time about participants’ outside 
physical activities. The last six intervention participants were equally disinclined to 
document their physical activity done outside of class. Participants were willing to talk 
casually during the intervention classes about engaging in occasional physical activities 
such as walking or riding a bike in their neighborhood and going on outings with their 
families but no structured pattern of leisure-time physical activity was discerned. The PI 
informed the participants that their 6-month YMCA membership allowed them to use the 
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facilities any time the YMCA was open but only two participants took advantage of this 
option and did so infrequently. Anecdotally, the PI’s impression was that the participants 
considered the 2 hours per week intervention class sufficient exercise. 
 
RQ 1.4.  
How do participants respond to the PALMS intervention (heart rate, ratings of 
perceived exertion, physical and mental fatigue, general wellbeing, and enjoyment)? 
A critical component of this study’s feasibility was determining whether the 
participants were able to exercise at a moderate to vigorous intensity level. Heart rate 
(HR) and rating of perceived exertion (RPE) were monitored every 10 minutes from the 
start to the end of the 60-minute class to make this determination. Goal RPE (between 3 
and 7 on the 10-point scale) and HR (40-60% of heart rate reserve) was achieved at every 
class by over 90% of the participants. Two participants infrequently achieved their goal 
HR (36% and 11%) but did meet the RPE goal at each class. One participant reported 
(participant 1 in Appendix E), and clearly appeared, more fatigue than the others. The 
other (participant 4 in Appendix E) told the PI that he had only so much energy each day 
and if he ‘over-exerted’ himself, he wouldn’t be able to accomplish everything he wanted 
to that day but if he kept his intensity ‘in check’ he would feel energized and have 
enough energy for the day.   
Every intervention class ended with the PI asking the participant to rate their level 
of physical fatigue, mental fatigue, general wellbeing and level of enjoyment. Participants 
rated physical fatigue higher (mean 3.99 + 2.33) than mental fatigue (mean 3.20 + 2.30). 
Responses range from 0 (no fatigue) to 10 (strongest feeling of fatigue ever felt) on the 
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physical and mental fatigue scale. Individually, participants were fairly consistent in their 
ratings of fatigue from session to session; some regularly reported high levels of fatigue 
while others reported minimal fatigue (see Appendix E). Participants reported feeling 
“good” after the exercise classes (mean 3.19 + 1.66) using the general well being scale, 
which ranges from +5 (very good) to 0 (neutral) to -5 (very bad). Ratings of enjoyment at 
the end of the class sessions were high (mean 6.38 + 0.85) on enjoyment scale where 1 = 
not at all, 4 = somewhat, 7 = very much. In summary, the PALMS intervention was 
feasible based on immediate post-session participant feedback. Participants reported 
moderate levels of physical and mental fatigue, positive levels of wellbeing, and 
decidedly enjoyed the supervised exercise program.  
Research Question 2 
What are the effects of the PALMS intervention? 
While no statistically significant interaction effects were found among the 
primary or secondary outcome variables investigated, several medium to small effect 
sizes primarily in self-report measures were established that could be used in future 
studies.  
RQ 2.1.  
What are the within groups, between-groups, and group-by-time interaction 
effects on the primary outcomes of clinical cognitive function (California Verbal 
Learning Test [CVLT] Brief Visuospatial Memory Test [BVMT], Controlled Oral Word 
Association Test [COWAT], the NIH Toolbox Flanker Inhibitory Control and Attention 
Test, and the NIH Toolbox Oral Symbol Digit Test), self-reported cognitive abilities and 
concerns (PROMIS v1.0 Cognitive Abilities and Cognitive Concerns Scales), and 
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neurocognitive function in everyday life (revised Everyday Problems Test [EPT-R] 
(Benedict, 1997; Benton et al., 1994; Cella et al., 2007; Delis et al., 2000; Weintraub et 
al., 2013; Willis et al., 1992)? 
While no significant interaction effects or between group differences were found 
among the primary outcome variables investigated in this study, several statistically 
significant (p<.05) within group effects were observed for the total sample: CVLT-total, 
COWAT, OSD, and PROMIS-cognitive concerns. Within group changes reflect change 
over time within the entire sample of 16 persons with MS. The total sample (N=16) had 
statistically significant (p<.05) improvements in verbal learning (CVLT-total) from T2 to 
T3 and in processing speed (OSD) from baseline to T2 and T3. While the main effect of 
time was significant (p<.05) for word finding (COWAT), no significant pairwise 
comparisons were found. These findings may be attributable to the study’s small sample 
size as well as a lack of sensitivity to change over time among these diagnostic 
neuropsychological tests. There was also a significant time effect for self-reported 
cognitive concerns for the total group.  Statistically significant improvement (reflected by 
lower scores) was seen from baseline to T2 and T3. The effect of time on self-reported 
cognitive abilities was not significant (p=.052), yet there was a significant pairwise 
difference from baseline to T3 (p=.022). Figure 4.8 shows pairwise comparison graphs 
for PROMIS-cognitive concerns and abilities, which suggest that the intervention group’s 
improvements, while not statistically significant, do improve and may reflect clinical 
significance. Ultimately, due to the study’s small sample size, great caution must be taken 
in interpreting these results.  
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RQ 2.2. 
 What are the within-group, between-groups, and group-by-time interaction 
effects on the secondary outcomes of exercise self-efficacy [ExSE], physical activity 
[GLTEQ and accelerometer activity counts: sedentary, light, moderate-to-vigorous 
physical activity, and steps], depressive symptoms [CES-D], and fatigue [MFIS] (Fisk et 
al., 1994; Godin & Shepard, 1985; McAuley, 1993; Pearson et al., 2004; Radloff, 1977)? 
No significant interaction effects or between group differences were found among 
the secondary outcome variables investigated in this study. One significant within group 
effect was observed for the total sample in fatigue impact (MFIS) (p<.05), which had a 
fairly large effect in both groups (see Figure 4.9). While there were no significant 
differences between groups, the intervention group did have a larger decrease in fatigue 
than the control group (see Table 4.9). Ultimately, both the PALMS intervention and 
attention-control condition (relaxation, stretching/yoga, and meditation) resulted in lower 
fatigue scores in this small study. The significant time effects observed among the 
primary and secondary outcomes may have been influenced by the enriched, mentally 
and socially stimulating environments the participants in both groups were both exposed 
to throughout the study. 
LIMITATIONS 
This dissertation study is not without limitations. Initially designed as a 
randomized clinical trial, the study was revised midway through data collection to a 
quasi-experimental design due to difficulty recruiting participants. Random assignment of 
participants was replaced with intentional assignment to balance the size of the 
intervention and control groups. The final sample of 16 was insufficient in size to achieve 
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the proposed 80% power. Statistical analysis was limited by the small sample size, which 
can be seen in large standard deviations among the outcome variables.  
Due to the nature of this study, participants could not be blinded to group 
assignment and those assigned to the attention-control group may have been motivated to 
be more physically active on their own in addition to their assigned group activity. 
Furthermore, this convenience sample may not reflect people with MS who do not live in 
the greater Austin are or have low-exercise self-efficacy, and may be biased towards 
individuals willing to participate in a research study involving twice weekly exercise 
classes for six months.  
Another limitation of this study is that clinical measures of neurocognitive 
function, designed to differentiate normal from impaired cognitive functioning, may not 
reflect day-to-day cognitive function critical to routine activities and roles. Furthermore, 
the neurocognitive tests used in this study were not specifically designed to measure 
change in function over time.  
Most of the measures used in this study were retrospective self–report instruments 
that may not accurately reflect the construct of interest. Physical activity measured by 
accelerometers required the participant to remember to wear a device on their waist/hip 
during waking hours for 7-days. This performance task was challenging to many of the 
participants and necessitated initiating a protocol of daily text reminders from the PI. 
IMPLICATIONS AND RECOMMENDATIONS 
Public Health Policy Implications  
Janet Fulton, PhD, the chief of the CDC’s Physical Activity and Health Branch 
recently pointed out that “Adults benefit from any amount of physical activity,” which 
includes persons with disabilities and chronic disabling conditions such as MS (CDC, 
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2016). Healthy People 2020 include objectives aimed at increasing physical activity for 
the general public, including persons with disabilities, aimed at maximizing health and 
quality of life (USDHHS, 2016). The disability and health objectives of Healthy People 
2020 cite adding “individuals with disabilities to community-based health promotion 
efforts” as one of its emerging issues (USDHHS, 2016). Therefore, nursing and public 
health initiatives must prioritize the inclusion of persons with disabilities into physical 
activity programming and promote full community participation (NCHPAD, 2014). 
Strategies such as those outlined by the CDC (2011) and NCHPAD (2014) offer clear 
guidance for developing inclusive policies and programs aimed at increasing physical 
activity in adults of all abilities and ages. Key policy strategies include individually 
tailored, social support programs set in the community and accessible by public 
transportation.  
Implications for developing policies to increase physical activity in persons with 
MS are manifold. Representatives of the study population must be included from the start 
in the development, implementation and evaluation of research (e.g., community-based 
participatory research). Existing community resources that are accessible, inclusive, and 
affordable (e.g., YMCA) must be leveraged against significant program costs (e.g., staff, 
training, accessible equipment). Community outreach policies are needed such that 
people with disabilities understand that they are valued and welcomed rather than 
stigmatized. 
New Zealand’s ‘Green Prescription’ initiative could serve as a model for 
government-supported public health programming to increase physical activity in at-risk 
individuals such as those with MS (Swinburn et al., 1998). The 3-month Green 
Prescription program integrates physical activity promotion into the primary health care 
system. Managed by New Zealand’s Ministry of Health, the program connects patients 
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referred by their health care provider with local resources that furnish detailed physical 
activity prescriptions along with crucial health promotion supports (e.g., facilities, social 
support, educational materials). Benefits of program participation lasting 2-3 years after 
completion were recently reported (Hamlin et al., 2016). This referral system may reach 
and motivate persons with low exercise self-efficacy who are unlikely to participate in 
physical activity programs without the added emphasis of a ‘prescription.’ 
Nursing Implications 
Nurses in clinical practice should leverage patient visits as ‘teachable moments’ 
to counsel and educate their patients on health promotion and physical activity. Asking 
patients about their current health promoting practices and providing tailored guidance as 
well as community resources can make a significant impact on positive behavior change. 
A wealth of tailored materials and clear physical activity guidelines for adults with MS 
are available free online from the Canadian Society for Exercise Physiology and 
Canadian MS Society. Yet a significant gap exists. It is unknown if nurses are aware of 
this valuable resource. A review of the most current guidelines for MS nurses published 
by the American Association of Neuroscience Nurses (AANN), the Association of 
Rehabilitation Nurses (ARN), and the International Organization of Multiple Sclerosis 
Nurses (IOMSN) revealed that exercise or physical activity were only referred to six 
times (Thompson & Mauk, 2011). The most explicit nursing implication related to 
physical activity was to “encourage exercise” as a strategy to manage bowel dysfunction 
(Thompson & Mauk, 2011, p. 30). This underscores the need to include health promotion 
strategies, including physical activity, in basic as well as continuing nursing education.  
Nurses, who continue to top the Gallup Polls’ list of trusted professionals, have a 
duty to promote healthy behaviors in individuals, families and the community 
 130 
(http://www.gallup.com/poll/1654/honesty-ethics-professions.aspx). Nurses could opt to 
gain experience in adaptive fitness by becoming certified through the American College 
of Sports Medicine (ACSM) in conjunction with the National Center on Health, Physical 
Activity and Disability (NCHPAD) as an Inclusive Fitness Trainer. There is considerable 
need for more personal trainers with this specialty certification. A search of the ACSM 
ProFinder database in September of 2016 revealed 259 ACSM/NCHPAD Certified 
Inclusive Fitness Trainers. Only 11 were in the state of Texas: 3 in Dallas/Ft Worth, 4 in 
Houston, 3 in San Antonio, and 1 in Austin (the PI).  
Future Research 
Studies conducted with larger sample sizes are critical for future studies 
examining the effect of physical activity on cognitive function in persons with MS. While 
this study demonstrated that a nurse-led physical activity program integrated with 
existing community- and faith-based organizations is feasible, future studies need to 
devise innovative methods to recruit and enroll larger samples.  
Future studies might consider incorporating internet-based technology (e.g., 
Skype, FaceTime) and telephone-based communication to reach more people and 
minimize program cost, while partnering with existing community- and faith-based 
resources. Specifically targeting individuals with lower levels of exercise self-efficacy 
than those enrolled in the current study would allow for growth in this key theoretical 
construct. Additionally, incorporating small groups, whether in person or virtually, may 
provide opportunity for role modeling and development of supportive relationships to 
foster physical activity behavior.  
Future studies are also needed to develop physical activity log measures that are 
more sensitive to reflect meaningful change over time. Important considerations include: 
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involving the target group from the project’s start (CBPR principals) and making the log 
convenient, easy-to-use, accessible (e.g., large print and icons for an app) and enjoyable.  
 
SUMMARY 
This dissertation study of the PALMS intervention provided initial evidence as to 
the feasibility of a nurse-led community-based physical activity intervention. While this 
study was underpowered due to its small sample size, effect sizes were observed that may 
be used in future studies examining the effect of physical activity on cognitive function in 
persons with MS.    
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APPENDIX C: LETTERS OF SUPPORT 
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APPENDIX D: FORMS AND INSTRUMENTS 
 
Forms and Instruments Included 
Phone Pre-Screening Form 
Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) (Jamnik et al., 2011) 
Verification of Multiple Sclerosis Diagnosis Form 
Physical Approval to Participate in the Physical Activity Program Form 
PALMS Physical Activity Log 
Background Information Sheet 
Exercise Self-Efficacy Questionnaire (McAuley, 1993) 
Godin Leisure-Time Exercise Questionnaire (Godin & Shepard, 1985) 
Center for Epidemiologic Studies Depression Scale – Revised (Radloff, 1977) 
Modified Fatigue Impact Scale (Fisk, Pontefract, et al., 1994) 
PROMIS Cognitive Abilities Scale (Cella et al., 2007) 
PROMIS Cognitive Concerns Scale (Cella et al., 2007) 
Controlled Oral Word Association Test (Benton et al., 1994) 
PALMS Accelerometry Log 
PALMS Intervention Log 
 
Proprietary Tests Not Included 
Self-Administered Expanded Disability Status Scale (Bowen et al., 2001; Kurtke, 1993) 
Symbol Digit Modalities Test (Smith, 1982) 
California Verbal Learning Test (Delis et al., 2000) 
Brief Visuospatial Memory Test (Benedict, 1997) 
Flanker Inhibitory Control & Attention Test (Weintraub et al., 2013) 
Oral Symbol Digit Test (Weintraub et al., 2013) 
Everyday Problems Test – Revised (Willis et al., 1992) 
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Phone Pre-Screening 
 
Name: _____________________________  Date: _________________________ 
1. Project Description:  
• Funded by the National Institutes of Health (NIH) 
• For adults, age 21 to 60, living in the greater Austin area with physician-
diagnosed MS 
• Meet twice a week on weekdays for 50 minutes of physical activity for 6 months. 
• Be physically inactive, defined as not engaging in regular physical activity - 30 
minutes accumulated each day - on more than 2 days per week during the 
previous 6 months  
• Able to walk independently (may use single-point assistance such as a cane)  
• 6-month time commitment with 3 data collection meetings (base-line, 3-months 
and 6-months). At the three data collection meetings, you will be given four 
cognitive function tests that take about 70 minutes to complete and given a 
questionnaire booklet to complete at home and return by mail in a postage-paid, 
addressed envelope we provide. 
• Wear an accelerometer (a watch-like device that records activity levels) for 7 days 
at baseline, 3-months and 6-months and complete a written log of your activities. 
You will be given instructions on wearing the accelerometer and completing the 
activity log at the first data collection meeting.  
• Confirmation of your MS diagnosis and medical clearance for you to participate 
in a physical activity program signed by your healthcare provider. 
o We will provide forms for you to sign and send to your healthcare 
provider and assist the process while conforming to privacy of health 
information protections (HIPAA). 
• Participants will be assigned by chance (like the flip of a coin) to be in one of two 
groups that receive different activities. 
 
2. Does this sound like a program that you would like to participate in?  
Yes: ____ No: _____ 
 
3. If so, I need to ask you a few more questions in order to establish your eligibility for 
the project: 
• What is your date of birth?  Day_____ Month _____ Year _____  
• What is your age? _________ (Confirm age 21-60) 
• Are you able to read and write in English?  
Yes: ____ No: _____ 
• Are you able to walk independently (about 2 to 3 blocks – with or without using a 
cane)?  
Yes: ____ No: _____ 
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• Have you had an MS exacerbation (MS symptoms lasting more than 24 hours not 
related to an infection) in the past 3 months (90 days)?  
Yes: ____ No: _____ 
• Are you physically inactive? (Defined as not engaging in regular physical activity 
- 30 minutes accumulated each day - on more than 2 days per week during the 
previous 6 months)  
Yes: ____ No: _____  
• Do you have transportation available to attend data collection meetings and the 
physical activity program? 
Yes: ____ No: _____ 
 
4. Administer PAR-Q+ to explore general health status and comorbid medical conditions  
If the participant does not meet any one of the inclusion criteria, thank the participant for 
their interest in the study explaining that they are not eligible for this study. 
Ask them if they would like to be contacted about future research activities?  
Yes: ____ No: _____ 
 
 
For those who meet the above inclusion criteria: 
5. Contact information  
• Phone Numbers:  
• Best number to call (circle below)   Best time to contact: _______ 
Home: ___________________________       
Work:  ___________________________   
Other: ___________________________ 
• Email address: 
_______________________________________________________________ 
• Mailing Address: 
__________________________________________________________________
__________________________________________________________________ 
6. Information about your MS 
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• When were you diagnosed with MS? Date: __________ (want > 6 months)  
• Age when you were diagnosed with MS: ________ 
• Do you know of any medical conditions that you might have that would keep you 
from participating in this physical activity program? (Pregnant or planning 
pregnancy, heart disease, lung disease, psychiatric disease – severe depression) 
Yes: ____ No: _____ 
 
7. Information about your availability 
• What weekdays and time of day are the most convenient for you to meet for the 
physical activity program? 
__________________________________________________________________
__________________________________________________________________ 
• Is there any time/dates that you cannot attend the physical activity program for 
more than a week or two? (Vacations, holidays) 
__________________________________________________________________
__________________________________________________________________ 
 
8. Schedule the IN-PERSON meeting at a location preferred by the subject (e.g., School 
of Nursing, subject’s home, public library).  
• This meeting includes: 
o Discussing any questions you may have about the study  
o Signing the informed consent form 
o Completing the Symbols Digit Modalities Test – a brief (5-minute) test of 
complex scanning and visual tracking. 
o Receiving an accelerometer to wear for 7 days and an activity log 
§ Verbal and written instructions on wearing the accelerometer and 
filling out the activity log. 
o Receiving a questionnaire booklet to take home to complete.  
o Providing you with a postage-paid, addressed envelope to return the 
accelerometer, accelerometer log, and the questionnaire booklet to us. 
o Obtaining your signed permission for us to contact your healthcare 
provider to:  
§ Confirm your MS diagnosis  
§ Sign a medical clearance form for you to participate in a physical 
activity program. 
 
§ Physician’s Name: ______________________________________ 
§ Address: ______________________________________________ 
§ Phone: _______________________________________________ 
§ Fax: _________________________________________________ 
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Scheduled In-person meeting:  
  
Date: ________________________  
Time: _______________________ 
Special Instructions: 
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PAR-Q+ 
The Physical Activity Readiness Questionnaire for Everyone 
 
SECTION 1 – GENERAL HEALTH 
Please answer each question honestly: YES or NO YES NO 
1. Has your doctor ever said that you have a heart condition OR high blood pressure? 
  
2. Do you feel pain in your chest at rest, during your daily activities of living, OR when you do physical activity? 
  
3. 
Do you lose balance because of dizziness OR have you lost 
consciousness in the last 12 months? Please answer NO if your 
dizziness was associated with over-breathing (including during vigorous 
exercise). 
  
4. Have you ever been diagnosed with another chronic medical condition (other than heart disease or high blood pressure)? 
  
5. Are you currently taking prescribed medications for a chronic medical condition? 
  
6. 
Do you have a bone or joint problem that could be made worse by 
becoming more physically active? Please answer NO if you had a joint 
problem in the past, but it does not limit your current ability to be 
physical active. For example, knee, ankle, shoulder or other. 
  
7. Has your doctor ever said that you should only do medically supervised physical activity? 
  
 
ü If the informant answered NO to questions # 1, 2, 3, 5, 6, & 7 and the only chronic medical 
condition in question # 4 is MS, return to phone screen question 4b. 
 
ü If the informant answered YES to ONE or more questions above, GO TO SECTION 2. 
 
SECTION 2 – CHRONIC MEDICAL CONDITIONS 
Please answer each question honestly: YES or NO 
1. Do you have Arthritis, Osteoporosis, or Back Problems? 
YES NO 
If yes, 
answer 
questions 
1a-1c 
If no, go 
to question 
2 
 1a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medications 
or other treatments). 
  
 1b. 
Do you have joint problems causing pain, a recent 
fracture or fracture caused by osteoporosis or cancer, 
displaced vertebra (e.g., spondylolisthesis), and/or 
  
 148 
spondylolysis/pars defect (a crack in the bony ring on 
the back of the spinal column)? 
 1c. Have you had steroid injections or taken steroid tablets regularly for more than 3 months? 
  
2. Do you have Cancer of any kind? 
YES NO 
If yes, 
answer 
questions 
2a-2b 
If no, go 
to question 
3 
 2a. 
Does your cancer diagnosis include any of the following 
types: lung/bronchogenic, multiple myeloma (cancer of 
plasma cells), head, and neck? 
  
 2b. Are you currently receiving cancer therapy (such as chemotherapy or radiotherapy)? 
  
3. 
Do you have Heart Disease or Cardiovascular Disease? 
This includes Coronary Artery Disease, High Blood Pressure, 
Heart Failure, Diagnosed Abnormality of Heart Rhythm 
YES NO 
If yes, 
answer 
questions 
3a-3e 
If no, go 
to question 
4 
 3a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medication 
or other treatments) 
  
 3b. 
Do you have an irregular heartbeat that requires medical 
management? 
(e.g. atrial fibrillation, premature ventricular contraction) 
  
 3c. Do you have chronic heart failure?   
 3d. 
Do you have a resting blood pressure equal to or greater 
than 1560/90 mmHg with or without medication 
(Answer YES if you do not know your resting blood 
pressure) 
  
 3e. 
Do you have diagnosed coronary artery (cardiovascular) 
disease and have not participated in regular physical 
activity in the last 2 months? 
  
4. Do you have any Metabolic Conditions? This includes Type 1 Diabetes, Type 2 Diabetes, Pre-Diabetes 
YES NO 
If yes, 
answer 
questions 
4a-4c 
If no, go 
to question 
5 
 4a. Is your blood sugar often above 13.0 mmol/L (Answer YES if you are not sure) 
  
 4b. 
Do you have any signs or symptoms of diabetes 
complications such as heart or vascular disease and/or 
complications affecting your eyes, kidneys, and the 
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sensation in your toes and feet? 
 4c. 
Do you have other metabolic conditions (such as thyroid 
disorders, pregnancy-related diabetes, chronic kidney 
disease, liver problems)? 
  
5. 
Do you have any Mental Health Problems or Learning 
Difficulties? This includes Alzheimer’s, Dementia, 
Depression, Anxiety Disorder, Eating Disorder, Psychotic 
Disorder, Intellectual Disability, Down Syndrome) 
YES NO 
If yes, 
answer 
questions 
4a-5b 
If no, go 
to question 
6 
 5a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medication 
or other treatments) 
  
 5b. Do you also have back problems affecting nerves or muscles? 
  
6. 
Do you have a Respiratory Disease? 
This includes Chronic Obstructive Pulmonary Disease, 
Asthma, Pulmonary High Blood Pressure 
YES NO 
If yes, 
answer 
questions 
6a-6d 
If no, go 
to question 
7 
 6a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medication 
or other treatments) 
  
 6b. 
Has your doctor ever said your blood oxygen level is 
low at rest or during exercise and/or that you require 
supplemental oxygen therapy? 
  
 6c. 
If asthmatic, do you currently have symptoms of chest 
tightness, wheezing, labored breathing, consistent cough 
(more than 2 days/week), or have you used your rescue 
medication more than twice in the last week? 
  
 6d. Has your doctor ever said you have high blood pressure in your blood vessels of your lungs? 
  
7. Do you have a Spinal Cord Injury? This includes Tetraplegia and Paraplegia 
YES NO 
If yes, 
answer 
questions 
7a-7c 
If no, go 
to question 
8 
 7a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medication 
or other treatments) 
  
 7b. Do you commonly exhibit low resting blood pressure significant enough to cause dizziness, light-headedness, 
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and/or fainting? 
 7c. 
Has your physician indicated that you exhibit sudden 
bouts of high blood pressure (known as Autonomic 
Dysreflexia)? 
  
8. 
Have you had a Stroke? 
This includes Transient Ischemic Attack (TIA) or 
Cerebrovascular Event 
YES NO 
If yes, 
answer 
questions 
8a-8c 
If no, go 
to question 
9 
 8a. 
Do you have difficulty controlling your condition with 
medications or other physician-prescribed therapies? 
(Answer NO if you are not currently taking medication 
or other treatments) 
  
 8b. Do you have any impairment in walking or mobility?   
 8c. Have you experienced a stroke or impairment in nerves or muscles in the past 6 months? 
  
9. Do you have any other medical condition not listed above or do you live with two chronic conditions? 
YES NO 
If yes, 
answer 
questions 
9a-9c 
 
 9a. 
Have you experienced a blackout, fainted, or lost 
consciousness as a result of a head injury within the last 
12 months OR have you had a diagnosed concussion 
within the last 12 months? 
  
 9b. Do you have a medical condition that is not listed (such as epilepsy, neurological conditions, kidney problems)? 
  
 9c. Do you currently live with two chronic conditions?   
 
ü If the informant answered NO to all of the follow-up questions about their medical 
conditions, return to phone screen question 4b. 
 
ü If the informant answered YES to ONE or more of the follow-up questions about their 
medical conditions consider excluding them from participating in the study. 
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Verification of Multiple Sclerosis Diagnosis 
 
 
To the attending physician/neurologist of _______________________________D.O.B.___/___/____ 
 
Your patient has expressed interest in participating in a study examining the effects of physical 
activity on cognitive function in persons with MS. To ensure that we are including individuals with a 
definite diagnosis of MS, we ask for your assistance in documenting the diagnosis. That is, we ask 
that you verify that your patient has multiple sclerosis based on standard diagnostic procedures. 
 
Does your patient have a definite diagnosis of MS? Yes _____    No _____ 
 
What type of MS was diagnosed? _____________________________________________________ 
 
 
Name (print) _____________________________ 
Signature _______________________________ 
Date_____________________________ 
 
Thank you for taking the time to read this summary and provide verification of your patient’s diagnosis 
with MS. In order to expedite our scheduling process, please fax this form to the number listed below, 
and use the provided envelope to return the original for our permanent record. Permission to release 
information to The University of Texas at Austin, School of Nursing can be found at the bottom of the 
page. 
 
1.  Fax to: 2.  Mail to: 
 Janet Morrison RN, MSN 
(512) 471-1571 
 Janet Morrison RN, MSN  
The University of Texas at Austin 
School of Nursing, RM3.420 
1710 Red River St 
Austin, TX 78701-1499    Campus Mail Code: D0100 
 
============================================================================= 
 
By signing this document I give permission to have my physician fax a verification of MS diagnosis for 
participation in the study to Janet Morrison at the School of Nursing at The University of Texas at 
Austin. 
 
Name (print) ___________________________ 
Signature _____________________________ 
Date_________________________________ 
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Physician Approval to Participate in the Physical Activity Program 
 
Dear Doctor: 
Your patient _____________________________________________ wishes to take part in a 
physical activity research study and fitness assessment. The study will involve the following: 
• Type of physical activity: 10-minute dynamic warm-up, 30-minute aerobic exercise (as 
tolerated based on Berg Perceived Exertion Scale < 6), 10-minute cool-down. 
• Frequency: Twice weekly supervised by an RN/Personal Trainer + 30 minutes of 
physical activity, 3/week at home on own.  
• Duration: Six months 
• Intensity: 40 – 60% maximal heart rate  
By completing this form, you are not assuming any responsibility for our exercise and 
assessment program. Please identify any recommendations or restrictions for your patient's 
fitness program below (Physician's Recommendations). 
Patient's Consent and Authorization 
I consent to and authorize __________________________________________ to release to 
__________________________________________, health information concerning my ability 
to participate in a physical activity research program and fitness assessment. I understand this 
consent is revocable except to the extent action has already been taken. Authorization is not 
valid beyond one year from date of signature. Further disclosure or release of my health 
information is prohibited without specific written consent of person to whom it pertains. 
Participant’s signature Date 
Researcher's signature   
Physician's Recommendations 
  
I am not aware of any contraindications to 
participation in the physical activity research 
program. 
  I believe the applicant can participate, but urge caution because: 
  
  The applicant should not engage in the following activities: 
  
  I recommend the applicant not participate in the above physical activity program. 
Physician's signature 
Physician's name (print) 
Date Phone Fax 
Address City State & Zip !
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January 2015 
 
Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
   1 2 3 4 
       
5 6 7 8 9 10 11 
       
12 13 14 15 16 17 18 
       
19 20 21 22 23 24 25 
       
26 27 28 29 30 31  
       
       
       
 
PALMS PHYSICAL 
ACTIVITY LOG 
1. Record the type of activity you did 
Did you go for a walk? Clean house? 
Garden? All types of physical activity 
count! 
2. Record the time in minutes each day 
Write down the number of minutes you 
were physically active each day. 
3. Bring your log to your PALMS session 
We will review your log each week  
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Exercise Self-Efficacy Scale 
 
The items listed below are designed to assess your beliefs in your ability to 
participate in physical activity on a three time per week basis at moderate 
intensities, for 20+ minutes per session in the future. Using the scales listed 
below please indicate how confident you are that you will be able to 
continue to exercise in the future. 
 
For example, if you have complete confidence that you could participate in 
physical activity three times per week at moderate intensity for 20+ minutes 
for the next four months without quitting, you would circle 100%. 
However, if you had no confidence at all that you could participate in 
physical activity for the next four months without quitting, you would circle 
0%. 
 
Please remember to answer honestly and accurately. There are no right or 
wrong answers. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
NOT AT ALL 
CONFIDENT 
MODERATELY 
CONFIDENT HIGHLY CONFIDENT 
1. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT MONTH. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
2. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT TWO MONTHS. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
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Mark your answer by circling a % 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
NOT AT ALL 
CONFIDENT 
MODERATELY 
CONFIDENT HIGHLY CONFIDENT 
3. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT THREE MONTHS. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
4. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT FOUR MONTHS. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
5. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT FIVE MONTHS. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
6. I am able to participate in physical activity three times per week at moderate intensity, 
for 20+ minutes without quitting for the NEXT SIX MONTHS. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
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Godin Leisure-Time Exercise Questionnaire 
 
 
1. During a typical 7-Day period (a week), how many times on the average 
do you do the following kinds of exercise for more than 15 minutes during 
your free time (write on each line the appropriate number).  
 
Times Per 
Week 
a) STRENUOUS EXERCISE  
(HEART BEATS RAPIDLY)       __________  
(e.g., running, jogging, hockey, football, soccer,  
squash, basketball, cross-country skiing, judo,  
roller skating, vigorous swimming,  
vigorous long distance bicycling) 
 
b) MODERATE EXERCISE  
(NOT EXHAUSTING)        __________  
(e.g., fast walking, baseball, tennis, easy bicycling,  
volleyball, badminton, easy swimming, alpine skiing,  
popular and folk dancing)  
 
c) MILD EXERCISE  
(MINIMAL EFFORT)        __________  
(e.g., yoga, archery, fishing from riverbank, bowling,  
horseshoes, golf, snow-mobiling, easy walking)  
 
 
2. During a typical 7-Day period (a week), in your leisure time, how often 
do you engage in any regular activity long enough to work up a sweat 
(heart beats rapidly)?  
 
OFTEN SOMETIMES NEVER/RARELY 
(1)  (2) (3) 
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Center for Epidemiologic Studies Depression Scale (CES-D), 
NIMH 
 
Below is a list of the ways you might have felt or behaved. Please 
tell me how often you have felt this way during the past week. 
 
 During the Past Week 
 Rarely or 
none of the 
time  
(less than 1 
day) 
Some or a 
little of the 
time  
(1-2 days) 
Occasionally 
or a moderate 
amount of 
time  
(3-4 days) 
Most or all of 
the time (5-7 
days) 
1. I was 
bothered by 
things that 
usually don’t 
bother me. 
    
2. I did not 
feel like 
eating; my 
appetite was 
poor. 
    
3. I felt that I 
could not 
shake off the 
blues even 
with help from 
my family or 
friends. 
    
4. I felt I was 
just as good as 
other people. 
    
5. I had trouble 
keeping my 
mind on what I 
was doing. 
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 During the Past Week 
 Rarely or 
none of the 
time  
(less than 1 
day) 
Some or a 
little of the 
time  
(1-2 days) 
Occasionally 
or a moderate 
amount of 
time  
(3-4 days) 
Most or all of 
the time (5-7 
days) 
6. I felt 
depressed. 
 
  
 
7. I felt that 
everything I 
did was an 
effort. 
 
  
 
8. I felt 
hopeful about 
the future.  
  
 
9. I thought 
my life had 
been a failure.  
  
 
10. I felt 
fearful. 
 
  
 
11. My sleep 
was restless. 
 
  
 
12. I was 
happy. 
 
  
 
13. I talked 
less than usual. 
 
  
 
14. I felt 
lonely. 
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 During the Past Week 
 Rarely or 
none of the 
time  
(less than 1 
day) 
Some or a 
little of the 
time  
(1-2 days) 
Occasionally 
or a moderate 
amount of 
time  
(3-4 days) 
Most or all of 
the time (5-7 
days) 
15. People 
were 
unfriendly.  
  
 
16. I enjoyed 
life. 
    
17. I had 
crying spells. 
    
18. I felt sad.     
19. I felt that 
people dislike 
me. 
    
20. I could not 
get “going”. 
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MODIFIED FATIGUE IMPACT SCALE (MFIS) 
 
Following is a list of statements that describe how fatigue may affect a person. Fatigue is 
a feeling of physical tiredness and lack of energy that many people experience from time 
to time. In medical conditions like MS, feelings of fatigue can occur more often and have 
a greater impact than usual. Please read each statement carefully, and then circle the 
one number that best indicates how often fatigue has affected you in this way during the 
past 4 weeks. If you are not sure which answer to select, please choose the one answer 
that comes closet to describing you. 
 
Because of my fatigue during the past 
4 weeks… 
 
  Never Rarely Sometimes Often Almost always 
1. I have been less alert. 0 1 2 3 4 
2. I have had difficulty 
paying attention for long 
periods of time. 
0 1 2 3 4 
3. I have been unable to 
think clearly. 0 1 2 3 4 
4. I have been clumsy and 
uncoordinated. 0 1 2 3 4 
5. I have been forgetful. 0 1 2 3 4 
6. I have had to pace myself 
in my physical activities. 0 1 2 3 4 
7. I have been less 
motivated to do anything 
that requires physical 
effort. 
0 1 2 3 4 
8. I have been less motived 
to participate in social 
activities. 
0 1 2 3 4 
9. I have been limited in my 
ability to do things away 
from home. 
0 1 2 3 4 
10. I have had trouble 0 1 2 3 4 
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Because of my fatigue during the past 
4 weeks… 
 
  Never Rarely Sometimes Often Almost always 
maintaining physical 
effort for long periods. 
11. I have had difficulty 
making decisions. 0 1 2 3 4 
12. I have been less 
motivated to do anything 
that requires thinking. 
0 1 2 3 4 
13. My muscles have felt 
weak. 0 1 2 3 4 
14. I have been physically 
uncomfortable. 0 1 2 3 4 
15. I have had trouble 
finishing tasks that 
require thinking. 
0 1 2 3 4 
16. I have had difficulty 
organizing my thoughts 
when doing things at 
home or work. 
0 1 2 3 4 
17. I have been less able to 
complete tasks that 
require physical effort. 
0 1 2 3 4 
18. My thinking has been 
slowed down. 0 1 2 3 4 
19. I have had trouble 
concentrating. 0 1 2 3 4 
20. I have limited my 
physical activities. 0 1 2 3 4 
21. I have needed to rest 
more often or for longer 
periods. 
0 1 2 3 4 
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CONTROLLED ORAL WORD ASSOCIATION TEST (test at Baseline) 
 
Name:  ______________________________________________  Date: ______________  
 
F  A  S 
 1   1   1 
 2   2   2 
 3   3   3 
 4   4   4 
 5   5   5 
 6   6   6 
 7   7   7 
 8   8   8 
 9   9   9 
10  10  10 
11  11  11 
12  12  12 
13  13  13 
14  14  14 
15  15  15 
16  16  16 
17  17  17 
18  18  18 
19  19  19 
20  20  20 
21  21  21 
22  22  22 
23  23  23 
 
Sum F: ____________ 
  
Sum A: ____________ 
  
Sum S: ____________ 
 
TOTAL: _____________ 
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CONTROLLED ORAL WORD ASSOCIATION TEST (test at T2) 
 
Name:  ______________________________________________  Date: ______________  
 
C  F  L 
 1   1   1 
 2   2   2 
 3   3   3 
 4   4   4 
 5   5   5 
 6   6   6 
 7   7   7 
 8   8   8 
 9   9   9 
10  10  10 
11  11  11 
12  12  12 
13  13  13 
14  14  14 
15  15  15 
16  16  16 
17  17  17 
18  18  18 
19  19  19 
20  20  20 
21  21  21 
22  22  22 
23  23  23 
 
Sum C: ____________ 
  
Sum F: ____________ 
  
Sum L: ____________ 
 
TOTAL: _____________ 
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CONTROLLED ORAL WORD ASSOCIATION TEST (test at T3) 
 
Name:  ______________________________________________  Date: ______________  
 
P  R  W 
 1   1   1 
 2   2   2 
 3   3   3 
 4   4   4 
 5   5   5 
 6   6   6 
 7   7   7 
 8   8   8 
 9   9   9 
10  10  10 
11  11  11 
12  12  12 
13  13  13 
14  14  14 
15  15  15 
16  16  16 
17  17  17 
18  18  18 
19  19  19 
20  20  20 
21  21  21 
22  22  22 
23  23  23 
 
Sum P: ____________ 
  
Sum R: ____________ 
  
Sum W: ____________ 
 
TOTAL: _____________ 
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APPENDIX E: POST-CLASS ASSESSMENTS 
Post-Class Physical Fatigue 
X-Axis : 	Class 	number	
Y-Axis : 	Rating	(0=No	fatigue, 	10=Strongest 	 fat igue	ever 	 fe lt)
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Post-Class Mental Fatigue 
X-Axis : 	Class 	number	
Y-Axis : 	Rating	(0=No	fatigue, 	10=Strongest 	 fat igue	ever 	 fe lt)
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Post-Class Well Being 
X-Axis : 	Class 	number	
Y-Axis : 	Rating	(-5=Very	Bad, 	0=Neutral , 	+5=Very	Good)
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Post-Class Enjoyment 
X-Axis : 	C lass 	number	
Y-Axis : 	Rating	(1=Not	at 	al l , 	7=Very	much)
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APPENDIX F: PHYSICAL ACTIVITY CRITERIA 
	
	 	
Godin	Self-Report	Criteria	(2011).	 	 Canadian	PA	Guidelines	for	Persons	with	MS	
(2013).	
	 USDHHS	PA	Guidelines	for	Adults	(2008).	
	 	 Intervention	 	 Intervention	 	 Intervention	
	 ID	 Baseline	 T2	 T3	 	 Baseline	 T2	 T3	 	 Baseline	 T2	 T3	
	 1	 0	 14	 47	 	 4	 3	 15	 	 4	 3	 15	
	 2	 5	 47	 47	 	 25	 37	 30	 	 25	 37	 30	
	 3	 0	 43	 0	 	 16	 13	 10	 	 16	 13	 10	
	 4	 0	 0	 0	 	 11	 16	 7	 	 11	 16	 7	
	 5	 98	 35	 15	 	 9	 16	 39	 	 9	 16	 39	
	 6	 0	 10	 10	 	 19	 17	 11	 	 19	 17	 11	
	 7	 0	 20	 15	 	 3	 24	 8	 	 3	 24	 8	
	 8	 0	 52	 28	 	 23	 43	 14	 	 23	 43	 14	
Total	 1	 5	 5	 	 6	 7	 6	 	 2	 3	 2	
	 	 Control	 	 Control	 	 Control	
	 ID	 Baseline	 T2	 T3	 	 Baseline	 T2	 T3	 	 Baseline	 T2	 T3	
	 9	 0	 0	 0	 	 21	 24	 43	 	 21	 24	 43	
	 10	 0	 88	 37	 	 4	 8	 3	 	 4	 8	 3	
	 11	 0	 0	 0	 	 8	 8	 8	 	 8	 8	 8	
	 12	 0	 0	 0	 	 6	 11	 11	 	 6	 11	 11	
	 13	 0	 0	 5	 	 6	 5	 3	 	 6	 5	 3	
	 14	 0	 5	 7.5	 	 4	 3	 13	 	 4	 3	 13	
	 15	 0	 0	 5	 	 35	 22	 21	 	 35	 22	 21	
	 16	 0	 15	 28	 	 12	 6	 4	 	 12	 6	 4	
Total	 0	 2	 2	 	 3	 3	 4	 	 1	 2	 1	
	 	 Moderately	active:	14	to	23	units	(7	to	13.9	kcal/kg/week).	
	 Guideline	criteria:	>60	min/week	(8.57	min/day)	MVPA.	 	 Guideline	criteria:	>150	min/week	(21.4	min/day)	MVPA.	
	 	 	 	
	 	
Active:	>	24	units	(~14	kcal/kg/week	or	more).	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	
	 	
Met	Moderately	Active	Criteria	 	 	 Met	MVPA	Criteria	 	 	 Met	MVPA	Criteria	 	
	 	
Met	Active	Criteria	 	 	 	 Sandroff	MVPA	cut-off	(2012)	 	 	 Sandroff	MVPA	cut-off	(2012)	 	
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APPENDIX G: CES-D SCORES 
Center	for	Epidemiological	Studies	Depression	Scale	
(CES-D)	
 	 Intervention	
ID	 Baseline	 T2	 T3	1	 29	 42	 20	2	 24	 15	 11	3	 16	 13	 9	4	 3	 7	 5	5	 17	 18	 13	6	 11	 19	 23	7	 27	 6	 6	8	 27	 16	 3	
 	 Control	
ID	 Baseline	 T2	 T3	9	 6	 7	 8	10	 6	 15	 9	11	 28	 28	 28	12	 15	 19	 16	13	 6	 7	 7	14	 5	 7	 6	15	 7	 4	 14	16	 33	 12	 30		 	 	 		 Scores	<	15	"no	depression"		 Scores	>	16	"elevated	depressive	symptomatology"		 (Radloff,	1977;	Verdier-Taillefer	et	al.,	2001)	
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APPENDIX H: REVIEW OF THE LITERATURE 
Table 1. 
Meta-Analyses Examining the Effect of Physical Activity on Cognition in Older Adults 
Table 2. 
Observational Studies of Physical Activity and Cognition in Persons with MS 
Table 3. 
Pre-experimental Studies of Physical Activity and Cognition in Persons with MS 
Table 4. 
Experimental Studies of Physical Activity and Cognition in Persons with MS 
180 
Table 1. Meta-Analyses Examining the Effect of Physical Activity on Cognition in Older Adults 
Reference Sample RCTs N 
Independent 
Variable 
Dependent 
Variables Effects Conclusions 
Colcombe, 
2003 
Sedentary older adults 
>55 to 80 including 
clinical and non-clinical 
samples 
18 197 Fitness 
training 
• General cognitive
performance
• Executive control
• Controlled
processing
• Visuospatial
tasks
• Speed tasks
• General
cognitive
performance
(ES: 0.478, SE =
0.029, n = 101, p
< .01)
• Executive
processes
(ES: = 0.68, SE
= 0.052, n = 37,
p < .05)
• Controlled tasks
(ES: = 0.461, SE
= 0.035, n = 74,
p < .05)
• Visuospatial
tasks
(ES: = 0.426, SE
= 0.062, n = 23,
p < .05)
• Speed tasks
(ES: = 0.274, SE
= 0.050, n = 32,
p < .05)
• Fitness training was
associated with a significant
improvement in general
cognitive performance
• Executive control benefitted
the most from improved
fitness followed by
controlled, visuospatial, and
speed tasks
Heyn, 2004 Adults > 65 with 
cognitive impairment 
and dementia  
30 2020 Exercise 
training 
• Cognitive
performance
• Cognitive
performance
(ES = 0.57, 95%
CI: 0.43 − 1.17)
• Exercise training is
associated with moderate
effects on cognitive
performance
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Table 1. Meta-Analyses Examining the Effect of Physical Activity on Cognition in Older Adults 
Smith, 
2010 
Non-demented adults > 
18 both healthy and 
with chronic conditions 
(MS, COPD, 
fibromyalgia) 
29 2049 Aerobic 
exercise 
training 
• Neurocognitive
performance
• Attention and
processing speed
(ES = 0.158,
95% CI: 0.055 −
0.260, p = .003)
• Executive
function
(ES = 0.123,
95% CI: 0.021 −
0.225, p = .018)
• Memory
(ES = 0.128,
95% CI: 0.015 −
0.241, p = .026)
• Working
memory
(ES = 0.032,
95% CI: -0.103
− 0.166, p =
.642) 
• Aerobic exercise training has
a modest effect on attention
and processing speed,
executive function, and
memory but null effects on
working memory
Hindin, 
2012 
Healthy, cognitively 
unimpaired adults >55 
17 1016 Aerobic 
exercise 
training 
• Untrained
cognitive tasks
• Untrained
cognitive tasks
(ES: 0.325, 95%
CI: 0.10 − 0.55,
n = 89)
• Aerobic exercise training
produced significant
improvement in untrained
cognitive tasks
(continued)
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Table 1. Meta-Analyses Examining the Effect of Physical Activity on Cognition in Older Adults 
Gates, 
2013 
Adults > 65 with mild 
cognitive impairment 
(MCI) 
14 1695 Exercise 
training 
• Cognitive
function
• Verbal fluency
(ES: 0.17, 95%
CI: 0.04, 0.30)
• Cognitive
flexibility
(ES: 0.13, 95%
CI: -0.01, 0.27)
• Response
inhibition
(ES: 0.12, 95%
CI: -0.07, 0.31)
• Delayed
memory
(ES: -0.01, 95%
CI: -0.16, 0.14)
• Information
processing
(ES: 0.57, 95%
CI: -0.11, 0.42)
• Exercise training had a trivial
but positive significant effect
on verbal fluency but no
significant effects on other
measures of cognition
ES = Effect Size, SE = Standard Error, CI = Confidence Interval, COPD = Chronic obstructive pulmonary disease 
(continued)
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Table 2. Observational Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Measure Cognitive Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Prakash, 
Snook, 
Erickson, et 
al., 2007 
• Cross-
sectional
• N = 24
• 100% female
• Definite
RRMS
• EDSS < 6.0
Cardiorespiratory 
Fitness 
• VO2peak (Cycle)
• Attention
• Memory
• Verbal learning and
fluency
• Delayed recall
• Visuo-spatial learning
• Sustained attention
• Working memory
• Information processing
speed
• K-Bit
• Wisconsin
Card Sorting
Test
• Selective
Reminding
Test
• Spatial
Reminding
Test
• Symbol Digit
Modalities
Test
• Paced
Auditory
Serial
Addition Test
(PASAT)
• Word List
Generation
MRI 
• Paced Visual
Serial 
Addition Test 
(fMRI) 
Significant associations 
between level of 
cardiorespiratory fitness 
and  
- Information processing 
speed, sustained attention 
and working memory 
[PASAT]  
(r = 0.42) 
- Cerebrovascular function 
[fMRI]        
(r = 0.44 to 0.46), 
controlling for age, 
education, and MS duration 
in both  
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Table 2. Observational Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Measure Cognitive Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Prakash, 
Snook, Motl 
& Kramer, 
2010 
• Cross-
sectional
• N = 21
• 100% female
• RRMS
• EDSS < 6.0
Cardiorespiratory 
Fitness  
• VO2peak (Cycle)
• Gray matter volume
• White matter integrity
MRI 
• T1- and T2-
weighted 
images 
• Fractional
anisotropy 
(FA) 
Significant associations 
between cardiorespiratory 
fitness and brain tissue 
preservation while 
controlling for age and 
intracranial volume 
- Lesion load  
(r = -0.44)  
- Gray matter volume  
(r = 0.45) and  
- FA values  
(r = 0.40 to 0.44) 
controlling for age alone 
Prakash, 
Snook, 
Kramer & 
Motl, 2010 
• Cross-
sectional
• N = 82
• 83% female
• RRMS
• EDSS < 7.5
Physical activity 
• Accelerometer
(ActiGraph 
7164) 
• Godin Leisure
Time Exercise 
Questionnaire 
(GLTQ) 
• Attention/concentration
• Retrospective memory
• Prospective memory
• Planning/organization
• Perceived
Deficits
Questionnaire
(PDQ)
Significant inverse 
relationship between 
perceived cognitive 
impairment (PDQ) and 
physical activity after 
removing variance 
associated with EDSS, 
FSS, CESD, MS duration 
and age measured by: 
- Accelerometer 
(r = -0.26) 
- GLTQ  
(r = -0.27) 
(continued)
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Table 2. Observational Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Measure Cognitive Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Motl, 
Gappmaier, et 
al., 2011 
• Cross-
sectional
• N = 33
• 66.7% female
• Definite MS
• Ambulatory
• EDSS < 7.0
Physical activity 
• Accelerometer
(StepWatch - Step 
Activity Monitor) 
• Processing Speed
• Episodic memory
• Learning
• Paced
Auditory
Serial
Addition Test
(PASAT)
• Symbol Digit
Modalities
Test (SDMT)
• Selective
Reminding
Test
• Brief
Visuospatial
Memory Test-
Revised
Physical activity 
significantly associated 
with composite score of 
cognitive processing speed 
(r = 0.35) after removing 
variance associated with 
age, education, gender, and 
MS duration 
(continued)
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Table 2. Observational Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Measure Cognitive Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Prakash, 
Patterson, et 
al., 2011 
• Cross-
sectional
• Post-hoc
• N = 45
• 75.5% female
• Clinically
definite MS
• EDSS < 6.0
Physical activity 
• Accelerometer
(ActiGraph 
GT3X) 
• Relational memory
• Hippocampus
connectivity
• Modified item
and relational
memory task
MRI 
• T2-weighted
images 
Significant association 
between physical activity 
and resting state 
hippocampal connectivity - 
posteromedial cortex:  
Left (r = 0.30)  
Right (r = 0.31) controlling 
for age, gender, education, 
MS duration and gray 
matter volume 
Left hippocampus-
posteromedial cortex 
connectivity was associated 
with relational memory (r = 
0.40, p = .006) in post-hoc 
analysis 
Beier, 
Bombardier, 
Hartoonian, 
Motl, & Kraft, 
2014 
• Longitudinal
• Post-hoc
• N = 88
• 80.5% female
• Clinically
confirmed MS
Physical fitness 
• Bicycle
ergometer 
• Processing speed
• Flexibility
• Calculation ability
• Divided attention
• Working memory
• Executive function
• Paced
Auditory
Serial
Addition Test
• Trail Making
Test (TMT)
Significant time by group 
interaction for group with 
improved physical fitness 
on executive functioning 
(TMT-B, p = .05; TMT-
BA, p = .02) 
CES-D = Center for Epidemiologic Studies Depression Scale; EDSS = Expanded Disability Status Scale; fMRI = Functional Magnetic Resonance 
Imaging; FSS = Fatigue Severity Scale; VO2peak = Peak oxygen consumption 
(continued)
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Table 3. Pre-experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Freeman & 
Allison, 2004 
• One group
pretest/posttest
• N = 10
• 10-week attrition
= not reported
• 80% female
• Confirmed MS
• EDSS < 6.5
• Type - Supervised group
floor exercise, posture &
stretch program
• Intensity – NR
• Time (min) – 60 (30 min
warm-up/cool-down)
• Frequency (times/week) –
1 
• Duration (weeks) - 10
• Fatigue
(cognitive)
• Fatigue Impact
Scale (cognitive
subscale)
No significant changes in 
cognitive function related 
to fatigue 
Roehrs & 
Karst, 2004 
• One group
pretest/posttest
• N = 31
• 12-week attrition
= 39%
• 65% female
• Progressive MS
• EDSS < 8.0
• Type - Supervised group
aquatic exercise program
• Intensity – NR
• Time (min) – 60
• Frequency (times/week) –
2 
• Duration (weeks) - 12
• Attention
• Retrospective
memory
• Prospective
memory
• Planning and
organization
• Perceived Deficits
Questionnaire
No significant change in 
perceived cognitive 
deficits 
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Table 3. Pre-experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive 
Outcome 
Measures 
Main Findings 
Filipi et al., 
2010 
• One group
pretest/posttest
• N = 33
• 24-week attrition
= not reported
• 67% female
• Laboratory
supported MS
• EDSS < 6.5
• Type - Supervised
individual resistance
training
• Intensity – NR
• Time (min) – 50
• Frequency (times/weeks)
– 2
• Duration (weeks) - 24
• Attention
• Memory
• Paced Auditory
Serial Addition
Test
Significant improvement 
in measure of attention 
and memory (p < .01) 
EDSS = Expanded Disability Status Scale; HRQOL = Health Related Quality of Life; RRMS = Relapsing-Remitting Multiple Sclerosis; PPMS = Primary 
Progressive Multiple Sclerosis; SPMS = Secondary Progressive Multiple Sclerosis, NR = not reported 
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Velikonja et 
al., 2010 
• Randomized
prospective
study
• No control
group
• N = 20
• Group n - not
reported
• 10-week
attrition = not
reported
• Gender not
reported
• Relapsing-
remitting or
progressive MS
• EDSS < 6.0
• Type – Supervised
group programs:
1. Sports climbing
2. Hatha yoga
• Intensity – NR
• Time (min) – NR
• Frequency
(times/week) – 1
• Duration (weeks) - 10
• Selective
attention
• Executive
function
• Mazes subtest of
Executive module
from the
Neuropsychological
assessment battery
• Tower of London
Test
• Brickenkamp d2 test
• Modified Fatigue
Impact Scale
(cognitive subscale)
Significant 
improvement on 
selective attention after 
yoga (p = .005) and 
cognitive function (p = 
.024) related to fatigue 
after sports climbing  
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Oken et al., 
2004 
• Randomized
controlled trial
• Wait-list
control group
• N = 57
• 22 yoga/15
aerobic
exercise/20
wait list
24-week 
attrition = 
17% 
• 93% female
• Clinically
definite MS
• EDSS < 6.0
• Type – Supervised
group programs
1. Iyengar yoga
2. Aerobic exercise
(stationary
cycling)
• Intensity
1. Yoga: Poses held
10-30 seconds
then rest for 30-60
seconds
2. Cycling: Light to
moderate (RPE 2-
3)
• Time (min)
1. Yoga: 90
2. Cycling: 90 (10m
warm up/cool
down)
• Frequency
(times/week) – 1 +
home practice
• Duration (weeks) - 24
• Attention
• Alertness
• Mood
• Anxiety
• Fatigue
(mental)
• Stroop Color and
Word Test
• Covert orienting of
spatial attention task
• Attentional shifting
task
• Modified Useful
Field of View task,
• Simple visual
reaction time,
• Paced Auditory
Serial Addition Test,
• Weschler Memory
Scales III Logical
Memory
• Weschler Adult
Intelligence Scale III
Similarities
• Multidimensional
Fatigue Inventory
(mental fatigue
subscale)
No statistical effect on 
cognitive function 
measures in either 
intervention group 
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Romberg et 
al., 2005 
• Randomized
controlled trial
• Control group
received no
intervention
• N = 95
• 47 intervention
/48 control
• 6-month
attrition = 4%
• 64% female
• Clinical or
laboratory
defined MS
• EDSS < 5.5
• Type
Week 1-3  
Supervised group 
inpatient 
rehabilitation 
program: 5 sessions 
resistance training + 5 
sessions aerobic 
exercise 
Week 4-26 
Home program: 
Resistance 
(Theraband®) training 
3-4/week + aerobic 
training 1/week 
• Intensity – NR
• Time (min) – NR
• Frequency
(times/week) –
Week 1-3 – NR 
Week 4-26 – 5 
• Duration (weeks) – 26
• Attention
• Memory
Paced Auditory 
Serial Addition Test 
No significant group x 
time interactions on 
measures of attention 
and memory 
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Kargarfard et 
al., 2012 
• Randomized
controlled trial
• Intention-to-
treat analysis
• Usual activity
control group
• N = 32
• 10
intervention/11
control
• 8-week attrition
= 34%
• 100% female
• Relapsing-
remitting MS
• EDSS < 3.5
• Type - Supervised
group aquatic exercise
program
• Intensity – NR
• Time (min)  - 60 (20
min warm-up/cool-
down)
• Frequency
(times/week) – 3
• Duration (weeks) - 8
• Fatigue -
Cognitive
• Cognitive
function
(HRQOL)
• Modified Fatigue
Impact Scale
(cognitive subscale)
• MS-Health Related
Quality of Life
(cognitive function
subscale)
Significant group x 
time effect on 
cognitive function 
related to fatigue 
(mean difference 
between baseline and 
8-weeks = -1.9 + 0.6, p 
< .05)  
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Briken et al., 
(2013) 
• Randomized
controlled trial
• Wait-list
control group
• Intention-to-
treat analysis
• N = 42
• 10 arm
ergometry/11
rowing/11
bicycle
ergometry/10
control
• 8-10 week
attrition =
10.6% 
• 57% Female
• 73.8% SPMS
• 2.4% PPMS
• EDSS < 6.1
• Type – Individual
exercise training
programs
1. Arm ergometry
2. Rowing
3. Bicycle ergometry
• Intensity – Mean Borg
Scale = 4.6
• Time – NR
• Frequency
(times/week) – 2 to 3
• Duration (weeks) – 8
to 10
• Attention
• Processing
speed
• Long-term
memory
• Executive
function
• Symbol Digit
Modalities Test
• Verbal Learning and
Memory Test
• Test Battery of
Attention
• Achievement Testing
System
• Regensburg Verbal
Fluency Test
• Modified Fatigue
Impact Scale
(cognitive subscale)
Significantly improved 
verbal learning and 
delayed recall (p 
=.011) for all exercise 
groups; tonic alertness 
(p < .001) bicycle 
group; shift of 
attention (p = .026) 
arm and (p = .002) 
bicycle groups 
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Pilutti, 
Dlugonski, 
Sandroff, 
Klaren, & 
Motl, 2014 
• Randomized
controlled trial
• Wait-list
control group
• N = 82
• 37 intervention/
39 control
• 24-week
attrition = 7.3%
• Female =
83.3% 
• RRMS = 79.3
% 
• SPMS = 12.1%
• PPMS = 8.5%
• PDDS 0-2
(mild
disability) =
47.4% 
• Median PDDS
= 3 (moderate) 
• Type - Internet
delivered theory-
based program
promoting physical
activity
• Intensity – NR
• Time (min) – NR
• Frequency
(times/week) – NR
• Duration (weeks) - 24
• Fatigue -
Cognitive
• Modified Fatigue
Impact Scale
(cognitive subscale)
No significant group 
difference on cognitive 
function related to 
fatigue 
(continued)
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Table 4. Experimental Studies of Physical Activity and Cognition in Persons with MS 
Reference Design Participant Characteristics 
Physical Activity 
Characteristics 
Cognitive 
Variables 
Cognitive Outcome 
Measures Main Findings 
Sandroff et 
al., 2014 
• Randomized
controlled trial
• Wait-list
control group
• N = 82
• 37 intervention/
39 control
• 24-week
attrition = 7.3%
• Female =
83.3% 
• RRMS =
78.9% 
• Progressive MS
= 21.1% 
• PDDS 0-2
(mild 
disability) = 
47.4% 
• PDDS 3-6
(moderate 
disability) = 
52.6% 
• Type - Internet
delivered theory-
based program
promoting physical
activity
• Intensity – NR
• Time (min) NR
• Frequency
(times/week) – NR
• Duration (weeks) - 24
• Processing
speed
• Symbol Digit
Modality Test
Significant time x 
condition x disability 
group on processing 
speed for those in the 
intervention group 
with mild disability 
(F1,66 = 5.68, p = 0.02) 
moderate effect size 
(η2p = 0.08) 
EDSS = Expanded Disability Status Scale; HRQOL = Health Related Quality of Life; RRMS = Relapsing-Remitting Multiple Sclerosis; PPMS = 
Primary Progressive Multiple Sclerosis; SPMS = Secondary Progressive Multiple Sclerosis; NR = not reported; RPE = rating of perceived exertion 
(continued)
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